A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer

<!DOCTYPE html> <html lang="en" xmlns:og="http://ogp.me/ns#" xmlns:fb="https://www.facebook.com/2008/fbml"> <head> <meta charset="utf-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"> <meta content="mdpi" name="sso-service" /> <meta content="width=device-width, initial-scale=1.0" name="viewport" /> <title>A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer</title><link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/font-awesome.min.css?eb190a3a77e5e1ee?1732706938"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/jquery.multiselect.css?f56c135cbf4d1483?1732706938"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/chosen.min.css?d7ca5ca9441ef9e1?1732706938"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/main2.css?69b39374e6b554b7?1732706938"> <link rel="mask-icon" href="https://pub.mdpi-res.com/img/mask-icon-128.svg?c1c7eca266cd7013?1732706938" color="#4f5671"> <link rel="apple-touch-icon" sizes="180x180" href="https://pub.mdpi-res.com/icon/apple-touch-icon-180x180.png?1732706938"> <link rel="apple-touch-icon" sizes="152x152" href="https://pub.mdpi-res.com/icon/apple-touch-icon-152x152.png?1732706938"> <link rel="apple-touch-icon" sizes="144x144" href="https://pub.mdpi-res.com/icon/apple-touch-icon-144x144.png?1732706938"> <link rel="apple-touch-icon" sizes="120x120" href="https://pub.mdpi-res.com/icon/apple-touch-icon-120x120.png?1732706938"> <link rel="apple-touch-icon" sizes="114x114" href="https://pub.mdpi-res.com/icon/apple-touch-icon-114x114.png?1732706938"> <link rel="apple-touch-icon" sizes="76x76" href="https://pub.mdpi-res.com/icon/apple-touch-icon-76x76.png?1732706938"> <link rel="apple-touch-icon" sizes="72x72" href="https://pub.mdpi-res.com/icon/apple-touch-icon-72x72.png?1732706938"> <link rel="apple-touch-icon" sizes="57x57" href="https://pub.mdpi-res.com/icon/apple-touch-icon-57x57.png?1732706938"> <link rel="apple-touch-icon" href="https://pub.mdpi-res.com/icon/apple-touch-icon-57x57.png?1732706938"> <link rel="apple-touch-icon-precomposed" href="https://pub.mdpi-res.com/icon/apple-touch-icon-57x57.png?1732706938"> <link rel="manifest" href="/manifest.json"> <meta name="theme-color" content="#ffffff"> <meta name="application-name" content=" "/> <link rel="apple-touch-startup-image" href="https://pub.mdpi-res.com/img/journals/ijms-logo-sq.png?41930e44070e4940"> <link rel="apple-touch-icon" href="https://pub.mdpi-res.com/img/journals/ijms-logo-sq.png?41930e44070e4940"> <meta name="msapplication-TileImage" content="https://pub.mdpi-res.com/img/journals/ijms-logo-sq.png?41930e44070e4940"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/jquery-ui-1.10.4.custom.min.css?80647d88647bf347?1732706938"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/magnific-popup.min.css?04d343e036f8eecd?1732706938"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/xml2html/article-html.css?230b005b39af4260?1732706938"> <style> h2, #abstract .related_suggestion_title { } .batch_articles a { color: #000; } a, .batch_articles .authors a, a:focus, a:hover, a:active, .batch_articles a:focus, .batch_articles a:hover, li.side-menu-li a { } span.label a { color: #fff; } #main-content a.title-link:hover, #main-content a.title-link:focus, #main-content div.generic-item a.title-link:hover, #main-content div.generic-item a.title-link:focus { } #main-content #middle-column .generic-item.article-item a.title-link:hover, #main-content #middle-column .generic-item.article-item a.title-link:focus { } .art-authors a.toEncode { color: #333; font-weight: 700; } #main-content #middle-column ul li::before { } .accordion-navigation.active a.accordion__title, .accordion-navigation.active a.accordion__title::after { } .accordion-navigation li:hover::before, .accordion-navigation li:hover a, .accordion-navigation li:focus a { } .relative-size-container .relative-size-image .relative-size { } .middle-column__help__fixed a:hover i, } input[type="checkbox"]:checked:after { } input[type="checkbox"]:not(:disabled):hover:before { } #main-content .bolded-text { } #main-content .hypothesis-count-container { } #main-content .hypothesis-count-container:before { } .full-size-menu ul li.menu-item .dropdown-wrapper { } .full-size-menu ul li.menu-item > a.open::after { } #title-story .title-story-orbit .orbit-caption { #background: url('/img/design/000000_background.png') !important; background: url('/img/design/ffffff_background.png') !important; color: rgb(51, 51, 51) !important; } #main-content .content__container__orbit { background-color: #000 !important; } #main-content .content__container__journal { color: #fff; } .html-article-menu .row span { } .html-article-menu .row span.active { } .accordion-navigation__journal .side-menu-li.active::before, .accordion-navigation__journal .side-menu-li.active a { color: rgba(64,16,59,0.75) !important; font-weight: 700; } .accordion-navigation__journal .side-menu-li:hover::before , .accordion-navigation__journal .side-menu-li:hover a { color: rgba(64,16,59,0.75) !important; } .side-menu-ul li.active a, .side-menu-ul li.active, .side-menu-ul li.active::before { color: rgba(64,16,59,0.75) !important; } .side-menu-ul li.active a { } .result-selected, .active-result.highlighted, .active-result:hover, .result-selected, .active-result.highlighted, .active-result:focus { } .search-container.search-container__default-scheme { } nav.tab-bar .open-small-search.active:after { } .search-container.search-container__default-scheme .custom-accordion-for-small-screen-link::after { color: #fff; } @media only screen and (max-width: 50em) { #main-content .content__container.journal-info { color: #fff; } #main-content .content__container.journal-info a { color: #fff; } } .button.button--color { } .button.button--color:hover, .button.button--color:focus { } .button.button--color-journal { position: relative; background-color: rgba(64,16,59,0.75); border-color: #fff; color: #fff !important; } .button.button--color-journal:hover::before { content: ''; position: absolute; top: 0; left: 0; height: 100%; width: 100%; background-color: #ffffff; opacity: 0.2; } .button.button--color-journal:visited, .button.button--color-journal:hover, .button.button--color-journal:focus { background-color: rgba(64,16,59,0.75); border-color: #fff; color: #fff !important; } .button.button--color path { } .button.button--color:hover path { fill: #fff; } #main-content #search-refinements .ui-slider-horizontal .ui-slider-range { } .breadcrumb__element:last-of-type a { } #main-header { } #full-size-menu .top-bar, #full-size-menu li.menu-item span.user-email { } .top-bar-section li:not(.has-form) a:not(.button) { } #full-size-menu li.menu-item .dropdown-wrapper li a:hover { } #full-size-menu li.menu-item a:hover, #full-size-menu li.menu.item a:focus, nav.tab-bar a:hover { } #full-size-menu li.menu.item a:active, #full-size-menu li.menu.item a.active { } #full-size-menu li.menu-item a.open-mega-menu.active, #full-size-menu li.menu-item div.mega-menu, a.open-mega-menu.active { } #full-size-menu li.menu-item div.mega-menu li, #full-size-menu li.menu-item div.mega-menu a { border-color: #9a9a9a; } div.type-section h2 { font-size: 20px; line-height: 26px; font-weight: 300; } div.type-section h3 { margin-left: 15px; margin-bottom: 0px; font-weight: 300; } .journal-tabs .tab-title.active a { } </style> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/slick.css?f38b2db10e01b157?1732706938"> <meta name="title" content="A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer"> <meta name="description" content="Circulating tumor cells (CTCs), potential precursors of most epithelial solid tumors, are mainly enriched by epithelial cell adhesion molecule (EpCAM)-dependent technologies. Hence, these approaches may overlook mesenchymal CTCs, considered highly malignant. Our aim was to establish a workflow to enrich and isolate patient-matched EpCAMhigh and EpCAMlow/negative CTCs within the same blood samples, and to investigate the phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) mutational status within single CTCs. We sequentially processed metastatic breast cancer (MBC) blood samples via CellSearch® (EpCAM-based) and via Parsortix™ (size-based) systems. After enrichment, cells captured in Parsortix™ cassettes were stained in situ for nuclei, cytokeratins, EpCAM and CD45. Afterwards, sorted cells were isolated via CellCelector™ micromanipulator and their genomes were amplified. Lastly, PIK3CA mutational status was analyzed by combining an amplicon-based approach with Sanger sequencing. In 54% of patients′ blood samples both EpCAMhigh and EpCAMlow/negative cells were identified and successfully isolated. High genomic integrity was observed in 8% of amplified genomes of EpCAMlow/negative cells vs. 28% of EpCAMhigh cells suggesting an increased apoptosis in the first CTC-subpopulation. Furthermore, PIK3CA hotspot mutations were detected in both EpCAMhigh and EpCAMlow/negative CTCs. Our workflow is suitable for single CTC analysis, permitting—for the first time—assessment of the heterogeneity of PIK3CA mutational status within patient-matched EpCAMhigh and EpCAMlow/negative CTCs." > <link rel="image_src" href="https://pub.mdpi-res.com/img/journals/ijms-logo.png?41930e44070e4940" > <meta name="dc.title" content="A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer"> <meta name="dc.creator" content="Rita Lampignano"> <meta name="dc.creator" content="Liwen Yang"> <meta name="dc.creator" content="Martin H. D. Neumann"> <meta name="dc.creator" content="André Franken"> <meta name="dc.creator" content="Tanja Fehm"> <meta name="dc.creator" content="Dieter Niederacher"> <meta name="dc.creator" content="Hans Neubauer"> <meta name="dc.type" content="Article"> <meta name="dc.source" content="International Journal of Molecular Sciences 2017, Vol. 18, Page 1885"> <meta name="dc.date" content="2017-08-31"> <meta name ="dc.identifier" content="10.3390/ijms18091885"> <meta name="dc.publisher" content="Multidisciplinary Digital Publishing Institute"> <meta name="dc.rights" content="http://creativecommons.org/licenses/by/3.0/"> <meta name="dc.format" content="application/pdf" > <meta name="dc.language" content="en" > <meta name="dc.description" content="Circulating tumor cells (CTCs), potential precursors of most epithelial solid tumors, are mainly enriched by epithelial cell adhesion molecule (EpCAM)-dependent technologies. Hence, these approaches may overlook mesenchymal CTCs, considered highly malignant. Our aim was to establish a workflow to enrich and isolate patient-matched EpCAMhigh and EpCAMlow/negative CTCs within the same blood samples, and to investigate the phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) mutational status within single CTCs. We sequentially processed metastatic breast cancer (MBC) blood samples via CellSearch® (EpCAM-based) and via Parsortix™ (size-based) systems. After enrichment, cells captured in Parsortix™ cassettes were stained in situ for nuclei, cytokeratins, EpCAM and CD45. Afterwards, sorted cells were isolated via CellCelector™ micromanipulator and their genomes were amplified. Lastly, PIK3CA mutational status was analyzed by combining an amplicon-based approach with Sanger sequencing. In 54% of patients′ blood samples both EpCAMhigh and EpCAMlow/negative cells were identified and successfully isolated. High genomic integrity was observed in 8% of amplified genomes of EpCAMlow/negative cells vs. 28% of EpCAMhigh cells suggesting an increased apoptosis in the first CTC-subpopulation. Furthermore, PIK3CA hotspot mutations were detected in both EpCAMhigh and EpCAMlow/negative CTCs. Our workflow is suitable for single CTC analysis, permitting—for the first time—assessment of the heterogeneity of PIK3CA mutational status within patient-matched EpCAMhigh and EpCAMlow/negative CTCs." > <meta name="dc.subject" content="circulating tumor cell" > <meta name="dc.subject" content="epithelial cell adhesion moleculeow/negative" > <meta name="dc.subject" content="CellSearch" > <meta name="dc.subject" content="Parsortix" > <meta name="dc.subject" content="CellCelector" > <meta name="dc.subject" content="phosphatidylinositol 3-kinase catalytic subunit alpha" > <meta name ="prism.issn" content="1422-0067"> <meta name ="prism.publicationName" content="International Journal of Molecular Sciences"> <meta name ="prism.publicationDate" content="2017-08-31"> <meta name ="prism.volume" content="18"> <meta name ="prism.number" content="9"> <meta name ="prism.section" content="Article" > <meta name ="prism.startingPage" content="1885" > <meta name="citation_issn" content="1422-0067"> <meta name="citation_journal_title" content="International Journal of Molecular Sciences"> <meta name="citation_publisher" content="Multidisciplinary Digital Publishing Institute"> <meta name="citation_title" content="A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer"> <meta name="citation_publication_date" content="2017/9"> <meta name="citation_online_date" content="2017/08/31"> <meta name="citation_volume" content="18"> <meta name="citation_issue" content="9"> <meta name="citation_firstpage" content="1885"> <meta name="citation_author" content="Lampignano, Rita"> <meta name="citation_author" content="Yang, Liwen"> <meta name="citation_author" content="Neumann, Martin H. D."> <meta name="citation_author" content="Franken, André"> <meta name="citation_author" content="Fehm, Tanja"> <meta name="citation_author" content="Niederacher, Dieter"> <meta name="citation_author" content="Neubauer, Hans"> <meta name="citation_doi" content="10.3390/ijms18091885"> <meta name="citation_id" content="mdpi-ijms18091885"> <meta name="citation_abstract_html_url" content="https://www.mdpi.com/1422-0067/18/9/1885"> <meta name="citation_pdf_url" content="https://www.mdpi.com/1422-0067/18/9/1885/pdf?version=1504228215"> <link rel="alternate" type="application/pdf" title="PDF Full-Text" href="https://www.mdpi.com/1422-0067/18/9/1885/pdf?version=1504228215"> <meta name="fulltext_pdf" content="https://www.mdpi.com/1422-0067/18/9/1885/pdf?version=1504228215"> <meta name="citation_fulltext_html_url" content="https://www.mdpi.com/1422-0067/18/9/1885/htm"> <link rel="alternate" type="text/html" title="HTML Full-Text" href="https://www.mdpi.com/1422-0067/18/9/1885/htm"> <meta name="fulltext_html" content="https://www.mdpi.com/1422-0067/18/9/1885/htm"> <link rel="alternate" type="text/xml" title="XML Full-Text" href="https://www.mdpi.com/1422-0067/18/9/1885/xml"> <meta name="fulltext_xml" content="https://www.mdpi.com/1422-0067/18/9/1885/xml"> <meta name="citation_xml_url" content="https://www.mdpi.com/1422-0067/18/9/1885/xml"> <meta name="twitter:card" content="summary" /> <meta name="twitter:site" content="@MDPIOpenAccess" /> <meta name="twitter:image" content="https://pub.mdpi-res.com/img/journals/ijms-logo-social.png?41930e44070e4940" /> <meta property="fb:app_id" content="131189377574"/> <meta property="og:site_name" content="MDPI"/> <meta property="og:type" content="article"/> <meta property="og:url" content="https://www.mdpi.com/1422-0067/18/9/1885" /> <meta property="og:title" content="A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer" /> <meta property="og:description" content="Circulating tumor cells (CTCs), potential precursors of most epithelial solid tumors, are mainly enriched by epithelial cell adhesion molecule (EpCAM)-dependent technologies. Hence, these approaches may overlook mesenchymal CTCs, considered highly malignant. Our aim was to establish a workflow to enrich and isolate patient-matched EpCAMhigh and EpCAMlow/negative CTCs within the same blood samples, and to investigate the phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) mutational status within single CTCs. We sequentially processed metastatic breast cancer (MBC) blood samples via CellSearch® (EpCAM-based) and via Parsortix™ (size-based) systems. After enrichment, cells captured in Parsortix™ cassettes were stained in situ for nuclei, cytokeratins, EpCAM and CD45. Afterwards, sorted cells were isolated via CellCelector™ micromanipulator and their genomes were amplified. Lastly, PIK3CA mutational status was analyzed by combining an amplicon-based approach with Sanger sequencing. In 54% of patients′ blood samples both EpCAMhigh and EpCAMlow/negative cells were identified and successfully isolated. High genomic integrity was observed in 8% of amplified genomes of EpCAMlow/negative cells vs. 28% of EpCAMhigh cells suggesting an increased apoptosis in the first CTC-subpopulation. Furthermore, PIK3CA hotspot mutations were detected in both EpCAMhigh and EpCAMlow/negative CTCs. Our workflow is suitable for single CTC analysis, permitting—for the first time—assessment of the heterogeneity of PIK3CA mutational status within patient-matched EpCAMhigh and EpCAMlow/negative CTCs." /> <meta property="og:image" content="https://pub.mdpi-res.com/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-ag-550.jpg?1569523674" /> <link rel="alternate" type="application/rss+xml" title="MDPI Publishing - Latest articles" href="https://www.mdpi.com/rss"> <meta name="google-site-verification" content="PxTlsg7z2S00aHroktQd57fxygEjMiNHydKn3txhvwY"> <meta name="facebook-domain-verification" content="mcoq8dtq6sb2hf7z29j8w515jjoof7" /> <script id="Cookiebot" data-cfasync="false" src="https://consent.cookiebot.com/uc.js" data-cbid="51491ddd-fe7a-4425-ab39-69c78c55829f" type="text/javascript" async></script>  <script type="text/plain" data-cookieconsent="statistics"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WPK7SW5'); </script> <script type="text/plain" data-cookieconsent="statistics"> _linkedin_partner_id = "2846186"; window._linkedin_data_partner_ids = window._linkedin_data_partner_ids || []; window._linkedin_data_partner_ids.push(_linkedin_partner_id); </script><script type="text/javascript"> (function(){var s = document.getElementsByTagName("script")[0]; var b = document.createElement("script"); b.type = "text/javascript";b.async = true; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBefore(b, s);})(); </script> <script type="text/plain" data-cookieconsent="statistics" data-cfasync="false" src="//script.crazyegg.com/pages/scripts/0116/4951.js" async="async" ></script> </head> <body> <div class="direction direction_right" id="small_right" style="border-right-width: 0px; padding:0;"> <i class="fa fa-caret-right fa-2x"></i> </div> <div class="big_direction direction_right" id="big_right" style="border-right-width: 0px;"> <div style="text-align: right;"> Next Article in Journal<br> <div><a href="/1422-0067/18/9/1886">The Role of <em>PALB2</em> in the DNA Damage Response and Cancer Predisposition</a></div> Next Article in Special Issue<br> <div><a href="/1422-0067/18/9/1944">Recent Advances in Experimental Whole Genome Haplotyping Methods</a></div> </div> </div> <div class="direction" id="small_left" style="border-left-width: 0px"> <i class="fa fa-caret-left fa-2x"></i> </div> <div class="big_direction" id="big_left" style="border-left-width: 0px;"> <div> Previous Article in Journal<br> <div><a href="/1422-0067/18/9/1881">Stable Membrane-Association of mRNAs in Etiolated, Greening and Mature Plastids</a></div> Previous Article in Special Issue<br> <div><a href="/1422-0067/18/6/1158">The Instrumentation of a Microfluidic Analyzer Enabling the Characterization of the Specific Membrane Capacitance, Cytoplasm Conductivity, and Instantaneous Young’s Modulus of Single Cells</a></div> </div> </div> <div style="clear: both;"></div> <div id="menuModal" class="reveal-modal reveal-modal-new reveal-modal-menu" aria-hidden="true" data-reveal role="dialog"> <div class="menu-container"> <div class="UI_NavMenu"> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>Journals</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; float: left;"> <a href="/about/journals">Active Journals</a> <a href="/about/journalfinder">Find a Journal</a> <a href="/about/journals/proposal">Journal Proposal</a> <a href="/about/proceedings">Proceedings Series</a> </div> </div> </div> </div> <a href="/topics"> <h2>Topics</h2> </a> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>Information</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; max-width: 200px; float: left;"> <a href="/authors">For Authors</a> <a href="/reviewers">For Reviewers</a> <a href="/editors">For Editors</a> <a href="/librarians">For Librarians</a> <a href="/publishing_services">For Publishers</a> <a href="/societies">For Societies</a> <a href="/conference_organizers">For Conference Organizers</a> </div> <div style="width: 100%; max-width: 250px; float: left;"> <a href="/openaccess">Open Access Policy</a> <a href="/ioap">Institutional Open Access Program</a> <a href="/special_issues_guidelines">Special Issues Guidelines</a> <a href="/editorial_process">Editorial Process</a> <a href="/ethics">Research and Publication Ethics</a> <a href="/apc">Article Processing Charges</a> <a href="/awards">Awards</a> <a href="/testimonials">Testimonials</a> </div> </div> </div> </div> <a href="/authors/english"> <h2>Editing Services</h2> </a> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>Initiatives</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; float: left;"> <a href="https://sciforum.net" target="_blank" rel="noopener noreferrer">Sciforum</a> <a href="https://www.mdpi.com/books" target="_blank" rel="noopener noreferrer">MDPI Books</a> <a href="https://www.preprints.org" target="_blank" rel="noopener noreferrer">Preprints.org</a> <a href="https://www.scilit.net" target="_blank" rel="noopener noreferrer">Scilit</a> <a href="https://sciprofiles.com" target="_blank" rel="noopener noreferrer">SciProfiles</a> <a href="https://encyclopedia.pub" target="_blank" rel="noopener noreferrer">Encyclopedia</a> <a href="https://jams.pub" target="_blank" rel="noopener noreferrer">JAMS</a> <a href="/about/proceedings">Proceedings Series</a> </div> </div> </div> </div> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>About</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; float: left;"> <a href="/about">Overview</a> <a href="/about/contact">Contact</a> <a href="https://careers.mdpi.com" target="_blank" rel="noopener noreferrer">Careers</a> <a href="/about/announcements">News</a> <a href="/about/press">Press</a> <a href="http://blog.mdpi.com/" target="_blank" rel="noopener noreferrer">Blog</a> </div> </div> </div> </div> </div> <div class="menu-container__buttons"> <a class="button UA_SignInUpButton" href="/user/login">Sign In / Sign Up</a> </div> </div> </div> <div id="captchaModal" class="reveal-modal reveal-modal-new reveal-modal-new--small" data-reveal aria-label="Captcha" aria-hidden="true" role="dialog"></div> <div id="actionDisabledModal" class="reveal-modal" data-reveal aria-labelledby="actionDisableModalTitle" aria-hidden="true" role="dialog" style="width: 300px;"> <h2 id="actionDisableModalTitle">Notice</h2> <form action="/email/captcha" method="post" id="emailCaptchaForm"> <div class="row"> <div id="js-action-disabled-modal-text" class="small-12 columns"> </div> <div id="js-action-disabled-modal-submit" class="small-12 columns" style="margin-top: 10px; display: none;"> You can make submissions to other journals <a href="https://susy.mdpi.com/user/manuscripts/upload">here</a>. </div> </div> </form> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div id="rssNotificationModal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="rssNotificationModalTitle" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 id="rssNotificationModalTitle">Notice</h2> <p> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div class="row"> <div class="small-12 columns"> <a class="button button--color js-rss-notification-confirm">Continue</a> <a class="button button--grey" onclick="$(this).closest('.reveal-modal').find('.close-reveal-modal').click(); return false;">Cancel</a> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div id="drop-article-label-openaccess" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to <a href="https://www.mdpi.com/openaccess">https://www.mdpi.com/openaccess</a>. </p> </div> <div id="drop-article-label-feature" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications. </p> <p> Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers. </p> </div> <div id="drop-article-label-choice" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. <div style="margin-top: -10px;"> <div id="drop-article-label-choice-journal-link" style="display: none; margin-top: -10px; padding-top: 10px;"> </div> </div> </p> </div> <div id="drop-article-label-resubmission" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> Original Submission Date Received: <span id="drop-article-label-resubmission-date"></span>. </p> </div> <div id="container"> <noscript> <div id="no-javascript"> You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled. </div> </noscript> <div class="fixed"> <nav class="tab-bar show-for-medium-down"> <div class="row full-width collapse"> <div class="medium-3 small-4 columns"> <a href="/"> <img class="full-size-menu__mdpi-logo" src="https://pub.mdpi-res.com/img/design/mdpi-pub-logo-black-small1.svg?da3a8dcae975a41c?1732706938" style="width: 64px;" title="MDPI Open Access Journals"> </a> </div> <div class="medium-3 small-4 columns right-aligned"> <div class="show-for-medium-down"> <a href="#" style="display: none;"> <i class="material-icons" onclick="$('#menuModal').foundation('reveal', 'close'); return false;">clear</i> </a> <a class="js-toggle-desktop-layout-link" title="Toggle desktop layout" style="display: none;" href="/toggle_desktop_layout_cookie"> <i class="material-icons">zoom_out_map</i> </a> <a href="#" class="js-open-small-search open-small-search"> <i class="material-icons show-for-small only">search</i> </a> <a title="MDPI main page" class="js-open-menu" data-reveal-id="menuModal" href="#"> <i class="material-icons">menu</i> </a> </div> </div> </div> </nav> </div> <section class="main-section"> <header> <div class="full-size-menu show-for-large-up"> <div class="row full-width"> <div class="large-1 columns"> <a href="/"> <img class="full-size-menu__mdpi-logo" src="https://pub.mdpi-res.com/img/design/mdpi-pub-logo-black-small1.svg?da3a8dcae975a41c?1732706938" title="MDPI Open Access Journals"> </a> </div> <div class="large-8 columns text-right UI_NavMenu"> <ul> <li class="menu-item"> <a href="/about/journals" data-dropdown="journals-dropdown" aria-controls="journals-dropdown" aria-expanded="false" data-options="is_hover: true; hover_timeout: 200">Journals</a> <ul id="journals-dropdown" class="f-dropdown dropdown-wrapper dropdown-wrapper__small" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-12 columns"> <ul> <li> <a href="/about/journals"> Active Journals </a> </li> <li> <a href="/about/journalfinder"> Find a Journal </a> </li> <li> <a href="/about/journals/proposal"> Journal Proposal </a> </li> <li> <a href="/about/proceedings"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="menu-item"> <a href="/topics">Topics</a> </li> <li class="menu-item"> <a href="/authors" data-dropdown="information-dropdown" aria-controls="information-dropdown" aria-expanded="false" data-options="is_hover:true; hover_timeout:200">Information</a> <ul id="information-dropdown" class="f-dropdown dropdown-wrapper" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-5 columns right-border"> <ul> <li> <a href="/authors">For Authors</a> </li> <li> <a href="/reviewers">For Reviewers</a> </li> <li> <a href="/editors">For Editors</a> </li> <li> <a href="/librarians">For Librarians</a> </li> <li> <a href="/publishing_services">For Publishers</a> </li> <li> <a href="/societies">For Societies</a> </li> <li> <a href="/conference_organizers">For Conference Organizers</a> </li> </ul> </div> <div class="small-7 columns"> <ul> <li> <a href="/openaccess">Open Access Policy</a> </li> <li> <a href="/ioap">Institutional Open Access Program</a> </li> <li> <a href="/special_issues_guidelines">Special Issues Guidelines</a> </li> <li> <a href="/editorial_process">Editorial Process</a> </li> <li> <a href="/ethics">Research and Publication Ethics</a> </li> <li> <a href="/apc">Article Processing Charges</a> </li> <li> <a href="/awards">Awards</a> </li> <li> <a href="/testimonials">Testimonials</a> </li> </ul> </div> </div> </li> </ul> </li> <li class="menu-item"> <a href="/authors/english">Editing Services</a> </li> <li class="menu-item"> <a href="/about/initiatives" data-dropdown="initiatives-dropdown" aria-controls="initiatives-dropdown" aria-expanded="false" data-options="is_hover: true; hover_timeout: 200">Initiatives</a> <ul id="initiatives-dropdown" class="f-dropdown dropdown-wrapper dropdown-wrapper__small" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-12 columns"> <ul> <li> <a href="https://sciforum.net" target="_blank" rel="noopener noreferrer"> Sciforum </a> </li> <li> <a href="https://www.mdpi.com/books" target="_blank" rel="noopener noreferrer"> MDPI Books </a> </li> <li> <a href="https://www.preprints.org" target="_blank" rel="noopener noreferrer"> Preprints.org </a> </li> <li> <a href="https://www.scilit.net" target="_blank" rel="noopener noreferrer"> Scilit </a> </li> <li> <a href="https://sciprofiles.com" target="_blank" rel="noopener noreferrer"> SciProfiles </a> </li> <li> <a href="https://encyclopedia.pub" target="_blank" rel="noopener noreferrer"> Encyclopedia </a> </li> <li> <a href="https://jams.pub" target="_blank" rel="noopener noreferrer"> JAMS </a> </li> <li> <a href="/about/proceedings"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="menu-item"> <a href="/about" data-dropdown="about-dropdown" aria-controls="about-dropdown" aria-expanded="false" data-options="is_hover: true; hover_timeout: 200">About</a> <ul id="about-dropdown" class="f-dropdown dropdown-wrapper dropdown-wrapper__small" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-12 columns"> <ul> <li> <a href="/about"> Overview </a> </li> <li> <a href="/about/contact"> Contact </a> </li> <li> <a href="https://careers.mdpi.com" target="_blank" rel="noopener noreferrer"> Careers </a> </li> <li> <a href="/about/announcements"> News </a> </li> <li> <a href="/about/press"> Press </a> </li> <li> <a href="http://blog.mdpi.com/" target="_blank" rel="noopener noreferrer"> Blog </a> </li> </ul> </div> </div> </li> </ul> </li> </ul> </div> <div class="large-3 columns text-right full-size-menu__buttons"> <div> <a class="button button--default-inversed UA_SignInUpButton" href="/user/login">Sign In / Sign Up</a> <a class="button button--default js-journal-active-only-link js-journal-active-only-submit-link UC_NavSubmitButton" href=" https://susy.mdpi.com/user/manuscripts/upload?journal=ijms " data-disabledmessage="new submissions are not possible.">Submit</a> </div> </div> </div> </div> <div class="header-divider"> </div> <div class="search-container hide-for-small-down row search-container__homepage-scheme"> <form id="basic_search" style="background-color: inherit !important;" class="large-12 medium-12 columns " action="/search" method="get"> <div class="row search-container__main-elements"> <div class="large-2 medium-2 small-12 columns text-right1 small-only-text-left"> <div class="show-for-medium-up"> <div class="search-input-label"> </div> </div> <span class="search-container__title">Search<span class="hide-for-medium"> for Articles</span><span class="hide-for-small">:</span></span> </div> <div class="custom-accordion-for-small-screen-content"> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Title / Keyword</div> </div> <input type="text" placeholder="Title / Keyword" id="q" tabindex="1" name="q" value="" /> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Author / Affiliation / Email</div> </div> <input type="text" id="authors" placeholder="Author / Affiliation / Email" tabindex="2" name="authors" value="" /> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Journal</div> </div> <select id="journal" tabindex="3" name="journal" class="chosen-select"> <option value="">All Journals</option> <option value="acoustics" > Acoustics </option> <option value="amh" > Acta Microbiologica Hellenica (AMH) </option> <option value="actuators" > Actuators </option> <option value="admsci" > Administrative Sciences </option> <option value="adolescents" > Adolescents </option> <option value="arm" > Advances in Respiratory Medicine (ARM) </option> <option value="aerobiology" > Aerobiology </option> <option value="aerospace" > Aerospace </option> <option value="agriculture" > Agriculture </option> <option value="agriengineering" > AgriEngineering </option> <option value="agrochemicals" > Agrochemicals </option> <option value="agronomy" > Agronomy </option> <option value="ai" > AI </option> <option value="air" > Air </option> <option value="algorithms" > Algorithms </option> <option value="allergies" > Allergies </option> <option value="alloys" > Alloys </option> <option value="analytica" > Analytica </option> <option value="analytics" > Analytics </option> <option value="anatomia" > Anatomia </option> <option value="anesthres" > Anesthesia Research </option> <option value="animals" > Animals </option> <option value="antibiotics" > Antibiotics </option> <option value="antibodies" > Antibodies </option> <option value="antioxidants" > Antioxidants </option> <option value="applbiosci" > Applied Biosciences </option> <option value="applmech" > Applied Mechanics </option> <option value="applmicrobiol" > Applied Microbiology </option> <option value="applnano" > Applied Nano </option> <option value="applsci" > Applied Sciences </option> <option value="asi" > Applied System Innovation (ASI) </option> <option value="appliedchem" > AppliedChem </option> <option value="appliedmath" > AppliedMath </option> <option value="aquacj" > Aquaculture Journal </option> <option value="architecture" > Architecture </option> <option value="arthropoda" > Arthropoda </option> <option value="arts" > Arts </option> <option value="astronomy" > Astronomy </option> <option value="atmosphere" > Atmosphere </option> <option value="atoms" > Atoms </option> <option value="audiolres" > Audiology Research </option> <option value="automation" > Automation </option> <option value="axioms" > Axioms </option> <option value="bacteria" > Bacteria </option> <option value="batteries" > Batteries </option> <option value="behavsci" > Behavioral Sciences </option> <option value="beverages" > Beverages </option> <option value="BDCC" > Big Data and Cognitive Computing (BDCC) </option> <option value="biochem" > BioChem </option> <option value="bioengineering" > Bioengineering </option> <option value="biologics" > Biologics </option> <option value="biology" > Biology </option> <option value="blsf" > Biology and Life Sciences Forum </option> <option value="biomass" > Biomass </option> <option value="biomechanics" > Biomechanics </option> <option value="biomed" > BioMed </option> <option value="biomedicines" > Biomedicines </option> <option value="biomedinformatics" > BioMedInformatics </option> <option value="biomimetics" > Biomimetics </option> <option value="biomolecules" > Biomolecules </option> <option value="biophysica" > Biophysica </option> <option value="biosensors" > Biosensors </option> <option value="biotech" > BioTech </option> <option value="birds" > Birds </option> <option value="blockchains" > Blockchains </option> <option value="brainsci" > Brain Sciences </option> <option value="buildings" > Buildings </option> <option value="businesses" > Businesses </option> <option value="carbon" > C </option> <option value="cancers" > Cancers </option> <option value="cardiogenetics" > Cardiogenetics </option> <option value="catalysts" > Catalysts </option> <option value="cells" > Cells </option> <option value="ceramics" > Ceramics </option> <option value="challenges" > Challenges </option> <option value="ChemEngineering" > ChemEngineering </option> <option value="chemistry" > Chemistry </option> <option value="chemproc" > Chemistry Proceedings </option> <option value="chemosensors" > Chemosensors </option> <option value="children" > Children </option> <option value="chips" > Chips </option> <option value="civileng" > CivilEng </option> <option value="cleantechnol" > Clean Technologies (Clean Technol.) </option> <option value="climate" > Climate </option> <option value="ctn" > Clinical and Translational Neuroscience (CTN) </option> <option value="clinbioenerg" > Clinical Bioenergetics </option> <option value="clinpract" > Clinics and Practice </option> <option value="clockssleep" > Clocks & Sleep </option> <option value="coasts" > Coasts </option> <option value="coatings" > Coatings </option> <option value="colloids" > Colloids and Interfaces </option> <option value="colorants" > Colorants </option> <option value="commodities" > Commodities </option> <option value="complications" > Complications </option> <option value="compounds" > Compounds </option> <option value="computation" > Computation </option> <option value="csmf" > Computer Sciences & Mathematics Forum </option> <option value="computers" > Computers </option> <option value="condensedmatter" > Condensed Matter </option> <option value="conservation" > Conservation </option> <option value="constrmater" > Construction Materials </option> <option value="cmd" > Corrosion and Materials Degradation (CMD) </option> <option value="cosmetics" > Cosmetics </option> <option value="covid" > COVID </option> <option value="crops" > Crops </option> <option value="cryo" > Cryo </option> <option value="cryptography" > Cryptography </option> <option value="crystals" > Crystals </option> <option value="cimb" > Current Issues in Molecular Biology (CIMB) </option> <option value="curroncol" > Current Oncology </option> <option value="dairy" > Dairy </option> <option value="data" > Data </option> <option value="dentistry" > Dentistry Journal </option> <option value="dermato" > Dermato </option> <option value="dermatopathology" > Dermatopathology </option> <option value="designs" > Designs </option> <option value="diabetology" > Diabetology </option> <option value="diagnostics" > Diagnostics </option> <option value="dietetics" > Dietetics </option> <option value="digital" > Digital </option> <option value="disabilities" > Disabilities </option> <option value="diseases" > Diseases </option> <option value="diversity" > Diversity </option> <option value="dna" > DNA </option> <option value="drones" > Drones </option> <option value="ddc" > Drugs and Drug Candidates (DDC) </option> <option value="dynamics" > Dynamics </option> <option value="earth" > Earth </option> <option value="ecologies" > Ecologies </option> <option value="econometrics" > Econometrics </option> <option value="economies" > Economies </option> <option value="education" > Education Sciences </option> <option value="electricity" > Electricity </option> <option value="electrochem" > Electrochem </option> <option value="electronicmat" > Electronic Materials </option> <option value="electronics" > Electronics </option> <option value="ecm" > Emergency Care and Medicine </option> <option value="encyclopedia" > Encyclopedia </option> <option value="endocrines" > Endocrines </option> <option value="energies" > Energies </option> <option value="esa" > Energy Storage and Applications (ESA) </option> <option value="eng" > Eng </option> <option value="engproc" > Engineering Proceedings </option> <option value="entropy" > Entropy </option> <option value="environsciproc" > Environmental Sciences Proceedings </option> <option value="environments" > Environments </option> <option value="epidemiologia" > Epidemiologia </option> <option value="epigenomes" > Epigenomes </option> <option value="ebj" > European Burn Journal (EBJ) </option> <option value="ejihpe" > European Journal of Investigation in Health, Psychology and Education (EJIHPE) </option> <option value="fermentation" > Fermentation </option> <option value="fibers" > Fibers </option> <option value="fintech" > FinTech </option> <option value="fire" > Fire </option> <option value="fishes" > Fishes </option> <option value="fluids" > Fluids </option> <option value="foods" > Foods </option> <option value="forecasting" > Forecasting </option> <option value="forensicsci" > Forensic Sciences </option> <option value="forests" > Forests </option> <option value="fossstud" > Fossil Studies </option> <option value="foundations" > Foundations </option> <option value="fractalfract" > Fractal and Fractional (Fractal Fract) </option> <option value="fuels" > Fuels </option> <option value="future" > Future </option> <option value="futureinternet" > Future Internet </option> <option value="futurepharmacol" > Future Pharmacology </option> <option value="futuretransp" > Future Transportation </option> <option value="galaxies" > Galaxies </option> <option value="games" > Games </option> <option value="gases" > Gases </option> <option value="gastroent" > Gastroenterology Insights </option> <option value="gastrointestdisord" > Gastrointestinal Disorders </option> <option value="gastronomy" > Gastronomy </option> <option value="gels" > Gels </option> <option value="genealogy" > Genealogy </option> <option value="genes" > Genes </option> <option value="geographies" > Geographies </option> <option value="geohazards" > GeoHazards </option> <option value="geomatics" > Geomatics </option> <option value="geometry" > Geometry </option> <option value="geosciences" > Geosciences </option> <option value="geotechnics" > Geotechnics </option> <option value="geriatrics" > Geriatrics </option> <option value="glacies" > Glacies </option> <option value="gucdd" > Gout, Urate, and Crystal Deposition Disease (GUCDD) </option> <option value="grasses" > Grasses </option> <option value="hardware" > Hardware </option> <option value="healthcare" > Healthcare </option> <option value="hearts" > Hearts </option> <option value="hemato" > Hemato </option> <option value="hematolrep" > Hematology Reports </option> <option value="heritage" > Heritage </option> <option value="histories" > Histories </option> <option value="horticulturae" > Horticulturae </option> <option value="hospitals" > Hospitals </option> <option value="humanities" > Humanities </option> <option value="humans" > Humans </option> <option value="hydrobiology" > Hydrobiology </option> <option value="hydrogen" > Hydrogen </option> <option value="hydrology" > Hydrology </option> <option value="hygiene" > Hygiene </option> <option value="immuno" > Immuno </option> <option value="idr" > Infectious Disease Reports </option> <option value="informatics" > Informatics </option> <option value="information" > Information </option> <option value="infrastructures" > Infrastructures </option> <option value="inorganics" > Inorganics </option> <option value="insects" > Insects </option> <option value="instruments" > Instruments </option> <option value="iic" > Intelligent Infrastructure and Construction </option> <option value="ijerph" > International Journal of Environmental Research and Public Health (IJERPH) </option> <option value="ijfs" > International Journal of Financial Studies (IJFS) </option> <option value="ijms" selected='selected'> International Journal of Molecular Sciences (IJMS) </option> <option value="IJNS" > International Journal of Neonatal Screening (IJNS) </option> <option value="ijpb" > International Journal of Plant Biology (IJPB) </option> <option value="ijt" > International Journal of Topology </option> <option value="ijtm" > International Journal of Translational Medicine (IJTM) </option> <option value="ijtpp" > International Journal of Turbomachinery, Propulsion and Power (IJTPP) </option> <option value="ime" > International Medical Education (IME) </option> <option value="inventions" > Inventions </option> <option value="IoT" > IoT </option> <option value="ijgi" > ISPRS International Journal of Geo-Information (IJGI) </option> <option value="J" > J </option> <option value="jal" > Journal of Ageing and Longevity (JAL) </option> <option value="jcdd" > Journal of Cardiovascular Development and Disease (JCDD) </option> <option value="jcto" > Journal of Clinical & Translational Ophthalmology (JCTO) </option> <option value="jcm" > Journal of Clinical Medicine (JCM) </option> <option value="jcs" > Journal of Composites Science (J. Compos. Sci.) </option> <option value="jcp" > Journal of Cybersecurity and Privacy (JCP) </option> <option value="jdad" > Journal of Dementia and Alzheimer's Disease (JDAD) </option> <option value="jdb" > Journal of Developmental Biology (JDB) </option> <option value="jeta" > Journal of Experimental and Theoretical Analyses (JETA) </option> <option value="jfb" > Journal of Functional Biomaterials (JFB) </option> <option value="jfmk" > Journal of Functional Morphology and Kinesiology (JFMK) </option> <option value="jof" > Journal of Fungi (JoF) </option> <option value="jimaging" > Journal of Imaging (J. Imaging) </option> <option value="jintelligence" > Journal of Intelligence (J. Intell.) </option> <option value="jlpea" > Journal of Low Power Electronics and Applications (JLPEA) </option> <option value="jmmp" > Journal of Manufacturing and Materials Processing (JMMP) </option> <option value="jmse" > Journal of Marine Science and Engineering (JMSE) </option> <option value="jmahp" > Journal of Market Access & Health Policy (JMAHP) </option> <option value="jmp" > Journal of Molecular Pathology (JMP) </option> <option value="jnt" > Journal of Nanotheranostics (JNT) </option> <option value="jne" > Journal of Nuclear Engineering (JNE) </option> <option value="ohbm" > Journal of Otorhinolaryngology, Hearing and Balance Medicine (JOHBM) </option> <option value="jop" > Journal of Parks </option> <option value="jpm" > Journal of Personalized Medicine (JPM) </option> <option value="jpbi" > Journal of Pharmaceutical and BioTech Industry (JPBI) </option> <option value="jor" > Journal of Respiration (JoR) </option> <option value="jrfm" > Journal of Risk and Financial Management (JRFM) </option> <option value="jsan" > Journal of Sensor and Actuator Networks (JSAN) </option> <option value="joma" > Journal of the Oman Medical Association (JOMA) </option> <option value="jtaer" > Journal of Theoretical and Applied Electronic Commerce Research (JTAER) </option> <option value="jvd" > Journal of Vascular Diseases (JVD) </option> <option value="jox" > Journal of Xenobiotics (JoX) </option> <option value="jzbg" > Journal of Zoological and Botanical Gardens (JZBG) </option> <option value="journalmedia" > Journalism and Media </option> <option value="kidneydial" > Kidney and Dialysis </option> <option value="kinasesphosphatases" > Kinases and Phosphatases </option> <option value="knowledge" > Knowledge </option> <option value="labmed" > LabMed </option> <option value="laboratories" > Laboratories </option> <option value="land" > Land </option> <option value="languages" > Languages </option> <option value="laws" > Laws </option> <option value="life" > Life </option> <option value="limnolrev" > Limnological Review </option> <option value="lipidology" > Lipidology </option> <option value="liquids" > Liquids </option> <option value="literature" > Literature </option> <option value="livers" > Livers </option> <option value="logics" > Logics </option> <option value="logistics" > Logistics </option> <option value="lubricants" > Lubricants </option> <option value="lymphatics" > Lymphatics </option> <option value="make" > Machine Learning and Knowledge Extraction (MAKE) </option> <option value="machines" > Machines </option> <option value="macromol" > Macromol </option> <option value="magnetism" > Magnetism </option> <option value="magnetochemistry" > Magnetochemistry </option> <option value="marinedrugs" > Marine Drugs </option> <option value="materials" > Materials </option> <option value="materproc" > Materials Proceedings </option> <option value="mca" > Mathematical and Computational Applications (MCA) </option> <option value="mathematics" > Mathematics </option> <option value="medsci" > Medical Sciences </option> <option value="msf" > Medical Sciences Forum </option> <option value="medicina" > Medicina </option> <option value="medicines" > Medicines </option> <option value="membranes" > Membranes </option> <option value="merits" > Merits </option> <option value="metabolites" > Metabolites </option> <option value="metals" > Metals </option> <option value="meteorology" > Meteorology </option> <option value="methane" > Methane </option> <option value="mps" > Methods and Protocols (MPs) </option> <option value="metrics" > Metrics </option> <option value="metrology" > Metrology </option> <option value="micro" > Micro </option> <option value="microbiolres" > Microbiology Research </option> <option value="micromachines" > Micromachines </option> <option value="microorganisms" > Microorganisms </option> <option value="microplastics" > Microplastics </option> <option value="minerals" > Minerals </option> <option value="mining" > Mining </option> <option value="modelling" > Modelling </option> <option value="mmphys" > Modern Mathematical Physics </option> <option value="molbank" > Molbank </option> <option value="molecules" > Molecules </option> <option value="mti" > Multimodal Technologies and Interaction (MTI) </option> <option value="muscles" > Muscles </option> <option value="nanoenergyadv" > Nanoenergy Advances </option> <option value="nanomanufacturing" > Nanomanufacturing </option> <option value="nanomaterials" > Nanomaterials </option> <option value="ndt" > NDT </option> <option value="network" > Network </option> <option value="neuroglia" > Neuroglia </option> <option value="neurolint" > Neurology International </option> <option value="neurosci" > NeuroSci </option> <option value="nitrogen" > Nitrogen </option> <option value="ncrna" > Non-Coding RNA (ncRNA) </option> <option value="nursrep" > Nursing Reports </option> <option value="nutraceuticals" > Nutraceuticals </option> <option value="nutrients" > Nutrients </option> <option value="obesities" > Obesities </option> <option value="oceans" > Oceans </option> <option value="onco" > Onco </option> <option value="optics" > Optics </option> <option value="oral" > Oral </option> <option value="organics" > Organics </option> <option value="organoids" > Organoids </option> <option value="osteology" > Osteology </option> <option value="oxygen" > Oxygen </option> <option value="parasitologia" > Parasitologia </option> <option value="particles" > Particles </option> <option value="pathogens" > Pathogens </option> <option value="pathophysiology" > Pathophysiology </option> <option value="pediatrrep" > Pediatric Reports </option> <option value="pets" > Pets </option> <option value="pharmaceuticals" > Pharmaceuticals </option> <option value="pharmaceutics" > Pharmaceutics </option> <option value="pharmacoepidemiology" > Pharmacoepidemiology </option> <option value="pharmacy" > Pharmacy </option> <option value="philosophies" > Philosophies </option> <option value="photochem" > Photochem </option> <option value="photonics" > Photonics </option> <option value="phycology" > Phycology </option> <option value="physchem" > Physchem </option> <option value="psf" > Physical Sciences Forum </option> <option value="physics" > Physics </option> <option value="physiologia" > Physiologia </option> <option value="plants" > Plants </option> <option value="plasma" > Plasma </option> <option value="platforms" > Platforms </option> <option value="pollutants" > Pollutants </option> <option value="polymers" > Polymers </option> <option value="polysaccharides" > Polysaccharides </option> <option value="populations" > Populations </option> <option value="poultry" > Poultry </option> <option value="powders" > Powders </option> <option value="proceedings" > Proceedings </option> <option value="processes" > Processes </option> <option value="prosthesis" > Prosthesis </option> <option value="proteomes" > Proteomes </option> <option value="psychiatryint" > Psychiatry International </option> <option value="psychoactives" > Psychoactives </option> <option value="psycholint" > Psychology International </option> <option value="publications" > Publications </option> <option value="qubs" > Quantum Beam Science (QuBS) </option> <option value="quantumrep" > Quantum Reports </option> <option value="quaternary" > Quaternary </option> <option value="radiation" > Radiation </option> <option value="reactions" > Reactions </option> <option value="realestate" > Real Estate </option> <option value="receptors" > Receptors </option> <option value="recycling" > Recycling </option> <option value="rsee" > Regional Science and Environmental Economics (RSEE) </option> <option value="religions" > Religions </option> <option value="remotesensing" > Remote Sensing </option> <option value="reports" > Reports </option> <option value="reprodmed" > Reproductive Medicine (Reprod. Med.) </option> <option value="resources" > Resources </option> <option value="rheumato" > Rheumato </option> <option value="risks" > Risks </option> <option value="robotics" > Robotics </option> <option value="ruminants" > Ruminants </option> <option value="safety" > Safety </option> <option value="sci" > Sci </option> <option value="scipharm" > Scientia Pharmaceutica (Sci. Pharm.) </option> <option value="sclerosis" > Sclerosis </option> <option value="seeds" > Seeds </option> <option value="sensors" > Sensors </option> <option value="separations" > Separations </option> <option value="sexes" > Sexes </option> <option value="signals" > Signals </option> <option value="sinusitis" > Sinusitis </option> <option value="smartcities" > Smart Cities </option> <option value="socsci" > Social Sciences </option> <option value="siuj" > Société Internationale d’Urologie Journal (SIUJ) </option> <option value="societies" > Societies </option> <option value="software" > Software </option> <option value="soilsystems" > Soil Systems </option> <option value="solar" > Solar </option> <option value="solids" > Solids </option> <option value="spectroscj" > Spectroscopy Journal </option> <option value="sports" > Sports </option> <option value="standards" > Standards </option> <option value="stats" > Stats </option> <option value="stresses" > Stresses </option> <option value="surfaces" > Surfaces </option> <option value="surgeries" > Surgeries </option> <option value="std" > Surgical Techniques Development </option> <option value="sustainability" > Sustainability </option> <option value="suschem" > Sustainable Chemistry </option> <option value="symmetry" > Symmetry </option> <option value="synbio" > SynBio </option> <option value="systems" > Systems </option> <option value="targets" > Targets </option> <option value="taxonomy" > Taxonomy </option> <option value="technologies" > Technologies </option> <option value="telecom" > Telecom </option> <option value="textiles" > Textiles </option> <option value="thalassrep" > Thalassemia Reports </option> <option value="therapeutics" > Therapeutics </option> <option value="thermo" > Thermo </option> <option value="timespace" > Time and Space </option> <option value="tomography" > Tomography </option> <option value="tourismhosp" > Tourism and Hospitality </option> <option value="toxics" > Toxics </option> <option value="toxins" > Toxins </option> <option value="transplantology" > Transplantology </option> <option value="traumacare" > Trauma Care </option> <option value="higheredu" > Trends in Higher Education </option> <option value="tropicalmed" > Tropical Medicine and Infectious Disease (TropicalMed) </option> <option value="universe" > Universe </option> <option value="urbansci" > Urban Science </option> <option value="uro" > Uro </option> <option value="vaccines" > Vaccines </option> <option value="vehicles" > Vehicles </option> <option value="venereology" > Venereology </option> <option value="vetsci" > Veterinary Sciences </option> <option value="vibration" > Vibration </option> <option value="virtualworlds" > Virtual Worlds </option> <option value="viruses" > Viruses </option> <option value="vision" > Vision </option> <option value="waste" > Waste </option> <option value="water" > Water </option> <option value="wild" > Wild </option> <option value="wind" > Wind </option> <option value="women" > Women </option> <option value="world" > World </option> <option value="wevj" > World Electric Vehicle Journal (WEVJ) </option> <option value="youth" > Youth </option> <option value="zoonoticdis" > Zoonotic Diseases </option> </select> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Article Type</div> </div> <select id="article_type" tabindex="4" name="article_type" class="chosen-select"> <option value="">All Article Types</option> <option value="research-article">Article</option> <option value="review-article">Review</option> <option value="rapid-communication">Communication</option> <option value="editorial">Editorial</option> <option value="abstract">Abstract</option> <option value="book-review">Book Review</option> <option value="brief-communication">Brief Communication</option> <option value="brief-report">Brief Report</option> <option value="case-report">Case Report</option> <option value="clinicopathological-challenge">Clinicopathological Challenge</option> <option value="article-commentary">Comment</option> <option value="commentary">Commentary</option> <option value="concept-paper">Concept Paper</option> <option value="conference-report">Conference Report</option> <option value="correction">Correction</option> <option value="creative">Creative</option> <option value="data-descriptor">Data Descriptor</option> <option value="discussion">Discussion</option> <option value="Entry">Entry</option> <option value="essay">Essay</option> <option value="expression-of-concern">Expression of Concern</option> <option value="extended-abstract">Extended Abstract</option> <option value="field-guide">Field Guide</option> <option value="guidelines">Guidelines</option> <option value="hypothesis">Hypothesis</option> <option value="interesting-image">Interesting Images</option> <option value="letter">Letter</option> <option value="books-received">New Book Received</option> <option value="obituary">Obituary</option> <option value="opinion">Opinion</option> <option value="perspective">Perspective</option> <option value="proceedings">Proceeding Paper</option> <option value="project-report">Project Report</option> <option value="protocol">Protocol</option> <option value="registered-report">Registered Report</option> <option value="reply">Reply</option> <option value="retraction">Retraction</option> <option value="note">Short Note</option> <option value="study-protocol">Study Protocol</option> <option value="systematic_review">Systematic Review</option> <option value="technical-note">Technical Note</option> <option value="tutorial">Tutorial</option> <option value="viewpoint">Viewpoint</option> </select> </div> <div class="large-1 medium-1 small-6 end columns small-push-6 medium-reset-order large-reset-order js-search-collapsed-button-container"> <div class="search-input-label"> </div> <input type="submit" id="search" value="Search" class="button button--dark button--full-width searchButton1 US_SearchButton" tabindex="12"> </div> <div class="large-1 medium-1 small-6 end columns large-text-left small-only-text-center small-pull-6 medium-reset-order large-reset-order js-search-collapsed-link-container"> <div class="search-input-label"> </div> <a class="main-search-clear search-container__link" href="#" onclick="openAdvanced(''); return false;">Advanced<span class="show-for-small-only"> Search</span></a> </div> </div> </div> <div class="search-container__advanced" style="margin-top: 0; padding-top: 0px; background-color: inherit; color: inherit;"> <div class="row"> <div class="large-2 medium-2 columns show-for-medium-up"> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Section</div> </div> <select id="section" tabindex="5" name="section" class="chosen-select"> <option value=""></option> </select> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Special Issue</div> </div> <select id="special_issue" tabindex="6" name="special_issue" class="chosen-select"> <option value=""></option> </select> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Volume</div> <input type="text" id="volume" tabindex="7" name="volume" placeholder="..." value="18" /> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Issue</div> <input type="text" id="issue" tabindex="8" name="issue" placeholder="..." value="9" /> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Number</div> <input type="text" id="number" tabindex="9" name="number" placeholder="..." value="" /> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Page</div> <input type="text" id="page" tabindex="10" name="page" placeholder="..." value="" /> </div> <div class="large-1 medium-1 small-6 columns small-push-6 medium-reset order large-reset-order medium-reset-order js-search-expanded-button-container"></div> <div class="large-1 medium-1 small-6 columns large-text-left small-only-text-center small-pull-6 medium-reset-order large-reset-order js-search-expanded-link-container"></div> </div> </div> </form> <form id="advanced-search" class="large-12 medium-12 columns"> <div class="search-container__advanced"> <div id="advanced-search-template" class="row advanced-search-row"> <div class="large-2 medium-2 small-12 columns show-for-medium-up"> </div> <div class="large-2 medium-2 small-3 columns connector-div"> <div class="search-input-label"><span class="show-for-medium-up">Logical Operator</span><span class="show-for-small">Operator</span></div> <select class="connector"> <option value="and">AND</option> <option value="or">OR</option> </select> </div> <div class="large-3 medium-3 small-6 columns search-text-div"> <div class="search-input-label">Search Text</div> <input type="text" class="search-text" placeholder="Search text"> </div> <div class="large-2 medium-2 small-6 large-offset-0 medium-offset-0 small-offset-3 columns search-field-div"> <div class="search-input-label">Search Type</div> <select class="search-field"> <option value="all">All fields</option> <option value="title">Title</option> <option value="abstract">Abstract</option> <option value="keywords">Keywords</option> <option value="authors">Authors</option> <option value="affiliations">Affiliations</option> <option value="doi">Doi</option> <option value="full_text">Full Text</option> <option value="references">References</option> </select> </div> <div class="large-1 medium-1 small-3 columns"> <div class="search-input-label"> </div> <div class="search-action-div"> <div class="search-plus"> <i class="material-icons">add_circle_outline</i> </div> </div> <div class="search-action-div"> <div class="search-minus"> <i class="material-icons">remove_circle_outline</i> </div> </div> </div> <div class="large-1 medium-1 small-6 large-offset-0 medium-offset-0 small-offset-3 end columns"> <div class="search-input-label"> </div> <input class="advanced-search-button button button--dark search-submit" type="submit" value="Search"> </div> <div class="large-1 medium-1 small-6 end columns show-for-medium-up"></div> </div> </div> </form> </div> <div class="header-divider"> </div> <div class="breadcrumb row full-row"> <div class="breadcrumb__element"> <a href="/about/journals">Journals</a> </div> <div class="breadcrumb__element"> <a href="/journal/ijms">IJMS</a> </div> <div class="breadcrumb__element"> <a href="/1422-0067/18">Volume 18</a> </div> <div class="breadcrumb__element"> <a href="/1422-0067/18/9">Issue 9</a> </div> <div class="breadcrumb__element"> <a href="#">10.3390/ijms18091885</a> </div> </div> </header> <div id="main-content" class=""> <div class="row full-width row-fixed-left-column"> <div id="left-column" class="content__column large-3 medium-3 small-12 columns"> <div class="content__container"> <a href="/journal/ijms"> <img src="https://pub.mdpi-res.com/img/journals/ijms-logo.png?41930e44070e4940" alt="ijms-logo" title="International Journal of Molecular Sciences" style="max-height: 60px; margin: 0 0 0 0;"> </a> <div class="generic-item no-border"> <a class="button button--color button--full-width js-journal-active-only-link js-journal-active-only-submit-link UC_ArticleSubmitButton" href="https://susy.mdpi.com/user/manuscripts/upload?form%5Bjournal_id%5D%3D2" data-disabledmessage="creating new submissions is not possible."> Submit to this Journal </a> <a class="button button--color button--full-width js-journal-active-only-link UC_ArticleReviewButton" href="https://susy.mdpi.com/volunteer/journals/review" data-disabledmessage="volunteering as journal reviewer is not possible."> Review for this Journal </a> <a class="button button--color-inversed button--color-journal button--full-width js-journal-active-only-link UC_ArticleEditIssueButton" href="/journalproposal/sendproposalspecialissue/ijms" data-path="/1422-0067/18/9/1885" data-disabledmessage="proposing new special issue is not possible."> Propose a Special Issue </a> </div> <div class="generic-item link-article-menu show-for-small"> <a href="#" class="link-article-menu show-for-small"> <span class="closed">►</span> <span class="open" style="display: none;">▼</span> Article Menu </a> </div> <div class="hide-small-down-initially UI_ArticleMenu"> <div class="generic-item"> <h2>Article Menu</h2> </div> <ul class="accordion accordion__menu" data-accordion data-options="multi_expand:true;toggleable: true"> <li class="accordion-direct-link"> <a href="/1422-0067/18/9/1885/scifeed_display" data-reveal-id="scifeed-modal" data-reveal-ajax="true">Subscribe SciFeed</a> </li> <li class="accordion-direct-link js-article-similarity-container" style="display: none"> <a href="#" class="js-similarity-related-articles">Recommended Articles</a> </li> <li class="accordion-navigation"> <a href="#related" class="accordion__title">Related Info Links</a> <div id="related" class="content UI_ArticleMenu_RelatedLinks"> <ul> <li class="li-link"> <a href="http://www.ncbi.nlm.nih.gov/sites/entrez/28858218" target="_blank" rel="noopener noreferrer">PubMed/Medline</a> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=A%20Novel%20Workflow%20to%20Enrich%20and%20Isolate%20Patient-Matched%20EpCAMhigh%20and%20EpCAMlow%2Fnegative%20CTCs%20Enables%20the%20Comparative%20Characterization%20of%20the%20PIK3CA%20Status%20in%20Metastatic%20Breast%20Cancer" target="_blank" rel="noopener noreferrer">Google Scholar</a> </li> </ul> </div> </li> <li class="accordion-navigation"> <a href="#authors" class="accordion__title">More by Authors Links</a> <div id="authors" class="content UI_ArticleMenu_AuthorsLinks"> <ul class="side-menu-ul"> <li> <a class="expand" onclick='$(this).closest("li").next("div").toggle(); return false;'>on DOAJ</a> </li> <div id="AuthorDOAJExpand" style="display:none;"> <ul class="submenu"> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Rita%20Lampignano%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Lampignano, R.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Liwen%20Yang%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Yang, L.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Martin%20H.%20D.%20Neumann%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Neumann, M. H. D.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Andr%C3%A9%20Franken%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Franken, A.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Tanja%20Fehm%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Fehm, T.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Dieter%20Niederacher%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Niederacher, D.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Hans%20Neubauer%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Neubauer, H.</a> <li> </li> </ul> </div> <li> <a class="expand" onclick='$(this).closest("li").next("div").toggle(); return false;'>on Google Scholar</a> </li> <div id="AuthorGoogleExpand" style="display:none;"> <ul class="submenu"> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Rita%20Lampignano" target="_blank" rel="noopener noreferrer">Lampignano, R.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Liwen%20Yang" target="_blank" rel="noopener noreferrer">Yang, L.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Martin%20H.%20D.%20Neumann" target="_blank" rel="noopener noreferrer">Neumann, M. H. D.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Andr%C3%A9%20Franken" target="_blank" rel="noopener noreferrer">Franken, A.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Tanja%20Fehm" target="_blank" rel="noopener noreferrer">Fehm, T.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Dieter%20Niederacher" target="_blank" rel="noopener noreferrer">Niederacher, D.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Hans%20Neubauer" target="_blank" rel="noopener noreferrer">Neubauer, H.</a> <li> </li> </ul> </div> <li> <a class="expand" onclick='$(this).closest("li").next("div").toggle(); return false;'>on PubMed</a> </li> <div id="AuthorPubMedExpand" style="display:none;"> <ul class="submenu"> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Rita%20Lampignano" target="_blank" rel="noopener noreferrer">Lampignano, R.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Liwen%20Yang" target="_blank" rel="noopener noreferrer">Yang, L.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Martin%20H.%20D.%20Neumann" target="_blank" rel="noopener noreferrer">Neumann, M. H. D.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Andr%C3%A9%20Franken" target="_blank" rel="noopener noreferrer">Franken, A.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Tanja%20Fehm" target="_blank" rel="noopener noreferrer">Fehm, T.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Dieter%20Niederacher" target="_blank" rel="noopener noreferrer">Niederacher, D.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Hans%20Neubauer" target="_blank" rel="noopener noreferrer">Neubauer, H.</a> <li> </li> </ul> </div> </ul> </div> </li> </ul> <span style="display:none" id="scifeed_hidden_flag"></span> <span style="display:none" id="scifeed_subscribe_url">/ajax/scifeed/subscribe</span> </div> </div> <div class="content__container responsive-moving-container large medium active hidden" data-id="article-counters"> <div id="counts-wrapper" class="row generic-item no-border" data-equalizer> <div id="js-counts-wrapper__views" class="small-12 hide columns count-div-container"> <a href="#metrics" > <div class="count-div" data-equalizer-watch> <span class="name">Article Views</span> <span class="count view-number"></span> </div> </a> </div> <div id="js-counts-wrapper__citations" class="small-12 columns hide count-div-container"> <a href="#metrics" > <div class="count-div" data-equalizer-watch> <span class="name">Citations</span> <span class="count citations-number Var_ArticleMaxCitations">-</span> </div> </a> </div> </div> </div> <div class="content__container"> <div class="hide-small-down-initially"> <ul class="accordion accordion__menu" data-accordion data-options="multi_expand:true;toggleable: true"> <li class="accordion-navigation"> <a href="#table_of_contents" class="accordion__title">Table of Contents</a> <div id="table_of_contents" class="content active"> <div class="menu-caption" id="html-quick-links-title"></div> </div> </li> </ul> </div> </div>  <div id="pbgrd-sky"></div> <script src="https://cdn.pbgrd.com/core-mdpi.js"></script> <style>.content__container { min-width: 300px; }</style>  </div> <div id="middle-column" class="content__column large-9 medium-9 small-12 columns end middle-bordered"> <div class="middle-column__help"> <div class="middle-column__help__fixed show-for-medium-up"> <span id="js-altmetrics-donut" href="#" target="_blank" rel="noopener noreferrer" style="display: none;"> <span data-badge-type='donut' class='altmetric-embed' data-doi='10.3390/ijms18091885'></span> <span>Altmetric</span> </span> <a href="#" class="UA_ShareButton" data-reveal-id="main-share-modal" title="Share"> <i class="material-icons">share</i> <span>Share</span> </a> <a href="#" data-reveal-id="main-help-modal" title="Help"> <i class="material-icons">announcement</i> <span>Help</span> </a> <a href="javascript:void(0);" data-reveal-id="cite-modal" data-counterslink = "https://www.mdpi.com/1422-0067/18/9/1885/cite" > <i class="material-icons">format_quote</i> <span>Cite</span> </a> <a href="https://sciprofiles.com/discussion-groups/public/10.3390/ijms18091885?utm_source=mpdi.com&utm_medium=publication&utm_campaign=discuss_in_sciprofiles" target="_blank" rel="noopener noreferrer" title="Discuss in Sciprofiles"> <i class="material-icons">question_answer</i> <span>Discuss in SciProfiles</span> </a> <a href="#" class="" data-hypothesis-trigger-endorses-tab title="Endorse"> <i data-hypothesis-endorse-trigger class="material-icons" >thumb_up</i> <div data-hypothesis-endorsement-count data-hypothesis-trigger-endorses-tab class="hypothesis-count-container"> ... </div> <span>Endorse</span> </a> <a href="#" data-hypothesis-trigger class="js-hypothesis-open UI_ArticleAnnotationsButton" title="Comment"> <i class="material-icons">textsms</i> <div data-hypothesis-annotation-count class="hypothesis-count-container"> ... </div> <span>Comment</span> </a> </div> <div id="main-help-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 style="margin: 0;">Need Help?</h2> </div> <div class="small-6 columns"> <h3>Support</h3> <p> Find support for a specific problem in the support section of our website. </p> <a target="_blank" href="/about/contactform" class="button button--color button--full-width"> Get Support </a> </div> <div class="small-6 columns"> <h3>Feedback</h3> <p> Please let us know what you think of our products and services. </p> <a target="_blank" href="/feedback/send" class="button button--color button--full-width"> Give Feedback </a> </div> <div class="small-6 columns end"> <h3>Information</h3> <p> Visit our dedicated information section to learn more about MDPI. </p> <a target="_blank" href="/authors" class="button button--color button--full-width"> Get Information </a> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> </div> <div class="middle-column__main "> <div class="page-highlight"> <style type="text/css"> img.review-status { width: 30px; } </style> <div id="jmolModal" class="reveal-modal" data-reveal aria-labelledby="Captcha" aria-hidden="true" role="dialog"> <h2>JSmol Viewer</h2> <div class="row"> <div class="small-12 columns text-center"> <iframe style="width: 520px; height: 520px;" frameborder="0" id="jsmol-content"></iframe> <div class="content"></div> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div itemscope itemtype="http://schema.org/ScholarlyArticle" id="abstract" class="abstract_div"> <div class="js-check-update-container"></div> <div class="html-content__container content__container content__container__combined-for-large__first" style="overflow: auto; position: inherit;"> <div class='html-profile-nav'> <div class='top-bar'> <div class='nav-sidebar-btn show-for-large-up' data-status='opened' > <i class='material-icons'>first_page</i> </div> <a id="js-button-download" class="button button--color-inversed" style="display: none;" href="/1422-0067/18/9/1885/pdf?version=1504228215" data-name="A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer" data-journal="ijms"> <i class="material-icons custom-download"></i> Download PDF </a> <div class='nav-btn'> <i class='material-icons'>settings</i> </div> <a href="/1422-0067/18/9/1885/reprints" id="js-button-reprints" class="button button--color-inversed"> Order Article Reprints </a> </div> <div class='html-article-menu'> <div class='html-first-step row'> <div class='html-font-family large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns'> Font Type: </div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option"><i style='font-family:Arial, Arial, Helvetica, sans-serif;' data-fontfamily='Arial, Arial, Helvetica, sans-serif'>Arial</i></span> <span class="html-article-menu-option"><i style='font-family:Georgia1, Georgia, serif;' data-fontfamily='Georgia1, Georgia, serif'>Georgia</i></span> <span class="html-article-menu-option"><i style='font-family:Verdana, Verdana, Geneva, sans-serif;' data-fontfamily='Verdana, Verdana, Geneva, sans-serif' >Verdana</i></span> </div> </div> </div> <div class='html-font-resize large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns'>Font Size:</div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option a1" data-percent="100">Aa</span> <span class="html-article-menu-option a2" data-percent="120">Aa</span> <span class="html-article-menu-option a3" data-percent="160">Aa</span> </div> </div> </div> </div> <div class='row'> <div class='html-line-space large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns' >Line Spacing:</div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option a1" data-line-height="1.5em"> <i class="fa"></i> </span> <span class="html-article-menu-option a2" data-line-height="1.8em"> <i class="fa"></i> </span> <span class="html-article-menu-option a3" data-line-height="2.1em"> <i class="fa"></i> </span> </div> </div> </div> <div class='html-column-width large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns' >Column Width:</div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option a1" data-column-width="20%"> <i class="fa"></i> </span> <span class="html-article-menu-option a2" data-column-width="10%"> <i class="fa"></i> </span> <span class="html-article-menu-option a3" data-column-width="0%"> <i class="fa"></i> </span> </div> </div> </div> </div> <div class='row'> <div class='html-font-bg large-6 medium-6 small-12 columns end'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns'>Background:</div> <div class='large-8 medium-8 small-12 columns'> <div class="html-article-menu-option html-nav-bg html-nav-bright" data-bg="bright"> <i class="fa fa-file-text"></i> </div> <div class="html-article-menu-option html-nav-bg html-nav-dark" data-bg="dark"> <i class="fa fa-file-text-o"></i> </div> <div class="html-article-menu-option html-nav-bg html-nav-creme" data-bg="creme"> <i class="fa fa-file-text"></i> </div> </div> </div> </div> </div> </div> </div> <article ><div class='html-article-content'> <span itemprop="publisher" content="Multidisciplinary Digital Publishing Institute"></span><span itemprop="url" content="https://www.mdpi.com/1422-0067/18/9/1885"></span> <div class="article-icons"><span class="label openaccess" data-dropdown="drop-article-label-openaccess" aria-expanded="false">Open Access</span><span class="label articletype">Article</span></div> <h1 class="title hypothesis_container" itemprop="name"> A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM<sup>high</sup> and EpCAM<sup>low/negative </sup>CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer </h1> <div class="art-authors hypothesis_container"> by <span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop862955' data-options='is_hover:true, hover_timeout:5000'> Rita Lampignano</div><div id="profile-card-drop862955" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Rita Lampignano</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/author/YjFmejh4QjJ2Q3hVNmtGWlJTSmdVWmJMMWtyK2pmTlpwNVBoQkdQQ0V2V3NBVjQ5TGNWNmphaGhJdWFLdHhVQQ==?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Rita%20Lampignano" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Rita%20Lampignano&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Rita%20Lampignano" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup></sup>, </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop862956' data-options='is_hover:true, hover_timeout:5000'> Liwen Yang</div><div id="profile-card-drop862956" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Liwen Yang</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/author/ck55YXdzZ3YySmpkd2FwNGxJbkdHOVY1Z0NzTDcxT2lIS0J1dm5YNDJSTzQ2K0t6VGZvdGlFQ3JpaFFUbXl0WQ==?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Liwen%20Yang" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Liwen%20Yang&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Liwen%20Yang" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup></sup>, </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop862957' data-options='is_hover:true, hover_timeout:5000'> Martin H. D. Neumann</div><div id="profile-card-drop862957" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Martin H. D. Neumann</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/author/cGllazEzTnpscDhlRDB2R0EzY2xZT2JYRUozUmQ0WmgreWlmUk9yZHVQcz0=?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Martin%20H.%20D.%20Neumann" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Martin%20H.%20D.%20Neumann&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Martin%20H.%20D.%20Neumann" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup></sup>, </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop862958' data-options='is_hover:true, hover_timeout:5000'> André Franken</div><div id="profile-card-drop862958" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">André Franken</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/author/WmR0VFFDdXJOb0ViL25CMm5lMWZaN2NURWsxank5SHhrUS9QMTBmSndKVkN0Qk4yNVNzS215anppazJHYkF4eg==?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Andr%C3%A9%20Franken" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Andr%C3%A9%20Franken&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Andr%C3%A9%20Franken" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup></sup>, </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop862959' data-options='is_hover:true, hover_timeout:5000'> Tanja Fehm</div><div id="profile-card-drop862959" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Tanja Fehm</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/1457735?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Tanja%20Fehm" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Tanja%20Fehm&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Tanja%20Fehm" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup></sup>, </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop862960' data-options='is_hover:true, hover_timeout:5000'> Dieter Niederacher</div><div id="profile-card-drop862960" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Dieter Niederacher</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/author/eGhtOWhtdTZHUitJU2lBcE9uRzUxYmFheEUvTHI1U0F2eEEzYnNvRkVwQT0=?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Dieter%20Niederacher" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Dieter%20Niederacher&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Dieter%20Niederacher" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup></sup> and </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop862961' data-options='is_hover:true, hover_timeout:5000'> Hans Neubauer</div><div id="profile-card-drop862961" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Hans Neubauer</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/294250?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Hans%20Neubauer" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Hans%20Neubauer&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Hans%20Neubauer" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup> *</sup><span style="display: inline; margin-left: 5px;"></span><a class="toEncode emailCaptcha visibility-hidden" data-author-id="862961" href="/cdn-cgi/l/email-protection#daf5b9b4bef7b9bdb3f5b6f5bfb7bbb3b6f7aaa8b5aebfb9aeb3b5b4f9eaeaeae3ece2eaecebb8eeeceaeceabeebbeeabbeae3ebbeeabeebbbe8e2eaefeabeeab9eeecebbeeaeceaebeeefeab9ebbeeabeebb8ebb8eabeeaeeeab9eaedebbbeabfeeeceab9eabe"><sup><i class="fa fa-envelope-o"></i></sup></a><a href="https://orcid.org/0000-0002-3467-4105" target="_blank" rel="noopener noreferrer"><img src="https://pub.mdpi-res.com/img/design/orcid.png?0465bc3812adeb52?1732706938" title="ORCID" style="position: relative; width: 13px; margin-left: 3px; max-width: 13px !important; height: auto; top: -5px;"></a></span> </div> <div class="nrm"></div> <span style="display:block; height:6px;"></span> <div></div> <div style="margin: 5px 0 15px 0;" class="hypothesis_container"> <div class="art-affiliations"> <div class="affiliation "> <div class="affiliation-name ">Department of Obstetrics and Gynecology, Heinrich Heine University of Duesseldorf, Life Science Center, Merowingerplatz 1A, Moorenstr. 5, 40225 Duesseldorf, Germany</div> </div> <div class="affiliation"> <div class="affiliation-item"><sup>*</sup></div> <div class="affiliation-name ">Author to whom correspondence should be addressed. </div> </div> </div> </div> <div class="bib-identity" style="margin-bottom: 10px;"> <em>Int. J. Mol. Sci.</em> <b>2017</b>, <em>18</em>(9), 1885; <a href="https://doi.org/10.3390/ijms18091885">https://doi.org/10.3390/ijms18091885</a> </div> <div class="pubhistory" style="font-weight: bold; padding-bottom: 10px;"> <span style="display: inline-block">Submission received: 14 July 2017</span> / <span style="display: inline-block">Revised: 21 August 2017</span> / <span style="display: inline-block">Accepted: 25 August 2017</span> / <span style="display: inline-block">Published: 31 August 2017</span> </div> <div class="belongsTo" style="margin-bottom: 10px;"> (This article belongs to the Special Issue <a href=" /journal/ijms/special_issues/single_cell_technol ">Single Cell Technology</a>)<br/> </div> <div class="highlight-box1"> <div class="download"> <a class="button button--color-inversed button--drop-down" data-dropdown="drop-download-110408" aria-controls="drop-supplementary-110408" aria-expanded="false"> Download <i class="material-icons">keyboard_arrow_down</i> </a> <div id="drop-download-110408" class="f-dropdown label__btn__dropdown label__btn__dropdown--button" data-dropdown-content aria-hidden="true" tabindex="-1"> <a class="UD_ArticlePDF" href="/1422-0067/18/9/1885/pdf?version=1504228215" data-name="A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer" data-journal="ijms">Download PDF</a> <br/> <a id="js-pdf-with-cover-access-captcha" href="#" data-target="/1422-0067/18/9/1885/pdf-with-cover" class="accessCaptcha">Download PDF with Cover</a> <br/> <a id="js-xml-access-captcha" href="#" data-target="/1422-0067/18/9/1885/xml" class="accessCaptcha">Download XML</a> <br/> <a href="/1422-0067/18/9/1885/epub" id="epub_link">Download Epub</a> <br/> <a href="javascript:void(0);" data-reveal-id="supplementaryModal">Download Supplementary Material</a> <br/> </div> <div class="js-browse-figures" style="display: inline-block;"> <a href="#" class="button button--color-inversed margin-bottom-10 openpopupgallery UI_BrowseArticleFigures" data-target='article-popup' data-counterslink = "https://www.mdpi.com/1422-0067/18/9/1885/browse" >Browse Figures</a> </div> <div id="article-popup" class="popupgallery" style="display: inline; line-height: 200%"> <a href="https://pub.mdpi-res.com/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-ag.png?1569523674" title=" <strong>Graphical abstract</strong><br/> "> </a> <a href="https://pub.mdpi-res.com/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g001.png?1569523674" title=" <strong>Figure 1</strong><br/> <p>Parsortix™-CellCelector™ workflow. Patients’ blood samples are depleted of EpCAM<span class="html-italic"><sup>high</sup></span> CTCs using CellSearch<sup>®</sup> and enriched for EpCAM<span class="html-italic"><sup>low/negative</sup></span> cells with the Parsortix™ system. Captured cells are stained for nuclei, cytokeratins, epithelial cell adhesion molecule (EpCAM) and CD45 within the Parsortix™ cartridge and then harvested. Tumor cells are detected and isolated via CellCelector™ micromanipulator into PCR tubes for further molecular characterizations. Inspired by our previous work [<a href="#B32-ijms-18-01885" class="html-bibr">32</a>].</p> "> </a> <a href="https://pub.mdpi-res.com/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g002.png?1569523674" title=" <strong>Figure 2</strong><br/> <p>MCF-7 cells and a leukocyte labeled inside the Parsortix™ cassette. (<b>A</b>) MCF-7 cells were spiked into healthy donor blood samples and processed within the Parsortix™ system. After capturing within the cassette, tumour cells were permeabilized and stained in situ, and harvested from the system. In fluorescence microscopy MCF-7 cells exhibit signals for nucleic DNA (DAPI), cytokeratins (TRITC) and epithelial cell adhesion molecule (EpCAM-FITC); they are negative for CD45 expression (Cy5); (<b>B</b>) A leukocyte captured within the Parsortix™ system and stained in situ with the same DAPI/antibodies mastermix, shows positive staining of the nucleus (DAPI) and of CD45 (Cy5). There is no expression of cytokeratins (TRITC) and EpCAM (FITC). Magnification: 40×.</p> "> </a> <a href="https://pub.mdpi-res.com/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g003.png?1569523674" title=" <strong>Figure 3</strong><br/> <p>Clinical samples containing both EpCAM<span class="html-italic"><sup>high</sup></span> and EpCAM<span class="html-italic"><sup>low/negative</sup></span> cells. Both subpopulation of potential tumor cells were detected in 54% (28/52) of blood samples of patients enrolled in this project. No correlation in positivity rate between the two fractions of cells was observed.</p> "> </a> <a href="https://pub.mdpi-res.com/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g004.png?1569523674" title=" <strong>Figure 4</strong><br/> <p>Isolated EpCAM<span class="html-italic"><sup>low/negative</sup></span> cells and EpCAM<span class="html-italic"><sup>high</sup></span> cells. (<b>A</b>) Prior isolation of (epithelial cell adhesion molecule ) EpCAM<span class="html-italic"><sup>low/negative</sup></span> cells, selected events were manually scanned at a magnification of 40× in the following channels: DAPI for nucleic DNA, TRITC for cytokeratins, FITC for EpCAM, Cy5 for CD45. EpCAM<span class="html-italic"><sup>low/negative</sup></span> cells show positive staining of nucleic DNA and cytokeratins, very weak or no staining of EpCAM, and no staining of CD45. (<b>B</b>) EpCAM<span class="html-italic"><sup>high</sup></span> cells enriched in CellSearch<sup>®</sup> cartridges were automatically scanned in the abovementioned fluorescent channels, at a magnification of 20×. They exhibit positive staining of nucleic DNA and cytokeratins, and no signals for CD45. After scanning, single cell isolation was performed in DAPI to assure the absence of contaminations.</p> "> </a> <a href="https://pub.mdpi-res.com/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g005.png?1569523674" title=" <strong>Figure 5</strong><br/> <p>PIK3CA Exons 9 and 20 sequencing profiles. Single circulating tumor cells (CTCs) collected from four different patients and sequenced for PIK3CA exon 9 and exon 20 show Phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) hotspot mutations. Two EpCAM<span class="html-italic"><sup>low/negative</sup></span> CTCs from 2 different patients exhibit the mutation 9/E545K (<b>**</b>) when compared to the sequencing profile of a single MCF-7 cell (<b>**</b>). Two EpCAM<span class="html-italic"><sup>high</sup></span> CTCs from different patients show the mutations 20/H1047R and the 20/H1047L (<b>**</b>) when compared to the sequencing profile of a single T47D cell (<b>**</b>). CTCs recorded as PIK3CA wild-type show no mutations (<b>*</b>). <b>**</b>: base exchange; <b>*</b> wild-type base.</p> "> </a> </div> <a class="button button--color-inversed" href="/1422-0067/18/9/1885/notes">Versions Notes</a> </div> </div> <div class="responsive-moving-container small hidden" data-id="article-counters" style="margin-top: 15px;"></div> <div class="html-dynamic"> <section> <div class="art-abstract art-abstract-new in-tab hypothesis_container"> <p> <div><section class="html-abstract" id="html-abstract"> <h2 id="html-abstract-title">Abstract</h2><b>:</b> <div class="html-p">Circulating tumor cells (CTCs), potential precursors of most epithelial solid tumors, are mainly enriched by epithelial cell adhesion molecule (EpCAM)-dependent technologies. Hence, these approaches may overlook mesenchymal CTCs, considered highly malignant. Our aim was to establish a workflow to enrich and isolate patient-matched EpCAM<span class="html-italic"><sup>high</sup></span> and EpCAM<span class="html-italic"><sup>low/negative</sup></span> CTCs within the same blood samples, and to investigate the phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) mutational status within single CTCs. We sequentially processed metastatic breast cancer (MBC) blood samples via CellSearch<sup>®</sup> (EpCAM-based) and via Parsortix™ (size-based) systems. After enrichment, cells captured in Parsortix™ cassettes were stained in situ for nuclei, cytokeratins, EpCAM and CD45. Afterwards, sorted cells were isolated via CellCelector™ micromanipulator and their genomes were amplified. Lastly, PIK3CA mutational status was analyzed by combining an amplicon-based approach with Sanger sequencing. In 54% of patients′ blood samples both EpCAM<span class="html-italic"><sup>high</sup></span> and EpCAM<span class="html-italic"><sup>low/negative</sup></span> cells were identified and successfully isolated. High genomic integrity was observed in 8% of amplified genomes of EpCAM<span class="html-italic"><sup>low/negative</sup></span> cells vs. 28% of EpCAM<span class="html-italic"><sup>high</sup></span> cells suggesting an increased apoptosis in the first CTC-subpopulation. Furthermore, PIK3CA hotspot mutations were detected in both EpCAM<span class="html-italic"><sup>high</sup></span> and EpCAM<span class="html-italic"><sup>low/negative</sup></span> CTCs. Our workflow is suitable for single CTC analysis, permitting—for the first time—assessment of the heterogeneity of PIK3CA mutational status within patient-matched EpCAM<span class="html-italic"><sup>high</sup></span> and EpCAM<span class="html-italic"><sup>low/negative</sup></span> CTCs.</div> </section> <div id="html-keywords"> <div class="html-gwd-group"><div id="html-keywords-title">Keywords: </div><a href="/search?q=circulating+tumor+cell">circulating tumor cell</a>; <a href="/search?q=epithelial+cell+adhesion+moleculelow%2Fnegative">epithelial cell adhesion molecule<span class="html-italic"><sup>low/negative</sup></span></a>; <a href="/search?q=CellSearch">CellSearch</a>; <a href="/search?q=Parsortix">Parsortix</a>; <a href="/search?q=CellCelector">CellCelector</a>; <a href="/search?q=phosphatidylinositol+3-kinase+catalytic+subunit+alpha">phosphatidylinositol 3-kinase catalytic subunit alpha</a></div> <div> </div> </div> </div> </p> </div> <div class="row"> <div class="columns large-12 text-center"> <div class="abstract-image-preview open js-browse-figures"> <a href="#" class="openpopupgallery" data-target='article-popup-ga'> <img src="https://pub.mdpi-res.com/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-ag-550.jpg?1569523674" style="max-width: 100%; max-height: 280px; padding: 10px;"> </a> <div id="article-popup-ga" class="popupgallery" style="display: inline; line-height: 200%"> <a href="https://pub.mdpi-res.com/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-ag.png?1569523674" title="<strong>Graphical Abstract</strong>"></a> </div> <p>Graphical Abstract</p> </div> </div> </div> </section> </div> <div class="hypothesis_container"> <ul class="menu html-nav" data-prev-node="#html-quick-links-title"> </ul> <div class="html-body"> <section id='sec1-ijms-18-01885' type='intro'><h2 data-nested='1'> 1. Introduction</h2><div class='html-p'>Circulating tumor cells (CTCs) are epithelial cells identified in the peripheral bloodstream of patients suffering from cancer and are commonly considered to be responsible for metastases formation in the majority of epithelial solid tumors [<a href="#B1-ijms-18-01885" class="html-bibr">1</a>,<a href="#B2-ijms-18-01885" class="html-bibr">2</a>]. Since they may differ in genotype and phenotype from the primary tumor, their detection and molecular characterization are of great interest for diagnosis, prognosis and selection of proper medical treatments [<a href="#B3-ijms-18-01885" class="html-bibr">3</a>,<a href="#B4-ijms-18-01885" class="html-bibr">4</a>]. Despite many technologic improvements, investigating CTCs is still challenging, mainly due to their low numbers in the blood and the necessity of working at single-cell level to overcome intercellular heterogeneity. Currently used CTC-enrichment technologies focus either on the cells’ biological or physical properties [<a href="#B5-ijms-18-01885" class="html-bibr">5</a>]. Among them, epithelial cell adhesion molecule (EpCAM)-dependent enrichment techniques are the most widely used with the automated CellSearch<sup>®</sup> being so far the only Food and Drug Administration (FDA) approved system [<a href="#B6-ijms-18-01885" class="html-bibr">6</a>].</div><div class='html-p'>It has previously been demonstrated that there are different subpopulations of CTCs ranging in a continuum of phenotypes from the epithelial-like to the mesenchymal-like cells as a result of a process termed epithelial to mesenchymal transition (EMT) [<a href="#B7-ijms-18-01885" class="html-bibr">7</a>,<a href="#B8-ijms-18-01885" class="html-bibr">8</a>,<a href="#B9-ijms-18-01885" class="html-bibr">9</a>]. EMT takes place during tumorigenesis, leading to a loss of a cell’s epithelial features in favor of gaining mesenchymal properties [<a href="#B10-ijms-18-01885" class="html-bibr">10</a>,<a href="#B11-ijms-18-01885" class="html-bibr">11</a>]. As a consequence, within the same patient, some CTCs may express lower or no levels of EpCAM proteins making them ‘invisible’ for EpCAM-based capturing and detection methods [<a href="#B12-ijms-18-01885" class="html-bibr">12</a>,<a href="#B13-ijms-18-01885" class="html-bibr">13</a>]. Moreover, it was observed that these tumor cells, which have already initiated EMT, are correlated to worse prognosis—independently on their EpCAM expression—and therefore they might provide additional information about the evolution of the disease [<a href="#B8-ijms-18-01885" class="html-bibr">8</a>,<a href="#B9-ijms-18-01885" class="html-bibr">9</a>,<a href="#B14-ijms-18-01885" class="html-bibr">14</a>,<a href="#B15-ijms-18-01885" class="html-bibr">15</a>,<a href="#B16-ijms-18-01885" class="html-bibr">16</a>,<a href="#B17-ijms-18-01885" class="html-bibr">17</a>,<a href="#B18-ijms-18-01885" class="html-bibr">18</a>].</div><div class='html-p'>Thus, robust EpCAM-independent detection and isolation approaches are needed to enrich for such CTC subpopulations. Many research groups focused on CTC analysis to investigate their heterogeneity and to stratify metastatic breast cancer (MBC) patients in order to acquire a better cancer-related knowledge and to guide the choice of CTC-based therapeutic treatments.</div><div class='html-p'>One of the most studied signaling proteins in breast cancer is the phosphatidylinositol 3-kinase (PI3K), which participates in many significant signaling networks involved in cell growth and survival, and which is frequently altered in many types of human cancer [<a href="#B16-ijms-18-01885" class="html-bibr">16</a>,<a href="#B17-ijms-18-01885" class="html-bibr">17</a>]. The phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) gene encodes for p110α—the catalytic subunit of PI3K—and is one of the most frequently mutated genes in invasive breast cancer (~26% of the cases), with most mutations clustered in either the helical domain (coded in exon 9) or in the catalytic domain (coded in exon 20), therefore named ‘hotspot’ regions [<a href="#B17-ijms-18-01885" class="html-bibr">17</a>]. These mutations were shown to activate PI3K and related pathways, conferring a remarkable selective growth gain to the cell along with in vitro and in vivo tumorigenicity [<a href="#B17-ijms-18-01885" class="html-bibr">17</a>,<a href="#B18-ijms-18-01885" class="html-bibr">18</a>,<a href="#B19-ijms-18-01885" class="html-bibr">19</a>].</div><div class='html-p'>However, the prognostic relevance of these mutations has not been clearly figured out, yet. Some recent studies reported improved clinical outcome in patients with luminal breast cancer harboring PIK3CA activating mutations [<a href="#B20-ijms-18-01885" class="html-bibr">20</a>,<a href="#B21-ijms-18-01885" class="html-bibr">21</a>]. In contrast, a correlation between the existence of PIK3CA mutations and drug resistance was observed, notably in anti-HER2-treatment regimen [<a href="#B22-ijms-18-01885" class="html-bibr">22</a>,<a href="#B23-ijms-18-01885" class="html-bibr">23</a>,<a href="#B24-ijms-18-01885" class="html-bibr">24</a>,<a href="#B25-ijms-18-01885" class="html-bibr">25</a>,<a href="#B26-ijms-18-01885" class="html-bibr">26</a>]. Early studies on CTCs point towards the presence of PIK3CA hotspot mutations—along with the wild-type form of this gene—in MBC patients [<a href="#B27-ijms-18-01885" class="html-bibr">27</a>,<a href="#B28-ijms-18-01885" class="html-bibr">28</a>,<a href="#B29-ijms-18-01885" class="html-bibr">29</a>,<a href="#B30-ijms-18-01885" class="html-bibr">30</a>,<a href="#B31-ijms-18-01885" class="html-bibr">31</a>], regardless of the PIK3CA status in the primary tumor [<a href="#B29-ijms-18-01885" class="html-bibr">29</a>,<a href="#B30-ijms-18-01885" class="html-bibr">30</a>]. Additionally, Markou et al. [<a href="#B29-ijms-18-01885" class="html-bibr">29</a>] observed that patients carrying CTCs with mutated PIK3CA have a significant shorter overall survival than those without.</div><div class='html-p'>All the abovementioned observations emphasize the necessity of acquiring additional molecular insights into both primary tumors and single CTCs to shed light on the clinical relevance of PIK3CA mutations, and to achieve personalized HER2-targeted therapies.</div><div class='html-p'>To the best of our knowledge, the mutational analysis of the PIK3CA within EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs has so far not been incorporated, and we believe that this information may actually contribute to understand the anti-HER2 treatment resistance in currently running clinical studies (e.g., DETECT III). Thus, the purpose of our study was to establish a workflow to enrich and isolate both EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs from the same MBC patient blood sample in order to assess the heterogeneity of the PIK3CA mutational status within the EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs in comparison to the EpCAM<span class='html-italic'><sup>high</sup></span> CTC-subpopulation.</div><div class='html-p'>For the former, we have recently presented a powerful workflow to enrich for, detect and isolate EpCAM<span class='html-italic'><sup>high</sup></span> CTCs by combining both the CellSearch<sup>®</sup> system and the CellCelector™ micromanipulator [<a href="#B32-ijms-18-01885" class="html-bibr">32</a>]. In parallel, we confirmed the presence of EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs in blood discarded after CellSearch<sup>®</sup> enrichment, further processed with immunomagnetic microbeads targeting proteins expressed on the surface of EpCAM<sup>low/<span class='html-italic'>negative</span></sup> CTCs [<a href="#B13-ijms-18-01885" class="html-bibr">13</a>].</div><div class='html-p'>However, since this antibody-based approach might still lose a consistent fraction of CTCs with epithelial-mesenchymal plasticity, in the project herein described, we expanded our workflow for CTC isolation and single cell molecular investigation by incorporating an additional label-free CTC enrichment step by using the Parsortix™ system (<a href="#ijms-18-01885-f001" class="html-fig">Figure 1</a>) on blood samples previously depleted for EpCAM<span class='html-italic'><sup>high</sup></span> CTCs. Successively, we isolated patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs and investigated the heterogeneity of their PIK3CA status in all the collected tumor cells via Sanger sequencing.</div><div class='html-p'>Our workflow was proved to be suitable for single CTC analysis and has enabled—for the first time—the characterization of the PIK3CA oncogene on patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs.</div></section><section id='sec2-ijms-18-01885' type='results'><h2 data-nested='1'> 2. Results</h2><section id='sec2dot1-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 2.1. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM<sup>high</sup> and EpCAM<sup>low/negative</sup> CTCs</h4><div class='html-p'>We focused on establishing a robust method that allows the enrichment, isolation and downstream processing of single EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs along with the collection of patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> cells. Our workflow starts by processing 7.5 mL blood sample through the CellSearch<sup>®</sup> system. After depletion of EpCAM<span class='html-italic'><sup>high</sup></span> CTCs, EpCAM-depleted blood is collected and further processed within the Parsortix™ system, representing our workflow′s novel component. Cells captured within this system are labeled with fluorochrome-conjugated antibodies in the Parsortix™ cassette, released and micromanipulated with the CellCelector™ system within 48 h. CTCs are identified based on the following features: intact nuclei (DAPI), expression of cytokeratins, CD45-negativity, and a diameter of 5–40 µm. In addition, EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs are verified by low or no expression of EpCAM. Successfully isolated cells are deposited in PCR tubes and processed for WGA prior to sequencing analysis.</div></section><section id='sec2dot2-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 2.2. Validation of Immunostaining on Cytospins</h4><div class='html-p'>Prior to the establishment of the workflow, the immunostaining mastermix necessary to identify CTCs was validated on cell lines. The cell line MCF-7 was utilized as positive control for staining of cytokeratins (anti-C11/AE1/AE3-TRITC) and EpCAM (anti-vu14D9-AF488) and as negative control for CD45 (anti 3Z5S-AF647). On the contrary, leukocytes were utilized as positive control for CD45 and as negative control for cytokeratins and EpCAM. Cells were effectively stained for the expected markers (<a href="#app1-ijms-18-01885" class="html-app">Figure S1</a>).</div></section><section id='sec2dot3-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 2.3. Validation of Tumor Cell Enrichment via Parsortix™ System</h4><div class='html-p'>First, capturing and harvesting rates within the Parsortix™ system were determined in 3 independent experiments using MCF-7 breast cancer cell line, whose diameter—measured via microscopy—was on average 18 ± 1.7 µm. In each Test 100 pre-labeled cells were spiked into healthy donor blood previously processed within the CellSearch<sup>®</sup> system. In order to determine capturing rates, cells in the cassette were scanned with the fluorescence microscope integrated in the CellCelector™. Captured cells were then harvested from the cassettes into tubes with 200 µL PBS. Cell suspensions were placed on glass slides and scanned under the fluorescent microscope in order to quantify harvested tumor cells. These were identified as described above. The average capturing rate for MCF-7 cells within disposable cassettes of 6.5 µm narrow passages was of 63 ± 17.8% and out of it, 72 ± 29.6% of cells could be harvested.</div></section><section id='sec2dot4-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 2.4. Establishment of in Situ Staining of Captured Tumour Cells</h4><div class='html-p'>In order to optimize the workflow for clinical routine application, we subsequently established the semi-automated in situ staining of captured tumor cells. The in situ labeling approach was chosen over the staining in suspension in order to reduce the great cell loss due to pipetting procedures and/or centrifugation steps otherwise needed. Unlabeled CellSave<sup>®</sup>-fixed MCF7 cells were spiked into healthy donor blood samples after processing within the CellSearch<sup>®</sup> system. Cells captured inside the Parsortix™ cassette were permeabilized in situ and then incubated with the antibodies/DAPI mastermix. Harvested cells were scanned under the fluorescent microscope for an intact nucleus, for cytokeratins expression as well as for EpCAM expression. A successful staining of all the selected markers could be observed (<a href="#ijms-18-01885-f002" class="html-fig">Figure 2</a>).</div></section><section id='sec2dot5-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 2.5. Processing of MBC Clinical Samples: Enrichment, Detection and Isolation of EpCAM<sup>high</sup> and EpCAM<sup>low/negative</sup> Cells</h4><div class='html-p'>From 07/2015 to 11/2016, 52 blood samples of 47 MBC patients were sequentially processed with our workflow. Patients´ characteristics for primary tumors and CTC fractions are reported in <a href="#app1-ijms-18-01885" class="html-app">Table S1</a>.</div><div class='html-p'>In 54% (<span class='html-italic'>n</span> = 28) of blood samples, we observed both EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> cell subpopulations with no correlation in positivity rates (<a href="#ijms-18-01885-f003" class="html-fig">Figure 3</a>).</div><div class='html-p'>Suitable cells for downstream analysis were selected based on their morphologic appearance and signal intensities, according to Polzer et al. [<a href="#B31-ijms-18-01885" class="html-bibr">31</a>]. We successfully isolated 107 EpCAM<span class='html-italic'><sup>high</sup></span> and 145 EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells from 13 patients. In <a href="#ijms-18-01885-f004" class="html-fig">Figure 4</a>, representative images of isolated EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells are depicted.</div></section><section id='sec2dot6-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 2.6. Whole Genome Amplification of Single Isolated Cells</h4><div class='html-p'>We tested whether enrichment and isolation conditions of our workflow were compatible with whole genome amplification in order to enable further genome analysis. We omitted the analysis of isolated cell line cells since these—in comparison to CTCs—are very robust feigning good conditions.</div><div class='html-p'>In order to characterize isolated EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells, these were lysed and WGA was performed. Quality control PCRs for the WGA products indicated that approximately 28% of WGA libraries from EpCAM<span class='html-italic'><sup>high</sup></span> cells show high genomic integrity compared to 8% of EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells (<a href="#ijms-18-01885-t001" class="html-table">Table 1</a>).</div></section><section id='sec2dot7-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 2.7. Mutational Analysis of PIK3CA Exons 9 and 20 in both CTC-Subpopulations</h4><div class='html-p'>Afterwards, we investigated the status of the PIK3CA exons 9 and 20 in patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs. WGA products were specifically amplified for PIK3CA sequences mainly flanking hotspots E542, E545, H1047, located in exons 9 and 20. Resulting amplicons of 38 EpCAM<span class='html-italic'><sup>high</sup></span> and of 39 EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells from 10 patients could be successfully sequenced for above reported hotspot mutations, known to cause constitutive activity of PIK3CA protein, involved in tumorigenesis [<a href="#B21-ijms-18-01885" class="html-bibr">21</a>,<a href="#B22-ijms-18-01885" class="html-bibr">22</a>].</div><div class='html-p'>Individual sequencing profiles of both EpCAM<span class='html-italic'><sup>low/negative</sup></span> and EpCAM<span class='html-italic'><sup>high</sup></span> CTCs were compared to sequencing profiles of single MCF-7—known to harbor mutations in exon 9 (amino acid change at position E542 and E545)—and of single T47D cells harboring mutations in exon 20 (amino acid change at position 1047) [<a href="#B33-ijms-18-01885" class="html-bibr">33</a>,<a href="#B34-ijms-18-01885" class="html-bibr">34</a>].</div><div class='html-p'>In six patients out of ten, both fractions of CTCs were classified as wild-type (WT) for the investigated PIK3CA hotspots (<a href="#ijms-18-01885-t002" class="html-table">Table 2</a>).</div><div class='html-p'>In four patients (I, IX, X, XLVII) CTCs harboring PIK3CA hotspot mutations could be observed (<a href="#ijms-18-01885-f005" class="html-fig">Figure 5</a>) as well as tumor cells carrying the WT form of the gene.</div><div class='html-p'>Patient I carried PIK3CA hotspot mutations in the EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTC group only. The mutation E545K (codon 545 of the exon 9, glutamine to lysine) could be observed in one out of ten analyzed CTCs. The remaining 9 EpCAM<span class='html-italic'><sup>low/negative</sup></span> and 2 patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> CTCs carried the WT form of the gene.</div><div class='html-p'>Patients X and XLVII exhibited the mutated PIK3CA in EpCAM<span class='html-italic'><sup>high</sup></span> CTCs only. In patient X the mutation H1047R (codon 1047 of the exon 20, histidine to arginine) could be detected in two out of 5 processed CTCs. The 3 remaining EpCAM<span class='html-italic'><sup>high</sup></span> CTCs and 1 patient-matched EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTC were classified as PIK3CA WT. In patient XLVII the rare mutation H1047L (codon 1047 of exon 20, histidine to leucine) could be detected in one out of 2 processed CTCs. The remaining EpCAM<span class='html-italic'><sup>high</sup></span> CTC and 2 patient-matched EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs were classified as PIK3CA WT.</div><div class='html-p'>A very heterogeneous situation was observed in patient IX who carried both mutated and the WT PIK3CA in both subpopulations of CTCs. Moreover, different hotspot mutations were observed within the two different fractions of CTCs. In one out of five EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs, the mutation E545K was detected. Four residual EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs were PIK3CA WT. In two out of eleven EpCAM<span class='html-italic'><sup>high</sup></span> CTCs the mutation H1047L (codon 1047 of exon 20, glutamine to leucine) could be observed and the remaining 9 EpCAM<span class='html-italic'><sup>high</sup></span> CTCs were classified as PIK3CA WT.</div><div class='html-p'>No other base exchanges could be detected within the whole sequencing profiles of both PIK3CA exons 9 and 20.</div></section></section><section id='sec3-ijms-18-01885' type='discussion'><h2 data-nested='1'> 3. Discussion</h2><div class='html-p'>The clinical relevance of EpCAM<span class='html-italic'><sup>positive</sup></span> CTCs was proved by several investigations [<a href="#B35-ijms-18-01885" class="html-bibr">35</a>,<a href="#B36-ijms-18-01885" class="html-bibr">36</a>,<a href="#B37-ijms-18-01885" class="html-bibr">37</a>]. However, whether transient and mesenchymal CTCs play a key role in the outcome of the patients is still an open question. Many studies reported the presence of EpCAM<span class='html-italic'><sup>negative</sup></span> CTCs in the blood of patients suffering from different types of cancer. In some of these investigations the potential clinical relevance of these tumor cells was examined [<a href="#B3-ijms-18-01885" class="html-bibr">3</a>,<a href="#B12-ijms-18-01885" class="html-bibr">12</a>,<a href="#B14-ijms-18-01885" class="html-bibr">14</a>,<a href="#B15-ijms-18-01885" class="html-bibr">15</a>,<a href="#B16-ijms-18-01885" class="html-bibr">16</a>,<a href="#B17-ijms-18-01885" class="html-bibr">17</a>,<a href="#B38-ijms-18-01885" class="html-bibr">38</a>,<a href="#B39-ijms-18-01885" class="html-bibr">39</a>], often highlighting the metastatic potential of EpCAM<span class='html-italic'><sup>negative</sup></span> CTCs [<a href="#B3-ijms-18-01885" class="html-bibr">3</a>,<a href="#B38-ijms-18-01885" class="html-bibr">38</a>,<a href="#B39-ijms-18-01885" class="html-bibr">39</a>]. In general, in all of the abovementioned studies the authors agree that this subpopulation of CTCs should be further analyzed to acquire further knowledge regarding their metastatic potential.</div><div class='html-p'>However, both enrichment and isolation steps for CTCs are still the bottleneck in the field of CTC analysis. Not many commercially available enrichment techniques can guarantee high cell recovery rates—regardless of protein expression—and low white blood cell contamination. Moreover, there are few technologies available to isolate single cells and most of them are time consuming, require high sample volumes, and face loss of cells.</div><div class='html-p'>We previously reported the existence of an EpCAM<span class='html-italic'><sup>low/negative</sup></span> subset of CTCs in MBC patients’ samples further processed after CellSearch<sup>®</sup> system [<a href="#B13-ijms-18-01885" class="html-bibr">13</a>]. Besides, we have recently described a powerful workflow to enrich EpCAM<span class='html-italic'><sup>high</sup></span> CTCs and to micromanipulate them as single cells by combining the CellSearch<sup>®</sup> system and the CellCelector™ micromanipulator [<a href="#B32-ijms-18-01885" class="html-bibr">32</a>]. Finally, in the herein described project we optimized our methods incorporating the Parsortix™ system in order to enrich, detect and isolate EpCAM<span class='html-italic'><sup>low/negative</sup></span> tumor cells along with patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> CTCs.</div><div class='html-p'>The Parsortix™ system enables size-dependent enrichment of cells independently on the expression of cell surface proteins, unlike antibody dependent technologies (e.g., reported by Schneck et al. [<a href="#B13-ijms-18-01885" class="html-bibr">13</a>]). First and foremost, effective capturing and harvesting rates of the system was assessed by using cassettes with narrow passages of 6.5 µm. We observed an average of 63 ± 17.8% of captured pre-labeled MCF-7 cells and from them 72 ± 29.6% could be successfully harvested. Our data indicate slightly higher cell recovery rates than those reported by Xu et al. [<a href="#B40-ijms-18-01885" class="html-bibr">40</a>] who utilized cassettes with 10 µm narrow passages. In addition, our recovery rates are in concordance with results published by Hvichia et al. [<a href="#B41-ijms-18-01885" class="html-bibr">41</a>] who reported a range of capturing rates of 42–70% and a range of harvesting rates of 54–69% for cancer cell lines of different tumor entities (PANC1, A375, PC3, A549, T24) by utilizing 10 µm cassettes. Hence, all the data point out how recovery rates depend on both size and deformability of tumor cells, as previously already hypothesized [<a href="#B41-ijms-18-01885" class="html-bibr">41</a>].</div><div class='html-p'>The high capturing and harvesting rates of the Parsortix™ system are the basis for the effective CTC analysis since Neumann et al. [<a href="#B32-ijms-18-01885" class="html-bibr">32</a>] already demonstrated that single cell micromanipulation can be performed with 97% efficacy. Therefore, optimizing the in situ labeling of cells in Parsortix™ cassettes is of high importance in order to minimize cell loss, which was observed during in suspension staining procedures [<a href="#B40-ijms-18-01885" class="html-bibr">40</a>,<a href="#B41-ijms-18-01885" class="html-bibr">41</a>].</div><div class='html-p'>By applying the established novel workflow, we were able to successfully enrich, detect and isolate single EpCAM<span class='html-italic'><sup>low/negative</sup></span> and patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> cells. In 54% of blood samples positive for EpCAM<span class='html-italic'><sup>high</sup></span> CTCs also EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells could be detected without any correlation in numbers. The resulting combined CTC positivity rate is higher than that reported by de Wit et al. [<a href="#B12-ijms-18-01885" class="html-bibr">12</a>], who found both EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells in 19% (5/27) of metastatic lung cancer samples. This may be explained either by the application of different CTC enrichment methods or by different abundance of EpCAM<span class='html-italic'><sup>low</sup></span> CTCs within the different tumor entities investigated. However, in agreement to our results, de Wit et al. [<a href="#B12-ijms-18-01885" class="html-bibr">12</a>] reported a lack of correlation between numbers of both EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> cell fractions. Of great interest for our future studies is whether EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells may provide prognostic and predictive information for early or MBC patients with no EpCAM<span class='html-italic'><sup>high</sup></span> CTC in the CellSearch<sup>®</sup> analysis.</div><div class='html-p'>Moreover, we proved the feasibility of our workflow for single cell downstream analysis. WGA products were of high genomic integrity in 28% of EpCAM<span class='html-italic'><sup>high</sup></span> CTCs, accordingly with data published by Polzer et al. [<a href="#B31-ijms-18-01885" class="html-bibr">31</a>]. In contrast, the unexpected finding of 8% WGA products of high genomic integrity among EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells may point towards early apoptosis mechanisms activated in this CTC subpopulation. In future experiments, we aim to complement our staining protocol with indicators for apoptosis, a phenomenon that has was already observed in CTCs and related to patients’ outcomes in several studies [<a href="#B42-ijms-18-01885" class="html-bibr">42</a>,<a href="#B43-ijms-18-01885" class="html-bibr">43</a>,<a href="#B44-ijms-18-01885" class="html-bibr">44</a>,<a href="#B45-ijms-18-01885" class="html-bibr">45</a>,<a href="#B46-ijms-18-01885" class="html-bibr">46</a>].</div><div class='html-p'>In the scenario of future personalized medicine, the characterization of single CTCs besides their enumeration may also play a key role, identifying potential biomarkers (e.g., PIK3CA) to predict resistance to therapies. The status of the PIK3CA gene in MBC primary tumors as well as in CTCs is increasingly attracting attention since in patients it was often observed an increased resistance to anti-HER2 therapies caused by PI3K activating mutations [<a href="#B47-ijms-18-01885" class="html-bibr">47</a>,<a href="#B48-ijms-18-01885" class="html-bibr">48</a>]. In some reports, hotspot mutations in EpCAM<span class='html-italic'><sup>positive</sup></span> CTCs were already described [<a href="#B30-ijms-18-01885" class="html-bibr">30</a>,<a href="#B31-ijms-18-01885" class="html-bibr">31</a>,<a href="#B49-ijms-18-01885" class="html-bibr">49</a>,<a href="#B50-ijms-18-01885" class="html-bibr">50</a>,<a href="#B51-ijms-18-01885" class="html-bibr">51</a>] and a first correlation of the PIK3CA status with the overall survival and prognosis free survival was analyzed [<a href="#B49-ijms-18-01885" class="html-bibr">49</a>].</div><div class='html-p'>The ability to collect and isolate different subpopulation of CTCs and to perform a single cell analysis allowed us to asses—at our best knowledge for the first time—the heterogeneity of the PIK3CA status within single EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs, along with patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> CTCs. We recorded the hotspot mutation E545K in EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs from 2 patients (patients I and IX) and the mutation H1047R in EpCAM<span class='html-italic'><sup>high</sup></span> CTCs from another patient (patient X). These are the two most frequently reported PIK3CA hotspot mutations in breast cancer tissues (<a href='http://www.mycancergenome.org' target='_blank' rel="noopener noreferrer">www.mycancergenome.org</a>) as well as in EpCAM<span class='html-italic'><sup>positive</sup></span> CTCs [<a href="#B30-ijms-18-01885" class="html-bibr">30</a>,<a href="#B31-ijms-18-01885" class="html-bibr">31</a>,<a href="#B49-ijms-18-01885" class="html-bibr">49</a>,<a href="#B50-ijms-18-01885" class="html-bibr">50</a>,<a href="#B51-ijms-18-01885" class="html-bibr">51</a>]. Interestingly, we could also detect the rare mutation H1047L in EpCAM<span class='html-italic'><sup>high</sup></span> CTCs from two different patients (patient IX and XLVII), already described by Gasch et al. [<a href="#B51-ijms-18-01885" class="html-bibr">51</a>]. The identification of PIK3CA mutations in only EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs in one patient (I) and in both EpCAM<span class='html-italic'><sup>low/negative</sup></span> and EpCAM<span class='html-italic'><sup>high</sup></span> CTCs in another one (IX) is of high interest, suggesting that incorporating the analysis of the PI3K mutation status of EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells might be of relevance for future CTC-based therapies targeting HER2-positive CTCs as envisioned in the DETECT III study.</div><div class='html-p'>Since genomic analysis within single cells require prior amplification—in our workflow Ampli1 WGA and PIK3CA specific PCRs—there is the chance that base exchanges may be introduced by polymerases. However, we excluded this possibility within our sequencing results, since only specific PIK3CA hotspot mutations could be detected within the whole sequencing profiles of both exons 9 and 20.</div><div class='html-p'>In the future, we aim to implement our molecular analysis with the assessment of the copy number variation profiles of the EpCAM<span class='html-italic'><sup>low/negative</sup></span> fraction of CTCs, in order to further confirm their malignancy and to investigate their clonal relatedness to the EpCAM<span class='html-italic'><sup>high</sup></span> CTCs. In addition we will perform longitudinal follow-up analysis of the frequency of EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs and of the PIK3CA mutational status to investigate their evolution during treatment regimen applied in the DETECT studies.</div></section><section id='sec4-ijms-18-01885' type=''><h2 data-nested='1'> 4. Materials and Methods </h2><section id='sec4dot1-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 4.1. Cell Lines and Culture Conditions</h4><div class='html-p'>For spiking and sequencing experiments, breast cancer cell lines MCF-7 and T47D were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA; catalogue numbers: HTB-22™ and HTB-133™). Cells were cultured in RPMI 1640 containing 10% fetal calf serum and 1% Penicillin-Streptomycin (all Gibco, Karlsruhe, Germany). For MCF-7, culture medium was supplemented with 25 mM HEPES (Gibco). For T47D cells 10 mM HEPES, 1 mM sodium pyruvate (Gibco) and 0.45% D-(β) Glucose solution (Sigma-Aldrich, Munich, Germany) was added. All cells were grown at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>. Both cell lines were authenticated via short tandem repeat (STRs) analysis. For spiking experiments, MCF-7 cells were fixed in CellSave<sup>®</sup> tubes for 24 h, at room temperature (RT).</div></section><section id='sec4dot2-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 4.2. Patient Material</h4><div class='html-p'>Patient blood samples were collected within the German DETECT III/IV trials (III: NCT01619111, IV: NCT02035813; for more information: <a href='http://www.detect-studien.de' target='_blank' rel="noopener noreferrer">www.detect-studien.de</a>) from patients with MBC. Written informed consent was obtained from all participating patients and the studies were approved by the Ethical Committee of the Eberhard-Karls University Tuebingen (responsible for DETECT III: 525/2011AMG1; approved on the 25 October 2012) and the local Ethical Committee of the Heinrich-Heine University Duesseldorf (DETECT III: MC-531; DETECT IV: MC-LKP-668; approved on the 17 December 2013).</div></section><section id='sec4dot3-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 4.3. Enrichment and Enumeration of EpCAM<sup>high</sup> CTCs via CellSearch<sup>®</sup></h4><div class='html-p'>The workflow starts by processing blood samples through the CellSearch<sup>®</sup> system (Menarini Silicon Biosystems, Bologna, Italy) in order to enrich and enumerate EpCAM<span class='html-italic'><sup>high</sup></span> CTCs [<a href="#B27-ijms-18-01885" class="html-bibr">27</a>]. In order to reduce the possible presence of skin contaminating cells, first milliliters of drawn blood samples are discarded and only following 7.5 mL of blood are processed through the CellSearch<sup>®</sup>.</div><div class='html-p'>After analysis, CTCs were stored in CellSearch<sup>®</sup> cartridges at 4 °C in the dark and were micromanipulated within one week [<a href="#B32-ijms-18-01885" class="html-bibr">32</a>].</div></section><section id='sec4dot4-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 4.4. Enrichment of EpCAM<sup>low/negative</sup> Cells with Parsortix™ System</h4><div class='html-p'>Blood samples depleted of EpCAM<span class='html-italic'><sup>high</sup></span> cells were processed within the Parsortix™ system to enrich potential EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs which were not captured by the EpCAM-specific ferrofluid used during the CellSearch<sup>®</sup>-approach.</div><div class='html-p'>Blood samples were pumped through a disposable cassette (Cell Separation Cassette GEN3D6.5, ANGLE plc) containing narrow passages of 6.5µm in height blocking flow-through of cells larger than most white blood cells—among them CTCs. By virtue of a priming protocol—which flushes each new cassette with ethanol 100% (<span class='html-italic'>v</span>/<span class='html-italic'>v</span>)—clean processing conditions could be guaranteed.</div><div class='html-p'>Cells captured inside the cassette were stained in situ for nucleic acid (DAPI; Roche Diagnostics GmbH, Heilingenhaus, Germany), cytokeratins (clones C11/AE1/AE3 [<a href="#B12-ijms-18-01885" class="html-bibr">12</a>,<a href="#B13-ijms-18-01885" class="html-bibr">13</a>], TRITC conjugate; Aczon Srl, Monte San Pietro BO, Italy), EpCAM (clone VU1D9 [<a href="#B13-ijms-18-01885" class="html-bibr">13</a>], Alexa Fluor<sup>®</sup> 488 conjugated; Cell Signaling Technology Inc., Danvers, MA, USA) and CD45 (clone 35-ZS [<a href="#B13-ijms-18-01885" class="html-bibr">13</a>], Alexa Fluor<sup>®</sup> 647 conjugated; Santa Cruz Biotechnology Inc., Dallas, TX, USA). The expression of the above reported markers (except for CD45), together with a range diameter of 4–30 µm are the only criteria available at the current state of the art, for the CTC-detection [<a href="#B52-ijms-18-01885" class="html-bibr">52</a>]. Further details about the validation of this immunostaining are provided as <a href="#app1-ijms-18-01885" class="html-app">supplementary material</a>.</div><div class='html-p'>Stained cells were harvested from the system into a PCR tube by inverting the flow direction of the buffer. In order to minimize a possible stickiness of captured and stained cells inside the cassette, PBS was supplemented with EDTA 2 mM. Samples were stored at 4 °C in the dark and micromanipulated within two days.</div><div class='html-p'>The Parsortix™ system was automatically cleaned with a decontaminating solution between processing of different samples.</div></section><section id='sec4dot5-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 4.5. Detection and Isolation of EpCAM<sup>high</sup> and EpCAM<sup>low/negative</sup> Cells via CellCelector™</h4><div class='html-p'>The CellCelector™ (ALS, Jena, Germany) is a semi-automated micromanipulator consisting of an inverted fluorescent microscope (CKX41, Olympus, Tokyo, Japan) with a CCD camera system (XM10-IR, Olympus, Tokyo, Japan) and a robotic arm with a vertical glass capillary of 30 µm in diameter [<a href="#B53-ijms-18-01885" class="html-bibr">53</a>]; ALS GmbH). EpCAM<span class='html-italic'><sup>high</sup></span> CTCs collected in CellSearch<sup>®</sup> cartridges and EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells harvested from the Parsortix™ cassette were transferred onto glass slides, placed on the automatic stage of the CellCelector™ microscope and were allowed to deposit. Then, samples released from the CellSearch<sup>®</sup> cartridges were automatically scanned in 20× as previously described [<a href="#B32-ijms-18-01885" class="html-bibr">32</a>]. Parsortix™ samples were manually scanned with 40× magnification using the following fluorescence channels: bright field (cell morphology), DAPI (morphology of nuclei and DNA integrity), TRITC (cytokeratins), FITC (EpCAM) and Cy5 (CD45). The following exposure times were used: 50 ms for DAPI, 300 ms (TRITC and FITC), and 500 ms (Cy5). For the analysis the CellCelector™ software 3.0 (ALS, Jena, Germany) was used. Images of single cells were stored for later documentation.</div><section id='sec4dot5dot1-ijms-18-01885' type=''><h4 class='' data-nested='3'> 4.5.1. Selection Criteria</h4><div class='html-p'>All cells were analyzed using the following scan parameters: diameter (signals ranging from 5 to 40 µm) and grey value mean (fluorescence intensity of >2000 for cytokeratins signal). DAPI<span class='html-italic'><sup>pos</sup></span>/Cytokeratins<span class='html-italic'><sup>pos</sup></span>/EpCAM<span class='html-italic'><sup>low/neg</sup></span>/CD45<span class='html-italic'><sup>neg</sup></span> events were identified and their morphologies were checked in bright field (BF). Only events with a round shape in BF, with specific fluorescence signals in the expected fluorescent channels only and without any sign of DNA fragmentation in DAPI—pointing towards apoptosis—were selected for further isolation. Prior to cell-isolation, images were checked by two operators experienced in CTC-detection via CellSearch<sup>®</sup> system.</div></section><section id='sec4dot5dot2-ijms-18-01885' type=''><h4 class='' data-nested='3'> 4.5.2. Cell Isolation Parameters</h4><div class='html-p'>Cell isolation was performed in DAPI as previously described [<a href="#B32-ijms-18-01885" class="html-bibr">32</a>]. Finally, PCR tubes containing single cells in 1 µL of buffer were stored at −80 °C until further processing.</div></section></section><section id='sec4dot6-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 4.6. Whole Genome Amplification of Isolated CTCs</h4><div class='html-p'>Genomic DNA of isolated single cells was amplified using the Ampli<span class='html-italic'>1</span>™ WGA-Kit (whole genome amplification) according to manufacturer’s protocol (Menarini Silicon Biosystems, Bologna, Italy). This procedure is based on a ligation-mediated PCR following a site-specific DNA restriction [<a href="#B54-ijms-18-01885" class="html-bibr">54</a>]. 1 µL of WGA products was analyzed for quality control utilizing the Ampli<span class='html-italic'>1</span>™ QC-Kit (Menarini Silicon Biosystems, Bologna, Italy), which assays four genomic areas in a multiplex PCR. As positive control high quality genomic DNA from cell lines was used. QC-PCR products were loaded on a 2% agarose-TAE gel. The presence of 3 or 4 amplicons in the QC-PCR indicates a high genomic integrity of the WGA product. Less than 3 amplicons point towards a low genomic integrity [<a href="#B31-ijms-18-01885" class="html-bibr">31</a>].</div></section><section id='sec4dot7-ijms-18-01885' type=''><h4 class='html-italic' data-nested='2'> 4.7. Sanger Sequencing of the PIK3CA Exons 9 and 20 on CTCs</h4><div class='html-p'>All WGA-products were processed in 2 specific PCRs amplifying PIK3CA exons 9 and 20 in a volume of 25 µL containing 1 U DreamTaq DNA polymerase (Thermo Fisher Scientific Inc., Waltham, MA, USA) and 1 µL of WGA-product as template. Primers were designed—in analogy to primers used in a previous study by Hurst and colleagues [<a href="#B55-ijms-18-01885" class="html-bibr">55</a>]—to produce amplicons covering hotspot codons mainly for E542, E545 (exon 9) and H1047 (exon 20; 0.2 µM each; <a href="#ijms-18-01885-t001" class="html-table">Table 1</a>). They were adapted to WGA restriction sites (Mse<span class='html-italic'>I</span>) and to exclude amplification of pseudogenes. PCR conditions were: 95 °C for 5 min, 35 cycles of 95 °C for 45 sec, 58 °C for 45 sec, 72 °C for 45 sec and finally 10 min at 72 °C. A 3% agarose-TAE gel electrophoresis was used to check for successful amplification. PCR products were purified using either the ExoSAP-IT<sup>®</sup> PCR Product Cleanup (Thermo Fisher Scientific Inc., Waltham, Massachusetts, USA) or the QIAEX II<sup>®</sup> Gel Extraction kit (Qiagen, Hilden, Germany) and DNA concentrations were measured with the NanoDrop™ Spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, USA). Sanger sequencing was performed by the Genomics & Transcriptomics Laboratory (GTL) of the Biological and Medical Research Center of Düsseldorf (BMFZ) using primers designed elongating PCR primers with sequencing binding sites (<a href="#ijms-18-01885-t003" class="html-table">Table 3</a>).</div></section></section><section id='sec5-ijms-18-01885' type='conclusions'><h2 data-nested='1'> 5. Conclusions</h2><div class='html-p'>In this study, we describe a robust workflow to enrich, detect and isolate patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs from the same clinical blood sample by combining the CellSearch<sup>®</sup> system, the Parsortix™ system and the CellCelector™ micromanipulator. Furthermore, we show our workflow′s feasibility for molecular analysis and report low DNA integrity and PIK3CA mutational heterogeneity within EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs compared to patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> CTCs. Although our molecular data are based on a small cohort of patients, they highlight that the assessment of the PIK3CA mutational status within EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs along with the EpCAM<span class='html-italic'><sup>high</sup></span> cells may provide further knowledge about resistance to HER2-targeted therapies and may help to choose optimal treatment strategies. In order to further support our findings, extended studies with larger cohorts of patients are planned.</div></section> </div> <div class="html-back"> <section><section id='app1-ijms-18-01885' type=''><h2 data-nested='1'> Supplementary Materials</h2><div class='html-p'>Supplementary materials can be found at <a href='https://www.mdpi.com/1422-0067/18/9/1885/s1' target='_blank' rel="noopener noreferrer">www.mdpi.com/1422-0067/18/9/1885/s1</a>.</div></section></section><section id='html-ack' class='html-ack'><h2 >Acknowledgments</h2><div class='html-p'>We thank our colleagues Meier-Stiegen, Hohmann and Köhler for the CellSearch<sup>®</sup> samples processing, Willibald for cell culture, van den Bosch and Steinau for their technical support with micromanipulation. We also thank Köhrer and all the BMFZ team for the great support with the sequencing experiments. Last but not least, we thank all the patients enrolled in this project. Work was partly supported by CTCTrap grant (EU no. 305341).</div></section><section class='html-notes'><h2 >Author Contributions</h2><div class='html-p'>Conceived and designed the experiments: Rita Lampignano, Martin H.D. Neumann, Hans Neubauer. Performed the experiments: Rita Lampignano, Liwen Yang. Designed the primers: André Franken. Analyzed the data: Rita Lampignano, Liwen Yang, Hans Neubauer. Contributed reagents/materials/analysis tools: Dieter Niederacher, Tanja Fehm. Wrote the paper: Rita Lampignano, Hans Neubauer.</div></section><section class='html-notes'><h2 >Conflicts of Interest</h2><div class='html-p'>The authors declare no conflict of interest.</div></section><section id='html-glossary'><h2 >Abbreviations</h2><table class='html-array_table'><tbody ><tr ><td align='left' valign='middle' class='html-align-left' >CTC</td><td align='left' valign='middle' class='html-align-left' >Circulating Tumor Cell</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >EpCAM</td><td align='left' valign='middle' class='html-align-left' >Epithelial Cell Adhesion Molecule</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >FDA</td><td align='left' valign='middle' class='html-align-left' >Food and Drug Administration</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >EMT</td><td align='left' valign='middle' class='html-align-left' >Epithelial to Mesenchymal Transition</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >MBC</td><td align='left' valign='middle' class='html-align-left' >Metastatic Breast Cancer</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >PI3K</td><td align='left' valign='middle' class='html-align-left' >Phosphatidylinositol 3-Kinase</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >PIK3CA</td><td align='left' valign='middle' class='html-align-left' >Phosphatidylinositol 3-Kinase Catalytic subunit Alpha</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >WGA</td><td align='left' valign='middle' class='html-align-left' >Whole Genome Amplification</td></tr><tr ><td align='left' valign='middle' class='html-align-left' >WT</td><td align='left' valign='middle' class='html-align-left' >Wild-type</td></tr></tbody></table></section><section id='html-references_list'><h2>References</h2><ol class='html-xx'><li id='B1-ijms-18-01885' class='html-x' data-content='1.'>Yu, M.; Stott, S.; Toner, M.; Maheswaran, S.; Haber, D.A. Circulating tumor cells: Approaches to isolation and characterization. <span class='html-italic'>J. Cell Biol.</span> <b>2011</b>, <span class='html-italic'>192</span>, 373–382. [<a href="https://scholar.google.com/scholar_lookup?title=Circulating+tumor+cells:+Approaches+to+isolation+and+characterization&author=Yu,+M.&author=Stott,+S.&author=Toner,+M.&author=Maheswaran,+S.&author=Haber,+D.A.&publication_year=2011&journal=J.+Cell+Biol.&volume=192&pages=373%E2%80%93382&doi=10.1083/jcb.201010021&pmid=21300848" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1083/jcb.201010021" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/21300848" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B2-ijms-18-01885' class='html-x' data-content='2.'>Allard, W.J.; Matera, J.; Miller, M.C.; Repollet, M.; Connelly, M.C.; Rao, C.; Tibbe, A.G.J.; Uhr, J.W.; Terstappen, L.W.M.M. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases. <span class='html-italic'>Clin. Cancer Res.</span> <b>2004</b>, <span class='html-italic'>10</span>, 6897–6904. [<a href="https://scholar.google.com/scholar_lookup?title=Tumor+Cells+Circulate+in+the+Peripheral+Blood+of+All+Major+Carcinomas+but+not+in+Healthy+Subjects+or+Patients+With+Nonmalignant+Diseases&author=Allard,+W.J.&author=Matera,+J.&author=Miller,+M.C.&author=Repollet,+M.&author=Connelly,+M.C.&author=Rao,+C.&author=Tibbe,+A.G.J.&author=Uhr,+J.W.&author=Terstappen,+L.W.M.M.&publication_year=2004&journal=Clin.+Cancer+Res.&volume=10&pages=6897%E2%80%936904&doi=10.1158/1078-0432.CCR-04-0378&pmid=15501967" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1078-0432.CCR-04-0378" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/15501967" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B3-ijms-18-01885' class='html-x' data-content='3.'>Zhang, L.; Riethdorf, S.; Wu, G.; Wang, T.; Yang, K.; Peng, G.; Liu, J.; Pantel, K. Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer. <span class='html-italic'>Clin. Cancer Res.</span> <b>2012</b>, <span class='html-italic'>18</span>, 5701–5710. [<a href="https://scholar.google.com/scholar_lookup?title=Meta-Analysis+of+the+Prognostic+Value+of+Circulating+Tumor+Cells+in+Breast+Cancer&author=Zhang,+L.&author=Riethdorf,+S.&author=Wu,+G.&author=Wang,+T.&author=Yang,+K.&author=Peng,+G.&author=Liu,+J.&author=Pantel,+K.&publication_year=2012&journal=Clin.+Cancer+Res.&volume=18&pages=5701%E2%80%935710&doi=10.1158/1078-0432.CCR-12-1587&pmid=22908097" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1078-0432.CCR-12-1587" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22908097" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B4-ijms-18-01885' class='html-x' data-content='4.'>Scher, H.I.; Jia, X.; de Bono, J.S.; Fleisher, M.; Pienta, K.J.; Raghavan, D.; Heller, G. Circulating Tumor Cell Number as a Prognostic Marker in Progressive Castration-Resistant Prostate Cancer: Use in Clinical Practice and Clinical Trials. <span class='html-italic'>Lancet Oncol.</span> <b>2009</b>, <span class='html-italic'>10</span>, 233–239. [<a href="https://scholar.google.com/scholar_lookup?title=Circulating+Tumor+Cell+Number+as+a+Prognostic+Marker+in+Progressive+Castration-Resistant+Prostate+Cancer:+Use+in+Clinical+Practice+and+Clinical+Trials&author=Scher,+H.I.&author=Jia,+X.&author=de+Bono,+J.S.&author=Fleisher,+M.&author=Pienta,+K.J.&author=Raghavan,+D.&author=Heller,+G.&publication_year=2009&journal=Lancet+Oncol.&volume=10&pages=233%E2%80%93239&doi=10.1016/S1470-2045(08)70340-1" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/S1470-2045(08)70340-1" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B5-ijms-18-01885' class='html-x' data-content='5.'>Alix-Panabières, C.; Pantel, K. Technologies for detection of circulating tumor cells: Facts and vision. <span class='html-italic'>Lab Chip</span> <b>2013</b>, <span class='html-italic'>14</span>, 57–62. [<a href="https://scholar.google.com/scholar_lookup?title=Technologies+for+detection+of+circulating+tumor+cells:+Facts+and+vision&author=Alix-Panabi%C3%A8res,+C.&author=Pantel,+K.&publication_year=2013&journal=Lab+Chip&volume=14&pages=57%E2%80%9362&doi=10.1039/C3LC50644D&pmid=24145967" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1039/C3LC50644D" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24145967" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B6-ijms-18-01885' class='html-x' data-content='6.'>Banys, M.; Müller, V.; Melcher, C.; Aktas, B.; Kasimir-Bauer, S.; Hagenbeck, C.; Hartkopf, A.; Fehm, T. Circulating tumor cells in breast cancer. <span class='html-italic'>Clin. Chim. Acta</span> <b>2013</b>, <span class='html-italic'>423</span>, 39–45. [<a href="https://scholar.google.com/scholar_lookup?title=Circulating+tumor+cells+in+breast+cancer&author=Banys,+M.&author=M%C3%BCller,+V.&author=Melcher,+C.&author=Aktas,+B.&author=Kasimir-Bauer,+S.&author=Hagenbeck,+C.&author=Hartkopf,+A.&author=Fehm,+T.&publication_year=2013&journal=Clin.+Chim.+Acta&volume=423&pages=39%E2%80%9345&doi=10.1016/j.cca.2013.03.029&pmid=23623805" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.cca.2013.03.029" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23623805" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B7-ijms-18-01885' class='html-x' data-content='7.'>Poruk, K.E. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma. <span class='html-italic'>Ann. Surg.</span> <b>2016</b>, <span class='html-italic'>264</span>, 1073–1081. [<a href="https://scholar.google.com/scholar_lookup?title=Circulating+Tumor+Cell+Phenotype+Predicts+Recurrence+and+Survival+in+Pancreatic+Adenocarcinoma&author=Poruk,+K.E.&publication_year=2016&journal=Ann.+Surg.&volume=264&pages=1073%E2%80%931081&doi=10.1097/SLA.0000000000001600&pmid=26756760" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1097/SLA.0000000000001600" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/26756760" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B8-ijms-18-01885' class='html-x' data-content='8.'>Yu, M.; Bardia, A.; Wittner, B.S.; Stott, S.L.; Smas, M.E.; Ting, D.T.; Isakoff, S.J.; Ciciliano, J.C.; Wells, M.N.; Shah, A.M.; et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition. <span class='html-italic'>Science</span> <b>2013</b>, <span class='html-italic'>339</span>, 580–584. [<a href="https://scholar.google.com/scholar_lookup?title=Circulating+Breast+Tumor+Cells+Exhibit+Dynamic+Changes+in+Epithelial+and+Mesenchymal+Composition&author=Yu,+M.&author=Bardia,+A.&author=Wittner,+B.S.&author=Stott,+S.L.&author=Smas,+M.E.&author=Ting,+D.T.&author=Isakoff,+S.J.&author=Ciciliano,+J.C.&author=Wells,+M.N.&author=Shah,+A.M.&publication_year=2013&journal=Science&volume=339&pages=580%E2%80%93584&doi=10.1126/science.1228522&pmid=23372014" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1126/science.1228522" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23372014" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B9-ijms-18-01885' class='html-x' data-content='9.'>Gorges, T.M.; Tinhofer, I.; Drosch, M.; Röse, L.; Zollner, T.M.; Krahn, T. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. <span class='html-italic'>BMC Cancer</span> <b>2012</b>, <span class='html-italic'>12</span>, 178. [<a href="https://scholar.google.com/scholar_lookup?title=Circulating+tumour+cells+escape+from+EpCAM-based+detection+due+to+epithelial-to-mesenchymal+transition&author=Gorges,+T.M.&author=Tinhofer,+I.&author=Drosch,+M.&author=R%C3%B6se,+L.&author=Zollner,+T.M.&author=Krahn,+T.&publication_year=2012&journal=BMC+Cancer&volume=12&pages=178&doi=10.1186/1471-2407-12-178&pmid=22591372" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1186/1471-2407-12-178" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22591372" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B10-ijms-18-01885' class='html-xx' data-content='10.'>Bednarz-Knoll, N.; Alix-Panabières, C.; Pantel, K. Plasticity of disseminating cancer cells in patients with epithelial malignancies. <span class='html-italic'>Cancer Metastasis Rev.</span> <b>2012</b>, <span class='html-italic'>31</span>, 673–687. [<a href="https://scholar.google.com/scholar_lookup?title=Plasticity+of+disseminating+cancer+cells+in+patients+with+epithelial+malignancies&author=Bednarz-Knoll,+N.&author=Alix-Panabi%C3%A8res,+C.&author=Pantel,+K.&publication_year=2012&journal=Cancer+Metastasis+Rev.&volume=31&pages=673%E2%80%93687&doi=10.1007/s10555-012-9370-z&pmid=22733306" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s10555-012-9370-z" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22733306" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B11-ijms-18-01885' class='html-xx' data-content='11.'>Kalluri, R.; Weinberg, R.A. The basics of epithelial-mesenchymal transition. <span class='html-italic'>J. Clin. Investig.</span> <b>2009</b>, <span class='html-italic'>119</span>, 1420–1428. [<a href="https://scholar.google.com/scholar_lookup?title=The+basics+of+epithelial-mesenchymal+transition&author=Kalluri,+R.&author=Weinberg,+R.A.&publication_year=2009&journal=J.+Clin.+Investig.&volume=119&pages=1420%E2%80%931428&doi=10.1172/JCI39104&pmid=19487818" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1172/JCI39104" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/19487818" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B12-ijms-18-01885' class='html-xx' data-content='12.'>De Wit, S.; van Dalum, G.van; Lenferink, A.T.M.; Tibbe, A.G.J.; Hiltermann, T.J.N.; Groen, H.J.M.; van Rijn, C.J.M.; Terstappen, L.W.M.M. The detection of EpCAM+ and EpCAM– circulating tumor cells. <span class='html-italic'>Sci. Rep.</span> <b>2015</b>, <span class='html-italic'>5</span>. [<a href="https://scholar.google.com/scholar_lookup?title=The+detection+of+EpCAM++and+EpCAM%E2%80%93+circulating+tumor+cells&author=De+Wit,+S.&author=van+Dalum,+G.van&author=Lenferink,+A.T.M.&author=Tibbe,+A.G.J.&author=Hiltermann,+T.J.N.&author=Groen,+H.J.M.&author=van+Rijn,+C.J.M.&author=Terstappen,+L.W.M.M.&publication_year=2015&journal=Sci.+Rep.&volume=5&doi=10.1038/srep12270" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/srep12270" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B13-ijms-18-01885' class='html-xx' data-content='13.'>Schneck, H.; Gierke, B.; Uppenkamp, F.; Behrens, B.; Niederacher, D.; Stoecklein, N.H.; Templin, M.F.; Pawlak, M.; Fehm, T.; Neubauer, H. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer. <span class='html-italic'>PLoS ONE</span> <b>2015</b>. [<a href="https://scholar.google.com/scholar_lookup?title=EpCAM-Independent+Enrichment+of+Circulating+Tumor+Cells+in+Metastatic+Breast+Cancer&author=Schneck,+H.&author=Gierke,+B.&author=Uppenkamp,+F.&author=Behrens,+B.&author=Niederacher,+D.&author=Stoecklein,+N.H.&author=Templin,+M.F.&author=Pawlak,+M.&author=Fehm,+T.&author=Neubauer,+H.&publication_year=2015&journal=PLoS+ONE&doi=10.1371/journal.pone.0144535&pmid=26695635" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1371/journal.pone.0144535" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/26695635" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B14-ijms-18-01885' class='html-xx' data-content='14.'>Aktas, B. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. <span class='html-italic'>Breast Cancer Res.</span> <b>2009</b>, <span class='html-italic'>11</span>, R46. [<a href="https://scholar.google.com/scholar_lookup?title=Stem+cell+and+epithelial-mesenchymal+transition+markers+are+frequently+overexpressed+in+circulating+tumor+cells+of+metastatic+breast+cancer+patients&author=Aktas,+B.&publication_year=2009&journal=Breast+Cancer+Res.&volume=11&pages=R46&doi=10.1186/bcr2333&pmid=19589136" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1186/bcr2333" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/19589136" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B15-ijms-18-01885' class='html-xx' data-content='15.'>Mego, M. Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation. <span class='html-italic'>J. Cancer</span> <b>2012</b>, <span class='html-italic'>3</span>, 369–380. [<a href="https://scholar.google.com/scholar_lookup?title=Prognostic+Value+of+EMT-Circulating+Tumor+Cells+in+Metastatic+Breast+Cancer+Patients+Undergoing+High-Dose+Chemotherapy+with+Autologous+Hematopoietic+Stem+Cell+Transplantation&author=Mego,+M.&publication_year=2012&journal=J.+Cancer&volume=3&pages=369%E2%80%93380&doi=10.7150/jca.5111&pmid=23074378" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.7150/jca.5111" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23074378" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B16-ijms-18-01885' class='html-xx' data-content='16.'>Yokobori, T. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. <span class='html-italic'>Cancer Res.</span> <b>2013</b>, <span class='html-italic'>73</span>, 2059–2069. [<a href="https://scholar.google.com/scholar_lookup?title=Plastin3+is+a+novel+marker+for+circulating+tumor+cells+undergoing+the+epithelial-mesenchymal+transition+and+is+associated+with+colorectal+cancer+prognosis&author=Yokobori,+T.&publication_year=2013&journal=Cancer+Res.&volume=73&pages=2059%E2%80%932069&doi=10.1158/0008-5472.CAN-12-0326&pmid=23378342" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-12-0326" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23378342" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B17-ijms-18-01885' class='html-xx' data-content='17.'>Ueo, H. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer. <span class='html-italic'>Br. J. Cancer</span> <b>2015</b>, <span class='html-italic'>112</span>, 1519–1526. [<a href="https://scholar.google.com/scholar_lookup?title=Circulating+tumour+cell-derived+plastin3+is+a+novel+marker+for+predicting+long-term+prognosis+in+patients+with+breast+cancer&author=Ueo,+H.&publication_year=2015&journal=Br.+J.+Cancer&volume=112&pages=1519%E2%80%931526&doi=10.1038/bjc.2015.132&pmid=25880010" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/bjc.2015.132" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/25880010" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B18-ijms-18-01885' class='html-xx' data-content='18.'>Lampignano, R.; Schneck, H.; Neumann, M.; Fehm, T.; Neubauer, H. Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells. <span class='html-italic'>Adv. Exp. Med. Biol.</span> <b>2017</b>, <span class='html-italic'>994</span>, 181–203. [<a href="https://scholar.google.com/scholar_lookup?title=Enrichment,+Isolation+and+Molecular+Characterization+of+EpCAM-Negative+Circulating+Tumor+Cells&author=Lampignano,+R.&author=Schneck,+H.&author=Neumann,+M.&author=Fehm,+T.&author=Neubauer,+H.&publication_year=2017&journal=Adv.+Exp.+Med.+Biol.&volume=994&pages=181%E2%80%93203&doi=10.1007/978%E2%80%933-319%E2%80%9355947%E2%80%936_10&pmid=28560675" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/978–3-319–55947–6_10" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/28560675" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B19-ijms-18-01885' class='html-xx' data-content='19.'>Wang, W.; Lv, J.; Wang, L.; Wang, X.; Ye, L. The impact of heterogeneity in phosphoinositide 3-kinase pathway in human cancer and possible therapeutic treatments. <span class='html-italic'>Semin. Cell Dev. Biol.</span> <b>2016</b>. [<a href="https://scholar.google.com/scholar_lookup?title=The+impact+of+heterogeneity+in+phosphoinositide+3-kinase+pathway+in+human+cancer+and+possible+therapeutic+treatments&author=Wang,+W.&author=Lv,+J.&author=Wang,+L.&author=Wang,+X.&author=Ye,+L.&publication_year=2016&journal=Semin.+Cell+Dev.+Biol.&doi=10.1016/j.semcdb.2016.08.024&pmid=27582428" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.semcdb.2016.08.024" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/27582428" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B20-ijms-18-01885' class='html-xx' data-content='20.'>Troxell, L.M. PIK3CA/AKT1 Mutations in Breast Carcinoma: A Comprehensive Review of Experimental and Clinical Studies. <span class='html-italic'>J. Clin. Exp. Pathol.</span> <b>2012</b>. [<a href="https://scholar.google.com/scholar_lookup?title=PIK3CA/AKT1+Mutations+in+Breast+Carcinoma:+A+Comprehensive+Review+of+Experimental+and+Clinical+Studies&author=Troxell,+L.M.&publication_year=2012&journal=J.+Clin.+Exp.+Pathol.&doi=10.4172/2161-0681.S1-002" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.4172/2161-0681.S1-002" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B21-ijms-18-01885' class='html-xx' data-content='21.'>Bader, A.G.; Kang, S.; Vogt, P.K. Cancer-specific mutations in PIK3CA are oncogenic in vivo. <span class='html-italic'>Proc. Natl. Acad. Sci. USA</span> <b>2006</b>, <span class='html-italic'>103</span>, 1475–1479. [<a href="https://scholar.google.com/scholar_lookup?title=Cancer-specific+mutations+in+PIK3CA+are+oncogenic+in+vivo&author=Bader,+A.G.&author=Kang,+S.&author=Vogt,+P.K.&publication_year=2006&journal=Proc.+Natl.+Acad.+Sci.+USA&volume=103&pages=1475%E2%80%931479&doi=10.1073/pnas.0510857103&pmid=16432179" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1073/pnas.0510857103" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/16432179" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B22-ijms-18-01885' class='html-xx' data-content='22.'>Zhao, J.J.; Liu, Z.; Wang, L.; Shin, E.; Loda, M.F.; Roberts, T.M. The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells. <span class='html-italic'>Proc. Natl. Acad. Sci. USA</span> <b>2005</b>, <span class='html-italic'>102</span>, 18443–18448. [<a href="https://scholar.google.com/scholar_lookup?title=The+oncogenic+properties+of+mutant+p110%CE%B1+and+p110%CE%B2+phosphatidylinositol+3-kinases+in+human+mammary+epithelial+cells&author=Zhao,+J.J.&author=Liu,+Z.&author=Wang,+L.&author=Shin,+E.&author=Loda,+M.F.&author=Roberts,+T.M.&publication_year=2005&journal=Proc.+Natl.+Acad.+Sci.+USA&volume=102&pages=18443%E2%80%9318448&doi=10.1073/pnas.0508988102&pmid=16339315" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1073/pnas.0508988102" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/16339315" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B23-ijms-18-01885' class='html-xx' data-content='23.'>Gonzalez-Angulo, A.M.; Blumenschein, G.R. Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer. <span class='html-italic'>Cancer Treat. Rev.</span> <b>2013</b>, <span class='html-italic'>39</span>, 313–320. [<a href="https://scholar.google.com/scholar_lookup?title=Defining+biomarkers+to+predict+sensitivity+to+PI3K/Akt/mTOR+pathway+inhibitors+in+breast+cancer&author=Gonzalez-Angulo,+A.M.&author=Blumenschein,+G.R.&publication_year=2013&journal=Cancer+Treat.+Rev.&volume=39&pages=313%E2%80%93320&doi=10.1016/j.ctrv.2012.11.002&pmid=23218708" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.ctrv.2012.11.002" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23218708" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B24-ijms-18-01885' class='html-xx' data-content='24.'>Loi, S.; Michiels, S.; Baselga, J.; Bartlett, J.M.S.; Singhal, S.K.; Sabine, V.S.; Sims, A.H.; Sahmoud, T.; Dixon, J.M.; Piccart, M.J.; et al. PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer. <span class='html-italic'>PLoS ONE</span> <b>2013</b>, <span class='html-italic'>8</span>. [<a href="https://scholar.google.com/scholar_lookup?title=PIK3CA+Genotype+and+a+PIK3CA+Mutation-Related+Gene+Signature+and+Response+to+Everolimus+and+Letrozole+in+Estrogen+Receptor+Positive+Breast+Cancer&author=Loi,+S.&author=Michiels,+S.&author=Baselga,+J.&author=Bartlett,+J.M.S.&author=Singhal,+S.K.&author=Sabine,+V.S.&author=Sims,+A.H.&author=Sahmoud,+T.&author=Dixon,+J.M.&author=Piccart,+M.J.&publication_year=2013&journal=PLoS+ONE&volume=8&doi=10.1371/journal.pone.0053292&pmid=23301057" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1371/journal.pone.0053292" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23301057" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://core.ac.uk/download/pdf/28970389.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B25-ijms-18-01885' class='html-xx' data-content='25.'>Cizkova, M.; Dujaric, M.-E.; Lehmann-Che, J.; Scott, V.; Tembo, O.; Asselain, B.; Pierga, J.-Y.; Marty, M.; de Cremoux, P.; Spyratos, F.; et al. Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab. <span class='html-italic'>Br. J. Cancer</span> <b>2013</b>, <span class='html-italic'>108</span>, 1807–1809. [<a href="https://scholar.google.com/scholar_lookup?title=Outcome+impact+of+PIK3CA+mutations+in+HER2-positive+breast+cancer+patients+treated+with+trastuzumab&author=Cizkova,+M.&author=Dujaric,+M.-E.&author=Lehmann-Che,+J.&author=Scott,+V.&author=Tembo,+O.&author=Asselain,+B.&author=Pierga,+J.-Y.&author=Marty,+M.&author=de+Cremoux,+P.&author=Spyratos,+F.&publication_year=2013&journal=Br.+J.+Cancer&volume=108&pages=1807%E2%80%931809&doi=10.1038/bjc.2013.164&pmid=23612454" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/bjc.2013.164" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23612454" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B26-ijms-18-01885' class='html-xx' data-content='26.'>Hanker, A.B.; Pfefferle, A.D.; Balko, J.M.; Kuba, M.G.; Young, C.D.; Sánchez, V.; Sutton, C.R.; Cheng, H.; Perou, C.M.; Zhao, J.J.; et al. Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies. <span class='html-italic'>Proc. Natl. Acad. Sci. USA</span> <b>2013</b>, <span class='html-italic'>110</span>, 14372–14377. [<a href="https://scholar.google.com/scholar_lookup?title=Mutant+PIK3CA+accelerates+HER2-driven+transgenic+mammary+tumors+and+induces+resistance+to+combinations+of+anti-HER2+therapies&author=Hanker,+A.B.&author=Pfefferle,+A.D.&author=Balko,+J.M.&author=Kuba,+M.G.&author=Young,+C.D.&author=S%C3%A1nchez,+V.&author=Sutton,+C.R.&author=Cheng,+H.&author=Perou,+C.M.&author=Zhao,+J.J.&publication_year=2013&journal=Proc.+Natl.+Acad.+Sci.+USA&volume=110&pages=14372%E2%80%9314377&doi=10.1073/pnas.1303204110&pmid=23940356" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1073/pnas.1303204110" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23940356" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B27-ijms-18-01885' class='html-xx' data-content='27.'>Martini, M.; Ciraolo, E.; Gulluni, F.; Hirsch, E. Targeting PI3K in Cancer: Any Good News? <span class='html-italic'>Front. Oncol.</span> <b>2013</b>, <span class='html-italic'>3</span>. [<a href="https://scholar.google.com/scholar_lookup?title=Targeting+PI3K+in+Cancer:+Any+Good+News?&author=Martini,+M.&author=Ciraolo,+E.&author=Gulluni,+F.&author=Hirsch,+E.&publication_year=2013&journal=Front.+Oncol.&volume=3&doi=10.3389/fonc.2013.00108&pmid=23658859" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.3389/fonc.2013.00108" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23658859" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B28-ijms-18-01885' class='html-xx' data-content='28.'>Cizkova, M.; Susini, A.; Vacher, S.; Cizeron-Clairac, G.; Andrieu, C.; Driouch, K.; Fourme, E.; Lidereau, R.; Bièche, I. PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups. <span class='html-italic'>Breast Cancer Res.</span> <b>2012</b>, <span class='html-italic'>14</span>, R28. [<a href="https://scholar.google.com/scholar_lookup?title=PIK3CA+mutation+impact+on+survival+in+breast+cancer+patients+and+in+ER%CE%B1,+PR+and+ERBB2-based+subgroups&author=Cizkova,+M.&author=Susini,+A.&author=Vacher,+S.&author=Cizeron-Clairac,+G.&author=Andrieu,+C.&author=Driouch,+K.&author=Fourme,+E.&author=Lidereau,+R.&author=Bi%C3%A8che,+I.&publication_year=2012&journal=Breast+Cancer+Res.&volume=14&pages=R28&doi=10.1186/bcr3113&pmid=22330809" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1186/bcr3113" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22330809" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B29-ijms-18-01885' class='html-xx' data-content='29.'>Andersen, J.N.; Sathyanarayanan, S.; Bacco, A.D.; Chi, A.; Zhang, T.; Chen, A.H.; Dolinski, B.; Kraus, M.; Roberts, B.; Arthur, W.; et al. Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors. <span class='html-italic'>Sci. Transl. Med.</span> <b>2010</b>, <span class='html-italic'>2</span>, 43ra55. [<a href="https://scholar.google.com/scholar_lookup?title=Pathway-Based+Identification+of+Biomarkers+for+Targeted+Therapeutics:+Personalized+Oncology+with+PI3K+Pathway+Inhibitors&author=Andersen,+J.N.&author=Sathyanarayanan,+S.&author=Bacco,+A.D.&author=Chi,+A.&author=Zhang,+T.&author=Chen,+A.H.&author=Dolinski,+B.&author=Kraus,+M.&author=Roberts,+B.&author=Arthur,+W.&publication_year=2010&journal=Sci.+Transl.+Med.&volume=2&pages=43ra55&doi=10.1126/scitranslmed.3001065&pmid=20686178" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1126/scitranslmed.3001065" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20686178" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B30-ijms-18-01885' class='html-xx' data-content='30.'>Schneck, H.; Blassl, C.; Meier-Stiegen, F.; Neves, R.P.; Janni, W.; Fehm, T.; Neubauer, H. Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients. <span class='html-italic'>Mol. Oncol.</span> <b>2013</b>, <span class='html-italic'>7</span>, 976–986. [<a href="https://scholar.google.com/scholar_lookup?title=Analysing+the+mutational+status+of+PIK3CA+in+circulating+tumor+cells+from+metastatic+breast+cancer+patients&author=Schneck,+H.&author=Blassl,+C.&author=Meier-Stiegen,+F.&author=Neves,+R.P.&author=Janni,+W.&author=Fehm,+T.&author=Neubauer,+H.&publication_year=2013&journal=Mol.+Oncol.&volume=7&pages=976%E2%80%93986&doi=10.1016/j.molonc.2013.07.007&pmid=23895914" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.molonc.2013.07.007" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23895914" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B31-ijms-18-01885' class='html-xx' data-content='31.'>Polzer, B.; Medoro, G.; Pasch, S.; Fontana, F.; Zorzino, L.; Pestka, A.; Andergassen, U.; Meier-Stiegen, F.; Czyz, Z.T.; Alberter, B.; et al. Molecular profiling of single circulating tumor cells with diagnostic intention. <span class='html-italic'>EMBO Mol. Med.</span> <b>2014</b>, <span class='html-italic'>6</span>, 1371–1386. [<a href="https://scholar.google.com/scholar_lookup?title=Molecular+profiling+of+single+circulating+tumor+cells+with+diagnostic+intention&author=Polzer,+B.&author=Medoro,+G.&author=Pasch,+S.&author=Fontana,+F.&author=Zorzino,+L.&author=Pestka,+A.&author=Andergassen,+U.&author=Meier-Stiegen,+F.&author=Czyz,+Z.T.&author=Alberter,+B.&publication_year=2014&journal=EMBO+Mol.+Med.&volume=6&pages=1371%E2%80%931386&doi=10.15252/emmm.201404033&pmid=25358515" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.15252/emmm.201404033" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/25358515" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B32-ijms-18-01885' class='html-xx' data-content='32.'>Neumann, M.H.D.; Schneck, H.; Decker, Y.; Schömer, S.; Franken, A.; Endris, V.; Pfarr, N.; Weichert, W.; Niederacher, D.; Fehm, T.; et al. Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch<sup>®</sup> system and the CellCelector™. <span class='html-italic'>Biotechnol. Prog.</span> <b>2017</b>, <span class='html-italic'>33</span>, 125–132. [<a href="https://scholar.google.com/scholar_lookup?title=Isolation+and+characterization+of+circulating+tumor+cells+using+a+novel+workflow+combining+the+CellSearch%C2%AE+system+and+the+CellCelector%E2%84%A2&author=Neumann,+M.H.D.&author=Schneck,+H.&author=Decker,+Y.&author=Sch%C3%B6mer,+S.&author=Franken,+A.&author=Endris,+V.&author=Pfarr,+N.&author=Weichert,+W.&author=Niederacher,+D.&author=Fehm,+T.&publication_year=2017&journal=Biotechnol.+Prog.&volume=33&pages=125%E2%80%93132&doi=10.1002/btpr.2294&pmid=27126369" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/btpr.2294" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/27126369" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B33-ijms-18-01885' class='html-xx' data-content='33.'>Hollestelle, A.; Elstrodt, F.; Nagel, J.H.A.; Kallemeijn, W.W.; Schutte, M. Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines. <span class='html-italic'>Mol. Cancer Res.</span> <b>2007</b>, <span class='html-italic'>5</span>, 195–201. [<a href="https://scholar.google.com/scholar_lookup?title=Phosphatidylinositol-3-OH+Kinase+or+RAS+Pathway+Mutations+in+Human+Breast+Cancer+Cell+Lines&author=Hollestelle,+A.&author=Elstrodt,+F.&author=Nagel,+J.H.A.&author=Kallemeijn,+W.W.&author=Schutte,+M.&publication_year=2007&journal=Mol.+Cancer+Res.&volume=5&pages=195%E2%80%93201&doi=10.1158/1541-7786.MCR-06-0263&pmid=17314276" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1541-7786.MCR-06-0263" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17314276" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B34-ijms-18-01885' class='html-xx' data-content='34.'>Kataoka, Y.; Mukohara, T.; Shimada, H.; Saijo, N.; Hirai, M.; Minami, H. Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines. <span class='html-italic'>Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. ESMO</span> <b>2010</b>, <span class='html-italic'>21</span>, 255–262. [<a href="https://scholar.google.com/scholar_lookup?title=Association+between+gain-of-function+mutations+in+PIK3CA+and+resistance+to+HER2-targeted+agents+in+HER2-amplified+breast+cancer+cell+lines&author=Kataoka,+Y.&author=Mukohara,+T.&author=Shimada,+H.&author=Saijo,+N.&author=Hirai,+M.&author=Minami,+H.&publication_year=2010&journal=Ann.+Oncol.+Off.+J.+Eur.+Soc.+Med.+Oncol.+ESMO&volume=21&pages=255%E2%80%93262&doi=10.1093/annonc/mdp304&pmid=19633047" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1093/annonc/mdp304" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/19633047" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B35-ijms-18-01885' class='html-xx' data-content='35.'>Bidard, F.-C.; Peeters, D.J.; Fehm, T.; Nolé, F.; Gisbert-Criado, R.; Mavroudis, D.; Grisanti, S.; Generali, D.; Garcia-Saenz, J.A.; Stebbing, J.; et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: A pooled analysis of individual patient data. <span class='html-italic'>Lancet Oncol.</span> <b>2014</b>, <span class='html-italic'>15</span>, 406–414. [<a href="https://scholar.google.com/scholar_lookup?title=Clinical+validity+of+circulating+tumour+cells+in+patients+with+metastatic+breast+cancer:+A+pooled+analysis+of+individual+patient+data&author=Bidard,+F.-C.&author=Peeters,+D.J.&author=Fehm,+T.&author=Nol%C3%A9,+F.&author=Gisbert-Criado,+R.&author=Mavroudis,+D.&author=Grisanti,+S.&author=Generali,+D.&author=Garcia-Saenz,+J.A.&author=Stebbing,+J.&publication_year=2014&journal=Lancet+Oncol.&volume=15&pages=406%E2%80%93414&doi=10.1016/S1470-2045(14)70069-5" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/S1470-2045(14)70069-5" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B36-ijms-18-01885' class='html-xx' data-content='36.'>Banys-Paluchowski, M.; Krawczyk, N.; Meier-Stiegen, F.; Fehm, T. Circulating tumor cells in breast cancer—Current status and perspectives. <span class='html-italic'>Crit. Rev. Oncol. Hematol.</span> <b>2016</b>, <span class='html-italic'>97</span>, 22–29. [<a href="https://scholar.google.com/scholar_lookup?title=Circulating+tumor+cells+in+breast+cancer%E2%80%94Current+status+and+perspectives&author=Banys-Paluchowski,+M.&author=Krawczyk,+N.&author=Meier-Stiegen,+F.&author=Fehm,+T.&publication_year=2016&journal=Crit.+Rev.+Oncol.+Hematol.&volume=97&pages=22%E2%80%9329&doi=10.1016/j.critrevonc.2015.10.010&pmid=26563820" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.critrevonc.2015.10.010" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/26563820" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B37-ijms-18-01885' class='html-xx' data-content='37.'>Cabel, L.; Proudhon, C.; Gortais, H.; Loirat, D.; Coussy, F.; Pierga, J.-Y.; Bidard, F.-C. Circulating tumor cells: Clinical validity and utility. <span class='html-italic'>Int. J. Clin. Oncol.</span> <b>2017</b>, <span class='html-italic'>22</span>, 421–430. [<a href="https://scholar.google.com/scholar_lookup?title=Circulating+tumor+cells:+Clinical+validity+and+utility&author=Cabel,+L.&author=Proudhon,+C.&author=Gortais,+H.&author=Loirat,+D.&author=Coussy,+F.&author=Pierga,+J.-Y.&author=Bidard,+F.-C.&publication_year=2017&journal=Int.+J.+Clin.+Oncol.&volume=22&pages=421%E2%80%93430&doi=10.1007/s10147-017-1105-2&pmid=28238187" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s10147-017-1105-2" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/28238187" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B38-ijms-18-01885' class='html-xx' data-content='38.'>Lustberg, M.B.; Balasubramanian, P.; Miller, B.; Garcia-Villa, A.; Deighan, C.; Wu, Y.; Carothers, S.; Berger, M.; Ramaswamy, B.; Macrae, E.R.; et al. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients. <span class='html-italic'>Breast Cancer Res. BCR</span> <b>2014</b>, <span class='html-italic'>16</span>, R23. [<a href="https://scholar.google.com/scholar_lookup?title=Heterogeneous+atypical+cell+populations+are+present+in+blood+of+metastatic+breast+cancer+patients&author=Lustberg,+M.B.&author=Balasubramanian,+P.&author=Miller,+B.&author=Garcia-Villa,+A.&author=Deighan,+C.&author=Wu,+Y.&author=Carothers,+S.&author=Berger,+M.&author=Ramaswamy,+B.&author=Macrae,+E.R.&publication_year=2014&journal=Breast+Cancer+Res.+BCR&volume=16&pages=R23&doi=10.1186/bcr3622&pmid=24602188" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1186/bcr3622" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24602188" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B39-ijms-18-01885' class='html-xx' data-content='39.'>Vishnoi, M.; Peddibhotla, S.; Yin, W.; T. Scamardo, A.; George, G.C.; Hong, D.S.; Marchetti, D. The isolation and characterization of CTC subsets related to breast cancer dormancy. <span class='html-italic'>Sci. Rep.</span> <b>2015</b>, <span class='html-italic'>5</span>, 17533. [<a href="https://scholar.google.com/scholar_lookup?title=The+isolation+and+characterization+of+CTC+subsets+related+to+breast+cancer+dormancy&author=Vishnoi,+M.&author=Peddibhotla,+S.&author=Yin,+W.&author=T.+Scamardo,+A.&author=George,+G.C.&author=Hong,+D.S.&author=Marchetti,+D.&publication_year=2015&journal=Sci.+Rep.&volume=5&pages=17533&doi=10.1038/srep17533&pmid=26631983" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/srep17533" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/26631983" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B40-ijms-18-01885' class='html-xx' data-content='40.'>Xu, L. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System. <span class='html-italic'>PLoS ONE</span> <b>2015</b>, <span class='html-italic'>10</span>, e0138032. [<a href="https://scholar.google.com/scholar_lookup?title=Optimization+and+Evaluation+of+a+Novel+Size+Based+Circulating+Tumor+Cell+Isolation+System&author=Xu,+L.&publication_year=2015&journal=PLoS+ONE&volume=10&pages=e0138032&doi=10.1371/journal.pone.0138032&pmid=26397728" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1371/journal.pone.0138032" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/26397728" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B41-ijms-18-01885' class='html-xx' data-content='41.'>Hvichia, G.E.; Parveen, Z.; Wagner, C.; Janning, M.; Quidde, J.; Stein, A.; Müller, V.; Loges, S.; Neves, R.P.; Stoecklein, N.H.; et al. A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells. <span class='html-italic'>Int. J. Cancer</span> <b>2016</b>, <span class='html-italic'>138</span>, 2894–2904. [<a href="https://scholar.google.com/scholar_lookup?title=A+novel+microfluidic+platform+for+size+and+deformability+based+separation+and+the+subsequent+molecular+characterization+of+viable+circulating+tumor+cells&author=Hvichia,+G.E.&author=Parveen,+Z.&author=Wagner,+C.&author=Janning,+M.&author=Quidde,+J.&author=Stein,+A.&author=M%C3%BCller,+V.&author=Loges,+S.&author=Neves,+R.P.&author=Stoecklein,+N.H.&publication_year=2016&journal=Int.+J.+Cancer&volume=138&pages=2894%E2%80%932904&doi=10.1002/ijc.30007&pmid=26789903" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/ijc.30007" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/26789903" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B42-ijms-18-01885' class='html-xx' data-content='42.'>Deutsch, T.M.; Riethdorf, S.; Nees, J.; Hartkopf, A.D.; Schönfisch, B.; Domschke, C.; Sprick, M.R.; Schütz, F.; Brucker, S.Y.; Stefanovic, S.; et al. Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer. <span class='html-italic'>Breast Cancer Res. Treat.</span> <b>2016</b>, <span class='html-italic'>160</span>, 277–290. [<a href="https://scholar.google.com/scholar_lookup?title=Impact+of+apoptotic+circulating+tumor+cells+(aCTC)+in+metastatic+breast+cancer&author=Deutsch,+T.M.&author=Riethdorf,+S.&author=Nees,+J.&author=Hartkopf,+A.D.&author=Sch%C3%B6nfisch,+B.&author=Domschke,+C.&author=Sprick,+M.R.&author=Sch%C3%BCtz,+F.&author=Brucker,+S.Y.&author=Stefanovic,+S.&publication_year=2016&journal=Breast+Cancer+Res.+Treat.&volume=160&pages=277%E2%80%93290&doi=10.1007/s10549-016-3997-3&pmid=27696083" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s10549-016-3997-3" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/27696083" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B43-ijms-18-01885' class='html-xx' data-content='43.'>Jansson, S.; Bendahl, P.-O.; Larsson, A.-M.; Aaltonen, K.E.; Rydén, L. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort. <span class='html-italic'>BMC Cancer</span> <b>2016</b>, <span class='html-italic'>16</span>, 433. [<a href="https://scholar.google.com/scholar_lookup?title=Prognostic+impact+of+circulating+tumor+cell+apoptosis+and+clusters+in+serial+blood+samples+from+patients+with+metastatic+breast+cancer+in+a+prospective+observational+cohort&author=Jansson,+S.&author=Bendahl,+P.-O.&author=Larsson,+A.-M.&author=Aaltonen,+K.E.&author=Ryd%C3%A9n,+L.&publication_year=2016&journal=BMC+Cancer&volume=16&pages=433&doi=10.1186/s12885-016-2406-y&pmid=27390845" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1186/s12885-016-2406-y" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/27390845" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B44-ijms-18-01885' class='html-xx' data-content='44.'>Spiliotaki, M.; Mavroudis, D.; Kapranou, K.; Markomanolaki, H.; Kallergi, G.; Koinis, F.; Kalbakis, K.; Georgoulias, V.; Agelaki, S. Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy. <span class='html-italic'>Breast Cancer Res. BCR</span> <b>2014</b>, <span class='html-italic'>16</span>. [<a href="https://scholar.google.com/scholar_lookup?title=Evaluation+of+proliferation+and+apoptosis+markers+in+circulating+tumor+cells+of+women+with+early+breast+cancer+who+are+candidates+for+tumor+dormancy&author=Spiliotaki,+M.&author=Mavroudis,+D.&author=Kapranou,+K.&author=Markomanolaki,+H.&author=Kallergi,+G.&author=Koinis,+F.&author=Kalbakis,+K.&author=Georgoulias,+V.&author=Agelaki,+S.&publication_year=2014&journal=Breast+Cancer+Res.+BCR&volume=16&doi=10.1186/s13058-014-0485-8&pmid=25432416" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1186/s13058-014-0485-8" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/25432416" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B45-ijms-18-01885' class='html-xx' data-content='45.'>Kallergi, G.; Konstantinidis, G.; Markomanolaki, H.; Papadaki, M.A.; Mavroudis, D.; Stournaras, C.; Georgoulias, V.; Agelaki, S. Apoptotic Circulating Tumor Cells in Early and Metastatic Breast Cancer Patients. <span class='html-italic'>Mol. Cancer Ther.</span> <b>2013</b>, <span class='html-italic'>12</span>, 1886–1895. [<a href="https://scholar.google.com/scholar_lookup?title=Apoptotic+Circulating+Tumor+Cells+in+Early+and+Metastatic+Breast+Cancer+Patients&author=Kallergi,+G.&author=Konstantinidis,+G.&author=Markomanolaki,+H.&author=Papadaki,+M.A.&author=Mavroudis,+D.&author=Stournaras,+C.&author=Georgoulias,+V.&author=Agelaki,+S.&publication_year=2013&journal=Mol.+Cancer+Ther.&volume=12&pages=1886%E2%80%931895&doi=10.1158/1535-7163.MCT-12-1167&pmid=23778153" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1535-7163.MCT-12-1167" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23778153" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B46-ijms-18-01885' class='html-xx' data-content='46.'>Rossi, E.; Basso, U.; Celadin, R.; Zilio, F.; Pucciarelli, S.; Aieta, M.; Barile, C.; Sava, T.; Bonciarelli, G.; Tumolo, S.; et al. M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis. <span class='html-italic'>Clin. Cancer Res.</span> <b>2010</b>, <span class='html-italic'>16</span>, 5233–5243. [<a href="https://scholar.google.com/scholar_lookup?title=M30+Neoepitope+Expression+in+Epithelial+Cancer:+Quantification+of+Apoptosis+in+Circulating+Tumor+Cells+by+CellSearch+Analysis&author=Rossi,+E.&author=Basso,+U.&author=Celadin,+R.&author=Zilio,+F.&author=Pucciarelli,+S.&author=Aieta,+M.&author=Barile,+C.&author=Sava,+T.&author=Bonciarelli,+G.&author=Tumolo,+S.&publication_year=2010&journal=Clin.+Cancer+Res.&volume=16&pages=5233%E2%80%935243&doi=10.1158/1078-0432.CCR-10-1449&pmid=20978147" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1078-0432.CCR-10-1449" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20978147" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B47-ijms-18-01885' class='html-xx' data-content='47.'>Dirican, E.; Akkiprik, M.; Özer, A. Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer. <span class='html-italic'>Tumor Biol.</span> <b>2016</b>, <span class='html-italic'>37</span>, 7033–7045. [<a href="https://scholar.google.com/scholar_lookup?title=Mutation+distributions+and+clinical+correlations+of+PIK3CA+gene+mutations+in+breast+cancer&author=Dirican,+E.&author=Akkiprik,+M.&author=%C3%96zer,+A.&publication_year=2016&journal=Tumor+Biol.&volume=37&pages=7033%E2%80%937045&doi=10.1007/s13277-016-4924-2&pmid=26921096" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s13277-016-4924-2" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/26921096" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B48-ijms-18-01885' class='html-xx' data-content='48.'>Mukohara, T. PI3K mutations in breast cancer: Prognostic and therapeutic implications. <span class='html-italic'>Breast Cancer Targets Ther.</span> <b>2015</b>, <span class='html-italic'>7</span>, 111–123. [<a href="https://scholar.google.com/scholar_lookup?title=PI3K+mutations+in+breast+cancer:+Prognostic+and+therapeutic+implications&author=Mukohara,+T.&publication_year=2015&journal=Breast+Cancer+Targets+Ther.&volume=7&pages=111%E2%80%93123&doi=10.2147/BCTT.S60696&pmid=26028978" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.2147/BCTT.S60696" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/26028978" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B49-ijms-18-01885' class='html-xx' data-content='49.'>Markou, A.; Farkona, S.; Schiza, C.; Efstathiou, T.; Kounelis, S.; Malamos, N.; Georgoulias, V.; Lianidou, E. PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer. <span class='html-italic'>Clin. Cancer Res.</span> <b>2014</b>, <span class='html-italic'>20</span>, 5823–5834. [<a href="https://scholar.google.com/scholar_lookup?title=PIK3CA+Mutational+Status+in+Circulating+Tumor+Cells+Can+Change+During+Disease+Recurrence+or+Progression+in+Patients+with+Breast+Cancer&author=Markou,+A.&author=Farkona,+S.&author=Schiza,+C.&author=Efstathiou,+T.&author=Kounelis,+S.&author=Malamos,+N.&author=Georgoulias,+V.&author=Lianidou,+E.&publication_year=2014&journal=Clin.+Cancer+Res.&volume=20&pages=5823%E2%80%935834&doi=10.1158/1078-0432.CCR-14-0149&pmid=25398847" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1078-0432.CCR-14-0149" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/25398847" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B50-ijms-18-01885' class='html-xx' data-content='50.'>Pestrin, M.; Salvianti, F.; Galardi, F.; De Luca, F.; Turner, N.; Malorni, L.; Pazzagli, M.; Di Leo, A.; Pinzani, P. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients. <span class='html-italic'>Mol. Oncol.</span> <b>2015</b>, <span class='html-italic'>9</span>, 749–757. [<a href="https://scholar.google.com/scholar_lookup?title=Heterogeneity+of+PIK3CA+mutational+status+at+the+single+cell+level+in+circulating+tumor+cells+from+metastatic+breast+cancer+patients&author=Pestrin,+M.&author=Salvianti,+F.&author=Galardi,+F.&author=De+Luca,+F.&author=Turner,+N.&author=Malorni,+L.&author=Pazzagli,+M.&author=Di+Leo,+A.&author=Pinzani,+P.&publication_year=2015&journal=Mol.+Oncol.&volume=9&pages=749%E2%80%93757&doi=10.1016/j.molonc.2014.12.001&pmid=25539732" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.molonc.2014.12.001" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/25539732" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B51-ijms-18-01885' class='html-xx' data-content='51.'>Gasch, C.; Oldopp, T.; Mauermann, O.; Gorges, T.M.; Andreas, A.; Coith, C.; Müller, V.; Fehm, T.; Janni, W.; Pantel, K.; et al. Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer. <span class='html-italic'>Mol. Oncol.</span> <b>2016</b>, <span class='html-italic'>10</span>, 1330–1343. [<a href="https://scholar.google.com/scholar_lookup?title=Frequent+detection+of+PIK3CA+mutations+in+single+circulating+tumor+cells+of+patients+suffering+from+HER2-negative+metastatic+breast+cancer&author=Gasch,+C.&author=Oldopp,+T.&author=Mauermann,+O.&author=Gorges,+T.M.&author=Andreas,+A.&author=Coith,+C.&author=M%C3%BCller,+V.&author=Fehm,+T.&author=Janni,+W.&author=Pantel,+K.&publication_year=2016&journal=Mol.+Oncol.&volume=10&pages=1330%E2%80%931343&doi=10.1016/j.molonc.2016.07.005&pmid=27491860" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.molonc.2016.07.005" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/27491860" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B52-ijms-18-01885' class='html-xx' data-content='52.'>Cristofanilli, M.; Budd, G.T.; Ellis, M.J.; Stopeck, A.; Matera, J.; Miller, M.C. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. <span class='html-italic'>N. Engl. J. Med.</span> <b>2004</b>, <span class='html-italic'>351</span>. [<a href="https://scholar.google.com/scholar_lookup?title=Circulating+tumor+cells,+disease+progression,+and+survival+in+metastatic+breast+cancer&author=Cristofanilli,+M.&author=Budd,+G.T.&author=Ellis,+M.J.&author=Stopeck,+A.&author=Matera,+J.&author=Miller,+M.C.&publication_year=2004&journal=N.+Engl.+J.+Med.&volume=351&doi=10.1056/NEJMoa040766&pmid=15317891" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1056/NEJMoa040766" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/15317891" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B53-ijms-18-01885' class='html-xx' data-content='53.'>Choi, J.H.; Ogunniyi, A.O.; Du, M.; Du, M.; Kretschmann, M.; Eberhardt, J.; Love, J.C. Development and optimization of a process for automated recovery of single cells identified by microengraving. <span class='html-italic'>Biotechnol. Prog.</span> <b>2010</b>, <span class='html-italic'>26</span>, 888–895. [<a href="https://scholar.google.com/scholar_lookup?title=Development+and+optimization+of+a+process+for+automated+recovery+of+single+cells+identified+by+microengraving&author=Choi,+J.H.&author=Ogunniyi,+A.O.&author=Du,+M.&author=Du,+M.&author=Kretschmann,+M.&author=Eberhardt,+J.&author=Love,+J.C.&publication_year=2010&journal=Biotechnol.+Prog.&volume=26&pages=888%E2%80%93895&doi=10.1002/btpr.374&pmid=20063389" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/btpr.374" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20063389" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B54-ijms-18-01885' class='html-xx' data-content='54.'>Klein, C.A.; Schmidt-Kittler, O.; Schardt, J.A.; Pantel, K.; Speicher, M.R.; Riethmüller, G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. <span class='html-italic'>Proc. Natl. Acad. Sci. USA</span> <b>1999</b>, <span class='html-italic'>96</span>, 4494–4499. [<a href="https://scholar.google.com/scholar_lookup?title=Comparative+genomic+hybridization,+loss+of+heterozygosity,+and+DNA+sequence+analysis+of+single+cells&author=Klein,+C.A.&author=Schmidt-Kittler,+O.&author=Schardt,+J.A.&author=Pantel,+K.&author=Speicher,+M.R.&author=Riethm%C3%BCller,+G.&publication_year=1999&journal=Proc.+Natl.+Acad.+Sci.+USA&volume=96&pages=4494%E2%80%934499&doi=10.1073/pnas.96.8.4494&pmid=10200290" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1073/pnas.96.8.4494" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/10200290" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B55-ijms-18-01885' class='html-xx' data-content='55.'>Hurst, C.D.; Zuiverloon, T.C.; Hafner, C.; Zwarthoff, E.C.; Knowles, M.A. A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene. <span class='html-italic'>BMC Res. Notes</span> <b>2009</b>, <span class='html-italic'>2</span>, 66. [<a href="https://scholar.google.com/scholar_lookup?title=A+SNaPshot+assay+for+the+rapid+and+simple+detection+of+four+common+hotspot+codon+mutations+in+the+PIK3CA+gene&author=Hurst,+C.D.&author=Zuiverloon,+T.C.&author=Hafner,+C.&author=Zwarthoff,+E.C.&author=Knowles,+M.A.&publication_year=2009&journal=BMC+Res.+Notes&volume=2&pages=66&doi=10.1186/1756-0500-2-66&pmid=19402901" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1186/1756-0500-2-66" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/19402901" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li></ol></section><section id='FiguresandTables' type='display-objects'><div class="html-fig-wrap" id="ijms-18-01885-f001"> <div class='html-fig_img'> <div class="html-figpopup html-figpopup-link" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#fig_body_display_ijms-18-01885-f001"> <img alt="Ijms 18 01885 g001 550" data-large="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g001.png" data-original="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g001.png" data-lsrc="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g001-550.jpg" /> <a class="html-expand html-figpopup" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#fig_body_display_ijms-18-01885-f001"></a> </div> </div> <div class="html-fig_description"> <b>Figure 1.</b> Parsortix™-CellCelector™ workflow. Patients’ blood samples are depleted of EpCAM<span class='html-italic'><sup>high</sup></span> CTCs using CellSearch<sup>®</sup> and enriched for EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells with the Parsortix™ system. Captured cells are stained for nuclei, cytokeratins, epithelial cell adhesion molecule (EpCAM) and CD45 within the Parsortix™ cartridge and then harvested. Tumor cells are detected and isolated via CellCelector™ micromanipulator into PCR tubes for further molecular characterizations. Inspired by our previous work [<a href="#B32-ijms-18-01885" class="html-bibr">32</a>].  </div> </div> <div class="html-fig_show mfp-hide" id ="fig_body_display_ijms-18-01885-f001" > <div class="html-caption" > <b>Figure 1.</b> Parsortix™-CellCelector™ workflow. Patients’ blood samples are depleted of EpCAM<span class='html-italic'><sup>high</sup></span> CTCs using CellSearch<sup>®</sup> and enriched for EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells with the Parsortix™ system. Captured cells are stained for nuclei, cytokeratins, epithelial cell adhesion molecule (EpCAM) and CD45 within the Parsortix™ cartridge and then harvested. Tumor cells are detected and isolated via CellCelector™ micromanipulator into PCR tubes for further molecular characterizations. Inspired by our previous work [<a href="#B32-ijms-18-01885" class="html-bibr">32</a>].</div> <div class="html-img"><img alt="Ijms 18 01885 g001" data-large="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g001.png" data-original="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g001.png" data-lsrc="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g001.png" /></div> </div><div class="html-fig-wrap" id="ijms-18-01885-f002"> <div class='html-fig_img'> <div class="html-figpopup html-figpopup-link" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#fig_body_display_ijms-18-01885-f002"> <img alt="Ijms 18 01885 g002 550" data-large="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g002.png" data-original="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g002.png" data-lsrc="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g002-550.jpg" /> <a class="html-expand html-figpopup" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#fig_body_display_ijms-18-01885-f002"></a> </div> </div> <div class="html-fig_description"> <b>Figure 2.</b> MCF-7 cells and a leukocyte labeled inside the Parsortix™ cassette. (<b>A</b>) MCF-7 cells were spiked into healthy donor blood samples and processed within the Parsortix™ system. After capturing within the cassette, tumour cells were permeabilized and stained in situ, and harvested from the system. In fluorescence microscopy MCF-7 cells exhibit signals for nucleic DNA (DAPI), cytokeratins (TRITC) and epithelial cell adhesion molecule (EpCAM-FITC); they are negative for CD45 expression (Cy5); (<b>B</b>) A leukocyte captured within the Parsortix™ system and stained in situ with the same DAPI/antibodies mastermix, shows positive staining of the nucleus (DAPI) and of CD45 (Cy5). There is no expression of cytokeratins (TRITC) and EpCAM (FITC). Magnification: 40×.  </div> </div> <div class="html-fig_show mfp-hide" id ="fig_body_display_ijms-18-01885-f002" > <div class="html-caption" > <b>Figure 2.</b> MCF-7 cells and a leukocyte labeled inside the Parsortix™ cassette. (<b>A</b>) MCF-7 cells were spiked into healthy donor blood samples and processed within the Parsortix™ system. After capturing within the cassette, tumour cells were permeabilized and stained in situ, and harvested from the system. In fluorescence microscopy MCF-7 cells exhibit signals for nucleic DNA (DAPI), cytokeratins (TRITC) and epithelial cell adhesion molecule (EpCAM-FITC); they are negative for CD45 expression (Cy5); (<b>B</b>) A leukocyte captured within the Parsortix™ system and stained in situ with the same DAPI/antibodies mastermix, shows positive staining of the nucleus (DAPI) and of CD45 (Cy5). There is no expression of cytokeratins (TRITC) and EpCAM (FITC). Magnification: 40×.</div> <div class="html-img"><img alt="Ijms 18 01885 g002" data-large="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g002.png" data-original="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g002.png" data-lsrc="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g002.png" /></div> </div><div class="html-fig-wrap" id="ijms-18-01885-f003"> <div class='html-fig_img'> <div class="html-figpopup html-figpopup-link" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#fig_body_display_ijms-18-01885-f003"> <img alt="Ijms 18 01885 g003 550" data-large="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g003.png" data-original="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g003.png" data-lsrc="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g003-550.jpg" /> <a class="html-expand html-figpopup" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#fig_body_display_ijms-18-01885-f003"></a> </div> </div> <div class="html-fig_description"> <b>Figure 3.</b> Clinical samples containing both EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells. Both subpopulation of potential tumor cells were detected in 54% (28/52) of blood samples of patients enrolled in this project. No correlation in positivity rate between the two fractions of cells was observed.  </div> </div> <div class="html-fig_show mfp-hide" id ="fig_body_display_ijms-18-01885-f003" > <div class="html-caption" > <b>Figure 3.</b> Clinical samples containing both EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells. Both subpopulation of potential tumor cells were detected in 54% (28/52) of blood samples of patients enrolled in this project. No correlation in positivity rate between the two fractions of cells was observed.</div> <div class="html-img"><img alt="Ijms 18 01885 g003" data-large="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g003.png" data-original="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g003.png" data-lsrc="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g003.png" /></div> </div><div class="html-fig-wrap" id="ijms-18-01885-f004"> <div class='html-fig_img'> <div class="html-figpopup html-figpopup-link" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#fig_body_display_ijms-18-01885-f004"> <img alt="Ijms 18 01885 g004 550" data-large="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g004.png" data-original="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g004.png" data-lsrc="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g004-550.jpg" /> <a class="html-expand html-figpopup" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#fig_body_display_ijms-18-01885-f004"></a> </div> </div> <div class="html-fig_description"> <b>Figure 4.</b> Isolated EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells and EpCAM<span class='html-italic'><sup>high</sup></span> cells. (<b>A</b>) Prior isolation of (epithelial cell adhesion molecule ) EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells, selected events were manually scanned at a magnification of 40× in the following channels: DAPI for nucleic DNA, TRITC for cytokeratins, FITC for EpCAM, Cy5 for CD45. EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells show positive staining of nucleic DNA and cytokeratins, very weak or no staining of EpCAM, and no staining of CD45. (<b>B</b>) EpCAM<span class='html-italic'><sup>high</sup></span> cells enriched in CellSearch<sup>®</sup> cartridges were automatically scanned in the abovementioned fluorescent channels, at a magnification of 20×. They exhibit positive staining of nucleic DNA and cytokeratins, and no signals for CD45. After scanning, single cell isolation was performed in DAPI to assure the absence of contaminations.  </div> </div> <div class="html-fig_show mfp-hide" id ="fig_body_display_ijms-18-01885-f004" > <div class="html-caption" > <b>Figure 4.</b> Isolated EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells and EpCAM<span class='html-italic'><sup>high</sup></span> cells. (<b>A</b>) Prior isolation of (epithelial cell adhesion molecule ) EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells, selected events were manually scanned at a magnification of 40× in the following channels: DAPI for nucleic DNA, TRITC for cytokeratins, FITC for EpCAM, Cy5 for CD45. EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells show positive staining of nucleic DNA and cytokeratins, very weak or no staining of EpCAM, and no staining of CD45. (<b>B</b>) EpCAM<span class='html-italic'><sup>high</sup></span> cells enriched in CellSearch<sup>®</sup> cartridges were automatically scanned in the abovementioned fluorescent channels, at a magnification of 20×. They exhibit positive staining of nucleic DNA and cytokeratins, and no signals for CD45. After scanning, single cell isolation was performed in DAPI to assure the absence of contaminations.</div> <div class="html-img"><img alt="Ijms 18 01885 g004" data-large="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g004.png" data-original="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g004.png" data-lsrc="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g004.png" /></div> </div><div class="html-fig-wrap" id="ijms-18-01885-f005"> <div class='html-fig_img'> <div class="html-figpopup html-figpopup-link" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#fig_body_display_ijms-18-01885-f005"> <img alt="Ijms 18 01885 g005 550" data-large="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g005.png" data-original="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g005.png" data-lsrc="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g005-550.jpg" /> <a class="html-expand html-figpopup" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#fig_body_display_ijms-18-01885-f005"></a> </div> </div> <div class="html-fig_description"> <b>Figure 5.</b> PIK3CA Exons 9 and 20 sequencing profiles. Single circulating tumor cells (CTCs) collected from four different patients and sequenced for PIK3CA exon 9 and exon 20 show Phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) hotspot mutations. Two EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs from 2 different patients exhibit the mutation 9/E545K (<b>**</b>) when compared to the sequencing profile of a single MCF-7 cell (<b>**</b>). Two EpCAM<span class='html-italic'><sup>high</sup></span> CTCs from different patients show the mutations 20/H1047R and the 20/H1047L (<b>**</b>) when compared to the sequencing profile of a single T47D cell (<b>**</b>). CTCs recorded as PIK3CA wild-type show no mutations (<b>*</b>). <b>**</b>: base exchange; <b>*</b> wild-type base.  </div> </div> <div class="html-fig_show mfp-hide" id ="fig_body_display_ijms-18-01885-f005" > <div class="html-caption" > <b>Figure 5.</b> PIK3CA Exons 9 and 20 sequencing profiles. Single circulating tumor cells (CTCs) collected from four different patients and sequenced for PIK3CA exon 9 and exon 20 show Phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) hotspot mutations. Two EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs from 2 different patients exhibit the mutation 9/E545K (<b>**</b>) when compared to the sequencing profile of a single MCF-7 cell (<b>**</b>). Two EpCAM<span class='html-italic'><sup>high</sup></span> CTCs from different patients show the mutations 20/H1047R and the 20/H1047L (<b>**</b>) when compared to the sequencing profile of a single T47D cell (<b>**</b>). CTCs recorded as PIK3CA wild-type show no mutations (<b>*</b>). <b>**</b>: base exchange; <b>*</b> wild-type base.</div> <div class="html-img"><img alt="Ijms 18 01885 g005" data-large="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g005.png" data-original="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g005.png" data-lsrc="/ijms/ijms-18-01885/article_deploy/html/images/ijms-18-01885-g005.png" /></div> </div><div class="html-table-wrap" id="ijms-18-01885-t001"> <div class="html-table_wrap_td" > <div class="html-tablepopup html-tablepopup-link" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href='#table_body_display_ijms-18-01885-t001'> <img alt="Table" data-lsrc="https://www.mdpi.com/img/table.png" /> <a class="html-expand html-tablepopup" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#table_body_display_ijms-18-01885-t001"></a> </div> </div> <div class="html-table_wrap_discription"> <b>Table 1.</b> WGA products of patients matched EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells. A cohort of 145 EpCAM<span class='html-italic'><sup>low/negative</sup></span> and 107 EpCAM<span class='html-italic'><sup>high</sup></span> circulating tumor cells (CTCs) was processed for whole genome amplification (WGA). EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs show a lower genomic integrity than EpCAM<span class='html-italic'><sup>high</sup></span> CTCs (8% vs. 28%). #: number of patients involved in the WGA of CTCs. </div> </div> <div class="html-table_show mfp-hide " id ="table_body_display_ijms-18-01885-t001" > <div class="html-caption" ><b>Table 1.</b> WGA products of patients matched EpCAM<span class='html-italic'><sup>high</sup></span> and EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells. A cohort of 145 EpCAM<span class='html-italic'><sup>low/negative</sup></span> and 107 EpCAM<span class='html-italic'><sup>high</sup></span> circulating tumor cells (CTCs) was processed for whole genome amplification (WGA). EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs show a lower genomic integrity than EpCAM<span class='html-italic'><sup>high</sup></span> CTCs (8% vs. 28%). #: number of patients involved in the WGA of CTCs.</div> <table > <thead ><tr ><th rowspan='2' align='center' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-center' >#</th><th rowspan='2' align='center' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-center' >Patient ID</th><th colspan='3' align='center' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-center' >EpCAM<span class='html-italic'><sup>high</sup></span> CTCs</th><th colspan='3' align='center' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-center' >EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs</th></tr><tr ><th align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >Sorted CTCs</th><th align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >High Integrity WGA Products</th><th align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >Low Integrity WGA Products</th><th align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >Sorted CTCs</th><th align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >High Integrity WGA Products</th><th align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >Low INTEGRITY WGA Products</th></tr></thead><tbody ><tr ><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >I</td><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >0</td><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >19</td><td align='center' valign='middle' class='html-align-center' >0</td><td align='center' valign='middle' class='html-align-center' >19</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >V</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >0</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >0</td><td align='center' valign='middle' class='html-align-center' >2</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >VI</td><td align='center' valign='middle' class='html-align-center' >11</td><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >6</td><td align='center' valign='middle' class='html-align-center' >24</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >21</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >4</td><td align='center' valign='middle' class='html-align-center' >VIII</td><td align='center' valign='middle' class='html-align-center' >8</td><td align='center' valign='middle' class='html-align-center' >0</td><td align='center' valign='middle' class='html-align-center' >8</td><td align='center' valign='middle' class='html-align-center' >12</td><td align='center' valign='middle' class='html-align-center' >0</td><td align='center' valign='middle' class='html-align-center' >12</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >IX</td><td align='center' valign='middle' class='html-align-center' >26</td><td align='center' valign='middle' class='html-align-center' >11</td><td align='center' valign='middle' class='html-align-center' >15</td><td align='center' valign='middle' class='html-align-center' >16</td><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >14</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >6</td><td align='center' valign='middle' class='html-align-center' >X</td><td align='center' valign='middle' class='html-align-center' >13</td><td align='center' valign='middle' class='html-align-center' >4</td><td align='center' valign='middle' class='html-align-center' >9</td><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >0</td><td align='center' valign='middle' class='html-align-center' >5</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >7</td><td align='center' valign='middle' class='html-align-center' >XI</td><td align='center' valign='middle' class='html-align-center' >7</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >4</td><td align='center' valign='middle' class='html-align-center' >6</td><td align='center' valign='middle' class='html-align-center' >0</td><td align='center' valign='middle' class='html-align-center' >6</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >8</td><td align='center' valign='middle' class='html-align-center' >XVI</td><td align='center' valign='middle' class='html-align-center' >9</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >8</td><td align='center' valign='middle' class='html-align-center' >27</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >26</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >9</td><td align='center' valign='middle' class='html-align-center' >XXIV (2)</td><td align='center' valign='middle' class='html-align-center' >6</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >4</td><td align='center' valign='middle' class='html-align-center' >0</td><td align='center' valign='middle' class='html-align-center' >4</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >10</td><td align='center' valign='middle' class='html-align-center' >XXXV</td><td align='center' valign='middle' class='html-align-center' >8</td><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >6</td><td align='center' valign='middle' class='html-align-center' >18</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >15</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >11</td><td align='center' valign='middle' class='html-align-center' >XLI</td><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >4</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >12</td><td align='center' valign='middle' class='html-align-center' >XLVI</td><td align='center' valign='middle' class='html-align-center' >7</td><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >4</td><td align='center' valign='middle' class='html-align-center' >0</td><td align='center' valign='middle' class='html-align-center' >4</td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >13</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >XLVII</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >4</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >0</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >4</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >3</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >1</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >2</td></tr><tr ><td align='center' valign='middle' class='html-align-center' > </td><td align='center' valign='middle' class='html-align-center' > </td><td align='center' valign='middle' class='html-align-center' >107</td><td align='center' valign='middle' class='html-align-center' >30</td><td align='center' valign='middle' class='html-align-center' >77</td><td align='center' valign='middle' class='html-align-center' >145</td><td align='center' valign='middle' class='html-align-center' >11</td><td align='center' valign='middle' class='html-align-center' >134</td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >28%</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >72%</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >8%</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >92%</td></tr></tbody> </table> </div><div class="html-table-wrap" id="ijms-18-01885-t002"> <div class="html-table_wrap_td" > <div class="html-tablepopup html-tablepopup-link" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href='#table_body_display_ijms-18-01885-t002'> <img alt="Table" data-lsrc="https://www.mdpi.com/img/table.png" /> <a class="html-expand html-tablepopup" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#table_body_display_ijms-18-01885-t002"></a> </div> </div> <div class="html-table_wrap_discription"> <b>Table 2.</b> Mutational status of PIK3CA exon 9 and exon 20 within patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells. Circulating tumor cells (CTCs) characterized by the heterogeneity of phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) exons 9 and 20 could be detected in 4/10 patients. In the remaining patients, CTCs were classified as PIK3CA-wildtype (WT). #: number of patients involved in the WGA of CTCs. </div> </div> <div class="html-table_show mfp-hide " id ="table_body_display_ijms-18-01885-t002" > <div class="html-caption" ><b>Table 2.</b> Mutational status of PIK3CA exon 9 and exon 20 within patient-matched EpCAM<span class='html-italic'><sup>high</sup></span> EpCAM<span class='html-italic'><sup>low/negative</sup></span> cells. Circulating tumor cells (CTCs) characterized by the heterogeneity of phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA) exons 9 and 20 could be detected in 4/10 patients. In the remaining patients, CTCs were classified as PIK3CA-wildtype (WT). #: number of patients involved in the WGA of CTCs.</div> <table > <tbody ><tr ><td colspan='6' align='center' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-center' ><b>EpCAM<span class='html-italic'><sup>high</sup></span> CTCs</b></td></tr><tr ><td rowspan='2' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >#</td><td rowspan='2' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>Patient ID</b></td><td colspan='2' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>PIK3CA Exon 9 Mutational Analysis</b></td><td colspan='2' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>PIK3CA Exon 20 Mutational Analysis</b></td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>Sequenced CTCs</b></td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>Mutational Status</b></td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>Sequenced CTCs</b></td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>Mutational Status</b></td></tr><tr ><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >I</td><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >VI</td><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >IX</td><td align='center' valign='middle' class='html-align-center' >13</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >11</td><td align='center' valign='middle' class='html-align-center' >2: p.H1047L (c.CAT > CTT); 9: WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >4</td><td align='center' valign='middle' class='html-align-center' >X</td><td align='center' valign='middle' class='html-align-center' >7</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >2: p.H1047R (c.CAT > CGT); 3: WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >XI</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >6</td><td align='center' valign='middle' class='html-align-center' >XVI</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >7</td><td align='center' valign='middle' class='html-align-center' >XXXV</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >8</td><td align='center' valign='middle' class='html-align-center' >XXXVI</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >9</td><td align='center' valign='middle' class='html-align-center' >XLVII</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >10</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >XLVII</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >2</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >WT</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >2</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >1: p.H1047L (c.CAT > CTT); 1: WT</td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >38</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >34</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td></tr><tr ><td colspan='6' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>EpCAM<span class='html-italic'><sup>low/negative</sup></span> CTCs</b></td></tr><tr ><td rowspan='2' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >#</td><td rowspan='2' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>Patient ID</b></td><td colspan='2' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>PIK3CA Exon 9 Mutational Analysis</b></td><td colspan='2' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>PIK3CA Exon 20 Mutational Analysis</b></td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>Sequenced CTCs</b></td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>Mutational Status</b></td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>Sequenced CTCs</b></td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' ><b>Mutational Status</b></td></tr><tr ><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >I</td><td align='center' valign='middle' class='html-align-center' >10</td><td align='center' valign='middle' class='html-align-center' >1: p.E545K (c.CAG > AAG); 9: WT</td><td align='center' valign='middle' class='html-align-center' >7</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >VI</td><td align='center' valign='middle' class='html-align-center' >7</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >7</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >IX</td><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >1: p.E545K (c.CAG > AAG); 4: WT</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >4</td><td align='center' valign='middle' class='html-align-center' >X</td><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >5</td><td align='center' valign='middle' class='html-align-center' >XI</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >6</td><td align='center' valign='middle' class='html-align-center' >XVI</td><td align='center' valign='middle' class='html-align-center' >0</td><td align='center' valign='middle' class='html-align-center' >n.d.</td><td align='center' valign='middle' class='html-align-center' >2</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >7</td><td align='center' valign='middle' class='html-align-center' >XXXV</td><td align='center' valign='middle' class='html-align-center' >8</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >8</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >8</td><td align='center' valign='middle' class='html-align-center' >XXXVI</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >3</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >9</td><td align='center' valign='middle' class='html-align-center' >XLVII</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >WT</td><td align='center' valign='middle' class='html-align-center' >1</td><td align='center' valign='middle' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >10</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >XLVII</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >2</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >WT</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >2</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >WT</td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >39</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >35</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' > </td></tr></tbody> </table> </div><div class="html-table-wrap" id="ijms-18-01885-t003"> <div class="html-table_wrap_td" > <div class="html-tablepopup html-tablepopup-link" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href='#table_body_display_ijms-18-01885-t003'> <img alt="Table" data-lsrc="https://www.mdpi.com/img/table.png" /> <a class="html-expand html-tablepopup" data-counterslinkmanual = "https://www.mdpi.com/1422-0067/18/9/1885/display" href="#table_body_display_ijms-18-01885-t003"></a> </div> </div> <div class="html-table_wrap_discription"> <b>Table 3.</b> Primer sequences for PCR amplification of exons 9 and 20 of PIK3CA and for Sanger sequencing. </div> </div> <div class="html-table_show mfp-hide " id ="table_body_display_ijms-18-01885-t003" > <div class="html-caption" ><b>Table 3.</b> Primer sequences for PCR amplification of exons 9 and 20 of PIK3CA and for Sanger sequencing.</div> <table > <thead ><tr ><th align='center' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-center' >PIK3CA Exon</th><th align='center' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-center' >Primer Name</th><th align='center' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-center' >Sequence (5′→3′)</th><th align='center' valign='middle' style='border-top:solid thin;border-bottom:solid thin' class='html-align-center' >Primer Length (bp)</th></tr></thead><tbody ><tr ><td rowspan='2' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >9</td><td align='center' valign='middle' class='html-align-center' >forward</td><td align='center' valign='middle' class='html-align-center' >CATCCGATGTACCTGATTGAACTGCATGCAGACAAAGAACAGCTCAAAGCAA</td><td align='center' valign='middle' class='html-align-center' >52</td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >reverse</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >CATTCCTTAGATAGCTCGGAAGTCCATTGCATTTTAGCACTTACCTGTGAC</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >52</td></tr><tr ><td rowspan='2' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >20</td><td align='center' valign='middle' class='html-align-center' >forward</td><td align='center' valign='middle' class='html-align-center' >CATCCGATGTACCTGATTGAACTGCATGCATTGATGACATTGCATACATTCG</td><td align='center' valign='middle' class='html-align-center' >52</td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >reverse</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >CATTCCTTAGATAGCTCGGAAGTCCATTGCGTGGAAGATCCAATCCATTT</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >50</td></tr><tr ><td rowspan='2' align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >Sequencing</td><td align='center' valign='middle' class='html-align-center' >forward</td><td align='center' valign='middle' class='html-align-center' >TCCGATGTACCTGATTGAAC</td><td align='center' valign='middle' class='html-align-center' >20</td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >reverse</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >TTCCTTAGATAGCTCGGAAG</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >20</td></tr></tbody> </table> </div></section> <section id="html-copyright"><br>© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href='http://creativecommons.org/licenses/by/4.0/' target='_blank' rel="noopener noreferrer" >http://creativecommons.org/licenses/by/4.0/</a>).</section> </div> </div> <div class="additional-content"> <h2><a name="cite"></a>Share and Cite</h2> <div class="social-media-links" style="text-align: left;"> <a href="/cdn-cgi/l/email-protection#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" title="Email"> <i class="fa fa-envelope-square" style="font-size: 30px;"></i> </a> <a href="https://twitter.com/intent/tweet?text=A+Novel+Workflow+to+Enrich+and+Isolate+Patient-Matched+EpCAMhigh+and+EpCAMlow%2Fnegative+CTCs+Enables+the+Comparative+Characterization+of+the+PIK3CA+Status+in+Metastatic+Breast+Cancer&hashtags=mdpiijms&url=https%3A%2F%2Fwww.mdpi.com%2F220816&via=IJMS_MDPI" onclick="windowOpen(this.href,600,800); return false" target="_blank" rel="noopener noreferrer"> <i class="fa fa-twitter-x-square" style="font-size: 30px;"></i> </a> <a href=" http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.mdpi.com%2F220816&title=A%20Novel%20Workflow%20to%20Enrich%20and%20Isolate%20Patient-Matched%20EpCAMhigh%20and%20EpCAMlow%2Fnegative%20CTCs%20Enables%20the%20Comparative%20Characterization%20of%20the%20PIK3CA%20Status%20in%20Metastatic%20Breast%20Cancer%26source%3Dhttps%3A%2F%2Fwww.mdpi.com%26summary%3DCirculating%20tumor%20cells%20%28CTCs%29%2C%20potential%20precursors%20of%20most%20epithelial%20solid%20tumors%2C%20are%20mainly%20enriched%20by%20epithelial%20cell%20adhesion%20molecule%20%28EpCAM%29-dependent%20technologies.%20Hence%2C%20these%20approaches%20may%20overlook%20mesenchymal%20CTCs%2C%20considered%20highly%20%5B...%5D" onclick="windowOpen(this.href,600,800); return false" title="LinkedIn" target="_blank" rel="noopener noreferrer"> <i class="fa fa-linkedin-square" style="font-size: 30px;"></i> </a> <a href="https://www.facebook.com/sharer.php?u=https://www.mdpi.com/220816" title="facebook" target="_blank" rel="noopener noreferrer"> <i class="fa fa-facebook-square" style="font-size: 30px;"></i> </a> <a href="javascript:void(0);" title="Wechat" data-reveal-id="weixin-share-modal"> <i class="fa fa-weixin-square" style="font-size: 26px;"></i> </a> <a href="http://www.reddit.com/submit?url=https://www.mdpi.com/220816" title="Reddit" target="_blank" rel="noopener noreferrer"> <i class="fa fa-reddit-square" style="font-size: 30px;"></i> </a> <a href="http://www.mendeley.com/import/?url=https://www.mdpi.com/220816" title="Mendeley" target="_blank" rel="noopener noreferrer"> <i class="fa fa-mendeley-square" style="font-size: 30px;"></i> </a> </div> <div class="in-tab" style="padding-top: 0px!important; margin-top: 15px;"> <div><b>MDPI and ACS Style</b></div> <p> Lampignano, R.; Yang, L.; Neumann, M.H.D.; Franken, A.; Fehm, T.; Niederacher, D.; Neubauer, H. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM<sup>high</sup> and EpCAM<sup>low/negative </sup>CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer. <em>Int. J. Mol. Sci.</em> <b>2017</b>, <em>18</em>, 1885. https://doi.org/10.3390/ijms18091885 </p> <div style="display: block"> <b>AMA Style</b><br> <p> Lampignano R, Yang L, Neumann MHD, Franken A, Fehm T, Niederacher D, Neubauer H. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM<sup>high</sup> and EpCAM<sup>low/negative </sup>CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer. <em>International Journal of Molecular Sciences</em>. 2017; 18(9):1885. https://doi.org/10.3390/ijms18091885 </p> <b>Chicago/Turabian Style</b><br> <p> Lampignano, Rita, Liwen Yang, Martin H. D. Neumann, André Franken, Tanja Fehm, Dieter Niederacher, and Hans Neubauer. 2017. "A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM<sup>high</sup> and EpCAM<sup>low/negative </sup>CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer" <em>International Journal of Molecular Sciences</em> 18, no. 9: 1885. https://doi.org/10.3390/ijms18091885 </p> <b>APA Style</b><br> <p> Lampignano, R., Yang, L., Neumann, M. H. D., Franken, A., Fehm, T., Niederacher, D., & Neubauer, H. (2017). A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM<sup>high</sup> and EpCAM<sup>low/negative </sup>CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer. <em>International Journal of Molecular Sciences</em>, <em>18</em>(9), 1885. https://doi.org/10.3390/ijms18091885 </p> </div> </div> <div class="info-box no-margin"> Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details <a target="_blank" href="https://www.mdpi.com/about/announcements/784">here</a>. </div> <h2><a name="metrics"></a>Article Metrics</h2> <div class="row"> <div class="small-12 columns"> <div id="loaded_cite_count" style="display:none">No</div> <div id="framed_div_cited_count" class="in-tab" style="display: none; overflow: auto;"></div> <div id="loaded" style="display:none">No</div> <div id="framed_div" class="in-tab" style="display: none; margin-top: 10px;"></div> </div> <div class="small-12 columns"> <div id="article_stats_div" style="display: none; margin-bottom: 1em;"> <h3>Article Access Statistics</h3> <div id="article_stats_swf" ></div> For more information on the journal statistics, click <a href="/journal/ijms/stats">here</a>. <div class="info-box"> Multiple requests from the same IP address are counted as one view. </div> </div> </div> </div> </div> </div> </article> </div> <div id="supplementaryModal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="Captcha" aria-hidden="true" role="dialog"> <div class="row"> <div class="large-12 medium-12 small-12 columns"> <h2>Supplementary Material</h2> <div class="custom-accordion-for-small-screen-content show-for-medium-up"> <div class="in-tab"> <ul style="margin:0; list-style: none; overflow: auto;"> <li><a name="supplementary_file1"></a><b>Supplementary File 1:</b> <p> <a href="/1422-0067/18/9/1885/s1?version=1504171443"> Supplementary </a> (PDF, 229 KiB) </p> </li> </ul> </div> </div> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> </div></div> <div class="webpymol-controls webpymol-controls-template" style="margin-top: 10px; display: none;"> <a class="bzoom">Zoom</a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="borient"> Orient </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="blines"> As Lines </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bsticks"> As Sticks </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bcartoon"> As Cartoon </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bsurface"> As Surface </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bprevscene">Previous Scene</a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bnextscene">Next Scene</a> </div> <div id="scifeed-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> </div> <div id="recommended-articles-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> </div> <div id="author-biographies-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> </div> <div id="cite-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="Captcha" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 style="margin: 0;">Cite</h2> </div> <div class="small-12 columns">  <form style="margin:0; padding:0; display:inline;" name="export-bibtex" method="POST" action="/export"> <input type="hidden" name="articles_ids[]" value="110408"> <input type="hidden" name="export_format_top" value="bibtex"> <input type="hidden" name="export_submit_top" value=""> </form>  <form style="margin:0; padding:0; display:inline;" name="export-endnote" method="POST" action="/export"> <input type="hidden" name="articles_ids[]" value="110408"> <input type="hidden" name="export_format_top" value="endnote_no_abstract"> <input type="hidden" name="export_submit_top" value=""> </form>  <form style="margin:0; padding:0; display:inline;" name="export-ris" method="POST" action="/export"> <input type="hidden" name="articles_ids[]" value="110408"> <input type="hidden" name="export_format_top" value="ris"> <input type="hidden" name="export_submit_top" value=""> </form> <div> Export citation file: <a href="javascript:window.document.forms['export-bibtex'].submit()">BibTeX</a> | <a href="javascript:window.document.forms['export-endnote'].submit()">EndNote</a> | <a href="javascript:window.document.forms['export-ris'].submit()">RIS</a> </div> </div> <div class="small-12 columns"> <div class="in-tab"> <div><b>MDPI and ACS Style</b></div> <p> Lampignano, R.; Yang, L.; Neumann, M.H.D.; Franken, A.; Fehm, T.; Niederacher, D.; Neubauer, H. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM<sup>high</sup> and EpCAM<sup>low/negative </sup>CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer. <em>Int. J. Mol. Sci.</em> <b>2017</b>, <em>18</em>, 1885. https://doi.org/10.3390/ijms18091885 </p> <div style="display: block"> <b>AMA Style</b><br> <p> Lampignano R, Yang L, Neumann MHD, Franken A, Fehm T, Niederacher D, Neubauer H. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM<sup>high</sup> and EpCAM<sup>low/negative </sup>CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer. <em>International Journal of Molecular Sciences</em>. 2017; 18(9):1885. https://doi.org/10.3390/ijms18091885 </p> <b>Chicago/Turabian Style</b><br> <p> Lampignano, Rita, Liwen Yang, Martin H. D. Neumann, André Franken, Tanja Fehm, Dieter Niederacher, and Hans Neubauer. 2017. "A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM<sup>high</sup> and EpCAM<sup>low/negative </sup>CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer" <em>International Journal of Molecular Sciences</em> 18, no. 9: 1885. https://doi.org/10.3390/ijms18091885 </p> <b>APA Style</b><br> <p> Lampignano, R., Yang, L., Neumann, M. H. D., Franken, A., Fehm, T., Niederacher, D., & Neubauer, H. (2017). A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM<sup>high</sup> and EpCAM<sup>low/negative </sup>CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer. <em>International Journal of Molecular Sciences</em>, <em>18</em>(9), 1885. https://doi.org/10.3390/ijms18091885 </p> </div> </div> <div class="info-box no-margin"> Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details <a target="_blank" href="https://www.mdpi.com/about/announcements/784">here</a>. </div> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> </div> </div> </div> </div> </section> <div id="footer"> <div class="journal-info"> <span> <em><a class="Var_JournalInfo" href="/journal/ijms">Int. J. Mol. Sci.</a></em>, EISSN 1422-0067, Published by MDPI </span> <div class="large-right"> <span> <a href="/rss/journal/ijms" class="rss-link">RSS</a> </span> <span> <a href="/journal/ijms/toc-alert">Content Alert</a> </span> </div> </div> <div class="row full-width footer-links" data-equalizer="footer" data-equalizer-mq="small"> <div class="large-2 large-push-4 medium-3 small-6 columns" data-equalizer-watch="footer"> <h3> Further Information </h3> <a href="/apc"> Article Processing Charges </a> <a href="/about/payment"> Pay an Invoice </a> <a href="/openaccess"> Open Access Policy </a> <a href="/about/contact"> Contact MDPI </a> <a href="https://careers.mdpi.com" target="_blank" rel="noopener noreferrer"> Jobs at MDPI </a> </div> <div class="large-2 large-push-4 medium-3 small-6 columns" data-equalizer-watch="footer"> <h3> Guidelines </h3> <a href="/authors"> For Authors </a> <a href="/reviewers"> For Reviewers </a> <a href="/editors"> For Editors </a> <a href="/librarians"> For Librarians </a> <a href="/publishing_services"> For Publishers </a> <a href="/societies"> For Societies </a> <a href="/conference_organizers"> For Conference Organizers </a> </div> <div class="large-2 large-push-4 medium-3 small-6 columns"> <h3> MDPI Initiatives </h3> <a href="https://sciforum.net" target="_blank" rel="noopener noreferrer"> Sciforum </a> <a href="https://www.mdpi.com/books" target="_blank" rel="noopener noreferrer"> MDPI Books </a> <a href="https://www.preprints.org" target="_blank" rel="noopener noreferrer"> Preprints.org </a> <a href="https://www.scilit.net" target="_blank" rel="noopener noreferrer"> Scilit </a> <a href="https://sciprofiles.com?utm_source=mpdi.com&utm_medium=bottom_menu&utm_campaign=initiative" target="_blank" rel="noopener noreferrer"> SciProfiles </a> <a href="https://encyclopedia.pub" target="_blank" rel="noopener noreferrer"> Encyclopedia </a> <a href="https://jams.pub" target="_blank" rel="noopener noreferrer"> JAMS </a> <a href="/about/proceedings"> Proceedings Series </a> </div> <div class="large-2 large-push-4 medium-3 small-6 right-border-large-without columns UA_FooterFollowMDPI"> <h3> Follow MDPI </h3> <a href="https://www.linkedin.com/company/mdpi" target="_blank" rel="noopener noreferrer"> LinkedIn </a> <a href="https://www.facebook.com/MDPIOpenAccessPublishing" target="_blank" rel="noopener noreferrer"> Facebook </a> <a href="https://twitter.com/MDPIOpenAccess" target="_blank" rel="noopener noreferrer"> Twitter </a> </div> <div id="footer-subscribe" class="large-4 large-pull-8 medium-12 small-12 left-border-large columns"> <div class="footer-subscribe__container"> <img class="show-for-large-up" src="https://pub.mdpi-res.com/img/design/mdpi-pub-logo-white-small.png?71d18e5f805839ab?1732706938" alt="MDPI" title="MDPI Open Access Journals" style="height: 50px; margin-bottom: 10px;"> <form id="newsletter" method="POST" action="/subscribe"> <p> Subscribe to receive issue release notifications and newsletters from MDPI journals </p> <select multiple id="newsletter-journal" class="foundation-select" name="journals[]"> <option value="acoustics">Acoustics</option> <option value="amh">Acta Microbiologica Hellenica</option> <option value="actuators">Actuators</option> <option value="admsci">Administrative Sciences</option> <option value="adolescents">Adolescents</option> <option value="arm">Advances in Respiratory Medicine</option> <option value="aerobiology">Aerobiology</option> <option value="aerospace">Aerospace</option> <option value="agriculture">Agriculture</option> <option value="agriengineering">AgriEngineering</option> <option value="agrochemicals">Agrochemicals</option> <option value="agronomy">Agronomy</option> <option value="ai">AI</option> <option value="air">Air</option> <option value="algorithms">Algorithms</option> <option value="allergies">Allergies</option> <option value="alloys">Alloys</option> <option value="analytica">Analytica</option> <option value="analytics">Analytics</option> <option value="anatomia">Anatomia</option> <option value="anesthres">Anesthesia Research</option> <option value="animals">Animals</option> <option value="antibiotics">Antibiotics</option> <option value="antibodies">Antibodies</option> <option value="antioxidants">Antioxidants</option> <option value="applbiosci">Applied Biosciences</option> <option value="applmech">Applied Mechanics</option> <option value="applmicrobiol">Applied Microbiology</option> <option value="applnano">Applied Nano</option> <option value="applsci">Applied Sciences</option> <option value="asi">Applied System Innovation</option> <option value="appliedchem">AppliedChem</option> <option value="appliedmath">AppliedMath</option> <option value="aquacj">Aquaculture Journal</option> <option value="architecture">Architecture</option> <option value="arthropoda">Arthropoda</option> <option value="arts">Arts</option> <option value="astronomy">Astronomy</option> <option value="atmosphere">Atmosphere</option> <option value="atoms">Atoms</option> <option value="audiolres">Audiology Research</option> <option value="automation">Automation</option> <option value="axioms">Axioms</option> <option value="bacteria">Bacteria</option> <option value="batteries">Batteries</option> <option value="behavsci">Behavioral Sciences</option> <option value="beverages">Beverages</option> <option value="BDCC">Big Data and Cognitive Computing</option> <option value="biochem">BioChem</option> <option value="bioengineering">Bioengineering</option> <option value="biologics">Biologics</option> <option value="biology">Biology</option> <option value="blsf">Biology and Life Sciences Forum</option> <option value="biomass">Biomass</option> <option value="biomechanics">Biomechanics</option> <option value="biomed">BioMed</option> <option value="biomedicines">Biomedicines</option> <option value="biomedinformatics">BioMedInformatics</option> <option value="biomimetics">Biomimetics</option> <option value="biomolecules">Biomolecules</option> <option value="biophysica">Biophysica</option> <option value="biosensors">Biosensors</option> <option value="biotech">BioTech</option> <option value="birds">Birds</option> <option value="blockchains">Blockchains</option> <option value="brainsci">Brain Sciences</option> <option value="buildings">Buildings</option> <option value="businesses">Businesses</option> <option value="carbon">C</option> <option value="cancers">Cancers</option> <option value="cardiogenetics">Cardiogenetics</option> <option value="catalysts">Catalysts</option> <option value="cells">Cells</option> <option value="ceramics">Ceramics</option> <option value="challenges">Challenges</option> <option value="ChemEngineering">ChemEngineering</option> <option value="chemistry">Chemistry</option> <option value="chemproc">Chemistry Proceedings</option> <option value="chemosensors">Chemosensors</option> <option value="children">Children</option> <option value="chips">Chips</option> <option value="civileng">CivilEng</option> <option value="cleantechnol">Clean Technologies</option> <option value="climate">Climate</option> <option value="ctn">Clinical and Translational Neuroscience</option> <option value="clinbioenerg">Clinical Bioenergetics</option> <option value="clinpract">Clinics and Practice</option> <option value="clockssleep">Clocks & Sleep</option> <option value="coasts">Coasts</option> <option value="coatings">Coatings</option> <option value="colloids">Colloids and Interfaces</option> <option value="colorants">Colorants</option> <option value="commodities">Commodities</option> <option value="complications">Complications</option> <option value="compounds">Compounds</option> <option value="computation">Computation</option> <option value="csmf">Computer Sciences & Mathematics Forum</option> <option value="computers">Computers</option> <option value="condensedmatter">Condensed Matter</option> <option value="conservation">Conservation</option> <option value="constrmater">Construction Materials</option> <option value="cmd">Corrosion and Materials Degradation</option> <option value="cosmetics">Cosmetics</option> <option value="covid">COVID</option> <option value="crops">Crops</option> <option value="cryo">Cryo</option> <option value="cryptography">Cryptography</option> <option value="crystals">Crystals</option> <option value="cimb">Current Issues in Molecular Biology</option> <option value="curroncol">Current Oncology</option> <option value="dairy">Dairy</option> <option value="data">Data</option> <option value="dentistry">Dentistry Journal</option> <option value="dermato">Dermato</option> <option value="dermatopathology">Dermatopathology</option> <option value="designs">Designs</option> <option value="diabetology">Diabetology</option> <option value="diagnostics">Diagnostics</option> <option value="dietetics">Dietetics</option> <option value="digital">Digital</option> <option value="disabilities">Disabilities</option> <option value="diseases">Diseases</option> <option value="diversity">Diversity</option> <option value="dna">DNA</option> <option value="drones">Drones</option> <option value="ddc">Drugs and Drug Candidates</option> <option value="dynamics">Dynamics</option> <option value="earth">Earth</option> <option value="ecologies">Ecologies</option> <option value="econometrics">Econometrics</option> <option value="economies">Economies</option> <option value="education">Education Sciences</option> <option value="electricity">Electricity</option> <option value="electrochem">Electrochem</option> <option value="electronicmat">Electronic Materials</option> <option value="electronics">Electronics</option> <option value="ecm">Emergency Care and Medicine</option> <option value="encyclopedia">Encyclopedia</option> <option value="endocrines">Endocrines</option> <option value="energies">Energies</option> <option value="esa">Energy Storage and Applications</option> <option value="eng">Eng</option> <option value="engproc">Engineering Proceedings</option> <option value="entropy">Entropy</option> <option value="environsciproc">Environmental Sciences Proceedings</option> <option value="environments">Environments</option> <option value="epidemiologia">Epidemiologia</option> <option value="epigenomes">Epigenomes</option> <option value="ebj">European Burn Journal</option> <option value="ejihpe">European Journal of Investigation in Health, Psychology and Education</option> <option value="fermentation">Fermentation</option> <option value="fibers">Fibers</option> <option value="fintech">FinTech</option> <option value="fire">Fire</option> <option value="fishes">Fishes</option> <option value="fluids">Fluids</option> <option value="foods">Foods</option> <option value="forecasting">Forecasting</option> <option value="forensicsci">Forensic Sciences</option> <option value="forests">Forests</option> <option value="fossstud">Fossil Studies</option> <option value="foundations">Foundations</option> <option value="fractalfract">Fractal and Fractional</option> <option value="fuels">Fuels</option> <option value="future">Future</option> <option value="futureinternet">Future Internet</option> <option value="futurepharmacol">Future Pharmacology</option> <option value="futuretransp">Future Transportation</option> <option value="galaxies">Galaxies</option> <option value="games">Games</option> <option value="gases">Gases</option> <option value="gastroent">Gastroenterology Insights</option> <option value="gastrointestdisord">Gastrointestinal Disorders</option> <option value="gastronomy">Gastronomy</option> <option value="gels">Gels</option> <option value="genealogy">Genealogy</option> <option value="genes">Genes</option> <option value="geographies">Geographies</option> <option value="geohazards">GeoHazards</option> <option value="geomatics">Geomatics</option> <option value="geometry">Geometry</option> <option value="geosciences">Geosciences</option> <option value="geotechnics">Geotechnics</option> <option value="geriatrics">Geriatrics</option> <option value="glacies">Glacies</option> <option value="gucdd">Gout, Urate, and Crystal Deposition Disease</option> <option value="grasses">Grasses</option> <option value="hardware">Hardware</option> <option value="healthcare">Healthcare</option> <option value="hearts">Hearts</option> <option value="hemato">Hemato</option> <option value="hematolrep">Hematology Reports</option> <option value="heritage">Heritage</option> <option value="histories">Histories</option> <option value="horticulturae">Horticulturae</option> <option value="hospitals">Hospitals</option> <option value="humanities">Humanities</option> <option value="humans">Humans</option> <option value="hydrobiology">Hydrobiology</option> <option value="hydrogen">Hydrogen</option> <option value="hydrology">Hydrology</option> <option value="hygiene">Hygiene</option> <option value="immuno">Immuno</option> <option value="idr">Infectious Disease Reports</option> <option value="informatics">Informatics</option> <option value="information">Information</option> <option value="infrastructures">Infrastructures</option> <option value="inorganics">Inorganics</option> <option value="insects">Insects</option> <option value="instruments">Instruments</option> <option value="iic">Intelligent Infrastructure and Construction</option> <option value="ijerph">International Journal of Environmental Research and Public Health</option> <option value="ijfs">International Journal of Financial Studies</option> <option value="ijms">International Journal of Molecular Sciences</option> <option value="IJNS">International Journal of Neonatal Screening</option> <option value="ijpb">International Journal of Plant Biology</option> <option value="ijt">International Journal of Topology</option> <option value="ijtm">International Journal of Translational Medicine</option> <option value="ijtpp">International Journal of Turbomachinery, Propulsion and Power</option> <option value="ime">International Medical Education</option> <option value="inventions">Inventions</option> <option value="IoT">IoT</option> <option value="ijgi">ISPRS International Journal of Geo-Information</option> <option value="J">J</option> <option value="jal">Journal of Ageing and Longevity</option> <option value="jcdd">Journal of Cardiovascular Development and Disease</option> <option value="jcto">Journal of Clinical & Translational Ophthalmology</option> <option value="jcm">Journal of Clinical Medicine</option> <option value="jcs">Journal of Composites Science</option> <option value="jcp">Journal of Cybersecurity and Privacy</option> <option value="jdad">Journal of Dementia and Alzheimer's Disease</option> <option value="jdb">Journal of Developmental Biology</option> <option value="jeta">Journal of Experimental and Theoretical Analyses</option> <option value="jfb">Journal of Functional Biomaterials</option> <option value="jfmk">Journal of Functional Morphology and Kinesiology</option> <option value="jof">Journal of Fungi</option> <option value="jimaging">Journal of Imaging</option> <option value="jintelligence">Journal of Intelligence</option> <option value="jlpea">Journal of Low Power Electronics and Applications</option> <option value="jmmp">Journal of Manufacturing and Materials Processing</option> <option value="jmse">Journal of Marine Science and Engineering</option> <option value="jmahp">Journal of Market Access & Health Policy</option> <option value="jmp">Journal of Molecular Pathology</option> <option value="jnt">Journal of Nanotheranostics</option> <option value="jne">Journal of Nuclear Engineering</option> <option value="ohbm">Journal of Otorhinolaryngology, Hearing and Balance Medicine</option> <option value="jop">Journal of Parks</option> <option value="jpm">Journal of Personalized Medicine</option> <option value="jpbi">Journal of Pharmaceutical and BioTech Industry</option> <option value="jor">Journal of Respiration</option> <option value="jrfm">Journal of Risk and Financial Management</option> <option value="jsan">Journal of Sensor and Actuator Networks</option> <option value="joma">Journal of the Oman Medical Association</option> <option value="jtaer">Journal of Theoretical and Applied Electronic Commerce Research</option> <option value="jvd">Journal of Vascular Diseases</option> <option value="jox">Journal of Xenobiotics</option> <option value="jzbg">Journal of Zoological and Botanical Gardens</option> <option value="journalmedia">Journalism and Media</option> <option value="kidneydial">Kidney and Dialysis</option> <option value="kinasesphosphatases">Kinases and Phosphatases</option> <option value="knowledge">Knowledge</option> <option value="labmed">LabMed</option> <option value="laboratories">Laboratories</option> <option value="land">Land</option> <option value="languages">Languages</option> <option value="laws">Laws</option> <option value="life">Life</option> <option value="limnolrev">Limnological Review</option> <option value="lipidology">Lipidology</option> <option value="liquids">Liquids</option> <option value="literature">Literature</option> <option value="livers">Livers</option> <option value="logics">Logics</option> <option value="logistics">Logistics</option> <option value="lubricants">Lubricants</option> <option value="lymphatics">Lymphatics</option> <option value="make">Machine Learning and Knowledge Extraction</option> <option value="machines">Machines</option> <option value="macromol">Macromol</option> <option value="magnetism">Magnetism</option> <option value="magnetochemistry">Magnetochemistry</option> <option value="marinedrugs">Marine Drugs</option> <option value="materials">Materials</option> <option value="materproc">Materials Proceedings</option> <option value="mca">Mathematical and Computational Applications</option> <option value="mathematics">Mathematics</option> <option value="medsci">Medical Sciences</option> <option value="msf">Medical Sciences Forum</option> <option value="medicina">Medicina</option> <option value="medicines">Medicines</option> <option value="membranes">Membranes</option> <option value="merits">Merits</option> <option value="metabolites">Metabolites</option> <option value="metals">Metals</option> <option value="meteorology">Meteorology</option> <option value="methane">Methane</option> <option value="mps">Methods and Protocols</option> <option value="metrics">Metrics</option> <option value="metrology">Metrology</option> <option value="micro">Micro</option> <option value="microbiolres">Microbiology Research</option> <option value="micromachines">Micromachines</option> <option value="microorganisms">Microorganisms</option> <option value="microplastics">Microplastics</option> <option value="minerals">Minerals</option> <option value="mining">Mining</option> <option value="modelling">Modelling</option> <option value="mmphys">Modern Mathematical Physics</option> <option value="molbank">Molbank</option> <option value="molecules">Molecules</option> <option value="mti">Multimodal Technologies and Interaction</option> <option value="muscles">Muscles</option> <option value="nanoenergyadv">Nanoenergy Advances</option> <option value="nanomanufacturing">Nanomanufacturing</option> <option value="nanomaterials">Nanomaterials</option> <option value="ndt">NDT</option> <option value="network">Network</option> <option value="neuroglia">Neuroglia</option> <option value="neurolint">Neurology International</option> <option value="neurosci">NeuroSci</option> <option value="nitrogen">Nitrogen</option> <option value="ncrna">Non-Coding RNA</option> <option value="nursrep">Nursing Reports</option> <option value="nutraceuticals">Nutraceuticals</option> <option value="nutrients">Nutrients</option> <option value="obesities">Obesities</option> <option value="oceans">Oceans</option> <option value="onco">Onco</option> <option value="optics">Optics</option> <option value="oral">Oral</option> <option value="organics">Organics</option> <option value="organoids">Organoids</option> <option value="osteology">Osteology</option> <option value="oxygen">Oxygen</option> <option value="parasitologia">Parasitologia</option> <option value="particles">Particles</option> <option value="pathogens">Pathogens</option> <option value="pathophysiology">Pathophysiology</option> <option value="pediatrrep">Pediatric Reports</option> <option value="pets">Pets</option> <option value="pharmaceuticals">Pharmaceuticals</option> <option value="pharmaceutics">Pharmaceutics</option> <option value="pharmacoepidemiology">Pharmacoepidemiology</option> <option value="pharmacy">Pharmacy</option> <option value="philosophies">Philosophies</option> <option value="photochem">Photochem</option> <option value="photonics">Photonics</option> <option value="phycology">Phycology</option> <option value="physchem">Physchem</option> <option value="psf">Physical Sciences Forum</option> <option value="physics">Physics</option> <option value="physiologia">Physiologia</option> <option value="plants">Plants</option> <option value="plasma">Plasma</option> <option value="platforms">Platforms</option> <option value="pollutants">Pollutants</option> <option value="polymers">Polymers</option> <option value="polysaccharides">Polysaccharides</option> <option value="populations">Populations</option> <option value="poultry">Poultry</option> <option value="powders">Powders</option> <option value="proceedings">Proceedings</option> <option value="processes">Processes</option> <option value="prosthesis">Prosthesis</option> <option value="proteomes">Proteomes</option> <option value="psychiatryint">Psychiatry International</option> <option value="psychoactives">Psychoactives</option> <option value="psycholint">Psychology International</option> <option value="publications">Publications</option> <option value="qubs">Quantum Beam Science</option> <option value="quantumrep">Quantum Reports</option> <option value="quaternary">Quaternary</option> <option value="radiation">Radiation</option> <option value="reactions">Reactions</option> <option value="realestate">Real Estate</option> <option value="receptors">Receptors</option> <option value="recycling">Recycling</option> <option value="rsee">Regional Science and Environmental Economics</option> <option value="religions">Religions</option> <option value="remotesensing">Remote Sensing</option> <option value="reports">Reports</option> <option value="reprodmed">Reproductive Medicine</option> <option value="resources">Resources</option> <option value="rheumato">Rheumato</option> <option value="risks">Risks</option> <option value="robotics">Robotics</option> <option value="ruminants">Ruminants</option> <option value="safety">Safety</option> <option value="sci">Sci</option> <option value="scipharm">Scientia Pharmaceutica</option> <option value="sclerosis">Sclerosis</option> <option value="seeds">Seeds</option> <option value="sensors">Sensors</option> <option value="separations">Separations</option> <option value="sexes">Sexes</option> <option value="signals">Signals</option> <option value="sinusitis">Sinusitis</option> <option value="smartcities">Smart Cities</option> <option value="socsci">Social Sciences</option> <option value="siuj">Société Internationale d’Urologie Journal</option> <option value="societies">Societies</option> <option value="software">Software</option> <option value="soilsystems">Soil Systems</option> <option value="solar">Solar</option> <option value="solids">Solids</option> <option value="spectroscj">Spectroscopy Journal</option> <option value="sports">Sports</option> <option value="standards">Standards</option> <option value="stats">Stats</option> <option value="stresses">Stresses</option> <option value="surfaces">Surfaces</option> <option value="surgeries">Surgeries</option> <option value="std">Surgical Techniques Development</option> <option value="sustainability">Sustainability</option> <option value="suschem">Sustainable Chemistry</option> <option value="symmetry">Symmetry</option> <option value="synbio">SynBio</option> <option value="systems">Systems</option> <option value="targets">Targets</option> <option value="taxonomy">Taxonomy</option> <option value="technologies">Technologies</option> <option value="telecom">Telecom</option> <option value="textiles">Textiles</option> <option value="thalassrep">Thalassemia Reports</option> <option value="therapeutics">Therapeutics</option> <option value="thermo">Thermo</option> <option value="timespace">Time and Space</option> <option value="tomography">Tomography</option> <option value="tourismhosp">Tourism and Hospitality</option> <option value="toxics">Toxics</option> <option value="toxins">Toxins</option> <option value="transplantology">Transplantology</option> <option value="traumacare">Trauma Care</option> <option value="higheredu">Trends in Higher Education</option> <option value="tropicalmed">Tropical Medicine and Infectious Disease</option> <option value="universe">Universe</option> <option value="urbansci">Urban Science</option> <option value="uro">Uro</option> <option value="vaccines">Vaccines</option> <option value="vehicles">Vehicles</option> <option value="venereology">Venereology</option> <option value="vetsci">Veterinary Sciences</option> <option value="vibration">Vibration</option> <option value="virtualworlds">Virtual Worlds</option> <option value="viruses">Viruses</option> <option value="vision">Vision</option> <option value="waste">Waste</option> <option value="water">Water</option> <option value="wild">Wild</option> <option value="wind">Wind</option> <option value="women">Women</option> <option value="world">World</option> <option value="wevj">World Electric Vehicle Journal</option> <option value="youth">Youth</option> <option value="zoonoticdis">Zoonotic Diseases</option> </select> <input name="email" type="email" placeholder="Enter your email address..." required="required" /> <button class="genericCaptcha button button--dark UA_FooterNewsletterSubscribeButton" type="submit">Subscribe</button> </form> </div> </div> </div> <div id="footer-copyright"> <div class="row"> <div class="columns large-6 medium-6 small-12 text-left"> © 1996-2024 MDPI (Basel, Switzerland) unless otherwise stated </div> <div class="columns large-6 medium-6 small-12 small-text-left medium-text-right large-text-right"> <a data-dropdown="drop-view-disclaimer" aria-controls="drop-view-disclaimer" aria-expanded="false" data-options="align:top; is_hover:true; hover_timeout:2000;"> Disclaimer </a> <div id="drop-view-disclaimer" class="f-dropdown label__btn__dropdown label__btn__dropdown--wide text-left" data-dropdown-content aria-hidden="true" tabindex="-1"> Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. </div> <a href="/about/terms-and-conditions"> Terms and Conditions </a> <a href="/about/privacy"> Privacy Policy </a> </div> </div> </div> </div> <div id="cookie-notification" class="js-allow-cookies" style="display: none;"> <div class="columns large-10 medium-10 small-12"> We use cookies on our website to ensure you get the best experience.<br class="show-for-medium-up"/> Read more about our cookies <a href="/about/privacy">here</a>. </div> <div class="columns large-2 medium-2 small-12 small-only-text-left text-right"> <a class="button button--default" href="/accept_cookies">Accept</a> </div> </div> </div> <div id="main-share-modal" class="reveal-modal reveal-modal-new reveal-modal-new--small" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 style="margin: 0;">Share Link</h2> </div> <div class="small-12 columns"> <div class="social-media-links UA_ShareModalLinks" style="text-align: left;"> <a href="/cdn-cgi/l/email-protection#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" title="Email"> <i class="fa fa-envelope-square" style="font-size: 30px;"></i> </a> <a href="https://twitter.com/intent/tweet?text=A+Novel+Workflow+to+Enrich+and+Isolate+Patient-Matched+EpCAMhigh+and+EpCAMlow%2Fnegative+CTCs+Enables+the+Comparative+Characterization+of+the+PIK3CA+Status+in+Metastatic+Breast+Cancer&hashtags=mdpiijms&url=https%3A%2F%2Fwww.mdpi.com%2F220816&via=IJMS_MDPI" onclick="windowOpen(this.href,600,800); return false" title="Twitter" target="_blank" rel="noopener noreferrer"> <i class="fa fa-twitter-x-square" style="font-size: 30px;"></i> </a> <a href=" http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.mdpi.com%2F220816&title=A%20Novel%20Workflow%20to%20Enrich%20and%20Isolate%20Patient-Matched%20EpCAMhigh%20and%20EpCAMlow%2Fnegative%20CTCs%20Enables%20the%20Comparative%20Characterization%20of%20the%20PIK3CA%20Status%20in%20Metastatic%20Breast%20Cancer%26source%3Dhttps%3A%2F%2Fwww.mdpi.com%26summary%3DCirculating%20tumor%20cells%20%28CTCs%29%2C%20potential%20precursors%20of%20most%20epithelial%20solid%20tumors%2C%20are%20mainly%20enriched%20by%20epithelial%20cell%20adhesion%20molecule%20%28EpCAM%29-dependent%20technologies.%20Hence%2C%20these%20approaches%20may%20overlook%20mesenchymal%20CTCs%2C%20considered%20highly%20%5B...%5D" onclick="windowOpen(this.href,600,800); return false" title="LinkedIn" target="_blank" rel="noopener noreferrer"> <i class="fa fa-linkedin-square" style="font-size: 30px;"></i> </a> <a href="https://www.facebook.com/sharer.php?u=https://www.mdpi.com/220816" title="facebook" target="_blank" rel="noopener noreferrer"> <i class="fa fa-facebook-square" style="font-size: 30px;"></i> </a> <a href="javascript:void(0);" title="Wechat" data-reveal-id="weixin-share-modal"> <i class="fa fa-weixin-square" style="font-size: 26px;"></i> </a> <a href="http://www.reddit.com/submit?url=https://www.mdpi.com/220816" title="Reddit" target="_blank" rel="noopener noreferrer"> <i class="fa fa-reddit-square" style="font-size: 30px;"></i> </a> <a href="http://www.mendeley.com/import/?url=https://www.mdpi.com/220816" title="Mendeley" target="_blank" rel="noopener noreferrer"> <i class="fa fa-mendeley-square" style="font-size: 30px;"></i> </a> <a href="http://www.citeulike.org/posturl?url=https://www.mdpi.com/220816" title="CiteULike" target="_blank" rel="noopener noreferrer"> <i class="fa fa-citeulike-square" style="font-size: 30px;"></i> </a> </div> </div> <div class="small-9 columns"> <input id="js-clipboard-text" type="text" readonly value="https://www.mdpi.com/220816" /> </div> <div class="small-3 columns text-left"> <a class="button button--color js-clipboard-copy" data-clipboard-target="#js-clipboard-text">Copy</a> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div id="weixin-share-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="weixin-share-modal-title" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 id="weixin-share-modal-title" style="margin: 0;">Share</h2> </div> <div class="small-12 columns"> <div class="weixin-qr-code-section"> <?xml version="1.0" standalone="no"?> <!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd"> <svg width="300" height="300" version="1.1" xmlns="http://www.w3.org/2000/svg"> <desc>https://www.mdpi.com/220816</desc> <g id="elements" fill="black" stroke="none"> <rect x="0" y="0" width="12" height="12" /> <rect x="12" y="0" width="12" height="12" /> <rect x="24" y="0" width="12" height="12" /> <rect x="36" y="0" width="12" height="12" /> <rect x="48" y="0" width="12" height="12" /> <rect x="60" y="0" width="12" height="12" /> <rect x="72" y="0" width="12" height="12" /> <rect x="132" y="0" width="12" height="12" /> <rect x="144" y="0" width="12" height="12" /> <rect x="156" y="0" width="12" height="12" /> <rect x="168" y="0" width="12" height="12" /> <rect x="216" y="0" width="12" height="12" /> <rect x="228" y="0" width="12" height="12" /> <rect x="240" y="0" width="12" height="12" /> <rect x="252" y="0" width="12" height="12" /> <rect x="264" y="0" width="12" height="12" /> <rect x="276" y="0" width="12" height="12" /> <rect x="288" y="0" width="12" height="12" /> <rect x="0" y="12" width="12" height="12" /> <rect x="72" y="12" width="12" height="12" /> <rect x="108" y="12" width="12" height="12" /> <rect x="120" y="12" width="12" height="12" /> <rect x="156" y="12" width="12" height="12" /> <rect x="216" y="12" width="12" height="12" /> <rect x="288" y="12" width="12" height="12" /> <rect x="0" y="24" width="12" height="12" /> <rect x="24" y="24" width="12" height="12" /> <rect x="36" y="24" width="12" height="12" /> <rect x="48" y="24" width="12" height="12" /> <rect x="72" y="24" width="12" height="12" /> <rect x="144" y="24" width="12" height="12" /> <rect x="168" y="24" width="12" height="12" /> <rect x="192" y="24" width="12" height="12" /> <rect x="216" y="24" width="12" height="12" /> <rect x="240" y="24" width="12" height="12" /> <rect x="252" y="24" width="12" height="12" /> <rect x="264" y="24" width="12" height="12" /> <rect x="288" y="24" width="12" height="12" /> <rect x="0" y="36" width="12" height="12" /> <rect x="24" y="36" width="12" height="12" /> <rect x="36" y="36" width="12" height="12" /> <rect x="48" y="36" width="12" height="12" /> <rect x="72" y="36" width="12" height="12" /> <rect x="96" y="36" width="12" height="12" /> <rect x="144" y="36" width="12" height="12" /> <rect x="156" y="36" width="12" height="12" /> <rect x="180" y="36" width="12" height="12" /> <rect x="192" y="36" width="12" height="12" /> <rect x="216" y="36" width="12" height="12" /> <rect x="240" y="36" width="12" height="12" /> <rect x="252" y="36" width="12" height="12" /> <rect x="264" y="36" width="12" height="12" /> <rect x="288" y="36" width="12" height="12" /> <rect x="0" y="48" width="12" height="12" /> <rect x="24" y="48" width="12" height="12" /> <rect x="36" y="48" width="12" height="12" /> <rect x="48" y="48" width="12" height="12" /> <rect x="72" y="48" width="12" height="12" /> <rect x="96" y="48" width="12" height="12" /> <rect x="108" y="48" width="12" height="12" /> <rect x="156" y="48" width="12" height="12" /> <rect x="216" y="48" width="12" height="12" /> <rect x="240" y="48" width="12" height="12" /> <rect x="252" y="48" width="12" height="12" /> <rect x="264" y="48" width="12" height="12" /> <rect x="288" y="48" width="12" height="12" /> <rect x="0" y="60" width="12" height="12" /> <rect x="72" y="60" width="12" height="12" /> <rect x="132" y="60" width="12" height="12" /> <rect x="144" y="60" width="12" height="12" /> <rect x="156" y="60" width="12" height="12" /> <rect x="168" y="60" width="12" height="12" /> <rect x="192" y="60" width="12" height="12" /> <rect x="216" y="60" width="12" height="12" /> <rect x="288" y="60" width="12" height="12" /> <rect x="0" y="72" width="12" height="12" /> <rect x="12" y="72" width="12" height="12" /> <rect x="24" y="72" width="12" height="12" /> <rect x="36" y="72" width="12" height="12" /> <rect x="48" y="72" width="12" height="12" /> <rect x="60" y="72" width="12" height="12" /> <rect x="72" y="72" width="12" height="12" /> <rect x="96" y="72" width="12" height="12" /> <rect x="120" y="72" width="12" height="12" /> <rect x="144" y="72" width="12" height="12" /> <rect x="168" y="72" width="12" height="12" /> <rect x="192" y="72" width="12" height="12" /> <rect x="216" y="72" width="12" height="12" /> <rect x="228" y="72" width="12" height="12" /> <rect x="240" y="72" width="12" height="12" /> <rect x="252" y="72" width="12" height="12" /> <rect x="264" y="72" width="12" height="12" /> <rect x="276" y="72" width="12" height="12" /> <rect x="288" y="72" width="12" height="12" /> <rect x="120" y="84" width="12" height="12" /> <rect x="132" y="84" width="12" height="12" /> <rect x="168" y="84" width="12" height="12" /> <rect x="0" y="96" width="12" height="12" /> <rect x="12" y="96" width="12" height="12" /> <rect x="60" y="96" width="12" height="12" /> <rect x="72" y="96" width="12" height="12" /> <rect x="84" y="96" width="12" height="12" /> <rect x="108" y="96" width="12" height="12" /> <rect x="132" y="96" width="12" height="12" /> <rect x="144" y="96" width="12" height="12" /> <rect x="156" y="96" width="12" height="12" /> <rect x="168" y="96" width="12" height="12" /> <rect x="240" y="96" width="12" height="12" /> <rect x="252" y="96" width="12" height="12" /> <rect x="0" y="108" width="12" height="12" /> <rect x="24" y="108" width="12" height="12" /> <rect x="84" y="108" width="12" height="12" /> <rect x="96" y="108" width="12" height="12" /> <rect x="108" y="108" width="12" height="12" /> <rect x="144" y="108" width="12" height="12" /> <rect x="156" y="108" width="12" height="12" /> <rect x="168" y="108" width="12" height="12" /> <rect x="180" y="108" width="12" height="12" /> <rect x="204" y="108" width="12" height="12" /> <rect x="228" y="108" width="12" height="12" /> <rect x="240" y="108" width="12" height="12" /> <rect x="252" y="108" width="12" height="12" /> <rect x="264" y="108" width="12" height="12" /> <rect x="276" y="108" width="12" height="12" /> <rect x="24" y="120" width="12" height="12" /> <rect x="36" y="120" width="12" height="12" /> <rect x="60" y="120" width="12" height="12" /> <rect x="72" y="120" width="12" height="12" /> <rect x="96" y="120" width="12" height="12" /> <rect x="120" y="120" width="12" height="12" /> <rect x="144" y="120" width="12" height="12" /> <rect x="168" y="120" width="12" height="12" /> <rect x="180" y="120" width="12" height="12" /> <rect x="204" y="120" width="12" height="12" /> <rect x="216" y="120" width="12" height="12" /> <rect x="228" y="120" width="12" height="12" /> <rect x="240" y="120" width="12" height="12" /> <rect x="252" y="120" width="12" height="12" /> <rect x="276" y="120" width="12" height="12" /> <rect x="288" y="120" width="12" height="12" /> <rect x="48" y="132" width="12" height="12" /> <rect x="108" y="132" width="12" height="12" /> <rect x="132" y="132" width="12" height="12" /> <rect x="168" y="132" width="12" height="12" /> <rect x="204" y="132" width="12" height="12" /> <rect x="228" y="132" width="12" height="12" /> <rect x="252" y="132" width="12" height="12" /> <rect x="288" y="132" width="12" height="12" /> <rect x="12" y="144" width="12" height="12" /> <rect x="60" y="144" width="12" height="12" /> <rect x="72" y="144" width="12" height="12" /> <rect x="84" y="144" width="12" height="12" /> <rect x="96" y="144" width="12" height="12" /> <rect x="108" y="144" width="12" height="12" /> <rect x="132" y="144" width="12" height="12" /> <rect x="168" y="144" width="12" height="12" /> <rect x="180" y="144" width="12" height="12" /> <rect x="216" y="144" width="12" height="12" /> <rect x="288" y="144" width="12" height="12" /> <rect x="0" y="156" width="12" height="12" /> <rect x="12" y="156" width="12" height="12" /> <rect x="24" y="156" width="12" height="12" /> <rect x="84" y="156" width="12" height="12" /> <rect x="96" y="156" width="12" height="12" /> <rect x="108" y="156" width="12" height="12" /> <rect x="132" y="156" width="12" height="12" /> <rect x="144" y="156" width="12" height="12" /> <rect x="156" y="156" width="12" height="12" /> <rect x="180" y="156" width="12" height="12" /> <rect x="192" y="156" width="12" height="12" /> <rect x="204" y="156" width="12" height="12" /> <rect x="228" y="156" width="12" height="12" /> <rect x="276" y="156" width="12" height="12" /> <rect x="0" y="168" width="12" height="12" /> <rect x="48" y="168" width="12" height="12" /> <rect x="60" y="168" width="12" height="12" /> <rect x="72" y="168" width="12" height="12" /> <rect x="156" y="168" width="12" height="12" /> <rect x="168" y="168" width="12" height="12" /> <rect x="180" y="168" width="12" height="12" /> <rect x="204" y="168" width="12" height="12" /> <rect x="216" y="168" width="12" height="12" /> <rect x="228" y="168" width="12" height="12" /> <rect x="240" y="168" width="12" height="12" /> <rect x="252" y="168" width="12" height="12" /> <rect x="276" y="168" width="12" height="12" /> <rect x="288" y="168" width="12" height="12" /> <rect x="0" y="180" width="12" height="12" /> <rect x="84" y="180" width="12" height="12" /> <rect x="96" y="180" width="12" height="12" /> <rect x="108" y="180" width="12" height="12" /> <rect x="144" y="180" width="12" height="12" /> <rect x="204" y="180" width="12" height="12" /> <rect x="228" y="180" width="12" height="12" /> <rect x="252" y="180" width="12" height="12" /> <rect x="264" y="180" width="12" height="12" /> <rect x="288" y="180" width="12" height="12" /> <rect x="0" y="192" width="12" height="12" /> <rect x="48" y="192" width="12" height="12" /> <rect x="72" y="192" width="12" height="12" /> <rect x="84" y="192" width="12" height="12" /> <rect x="96" y="192" width="12" height="12" /> <rect x="120" y="192" width="12" height="12" /> <rect x="156" y="192" width="12" height="12" /> <rect x="180" y="192" width="12" height="12" /> <rect x="192" y="192" width="12" height="12" /> <rect x="204" y="192" width="12" height="12" /> <rect x="216" y="192" width="12" height="12" /> <rect x="228" y="192" width="12" height="12" /> <rect x="240" y="192" width="12" height="12" /> <rect x="264" y="192" width="12" height="12" /> <rect x="96" y="204" width="12" height="12" /> <rect x="108" y="204" width="12" height="12" /> <rect x="132" y="204" width="12" height="12" /> <rect x="144" y="204" width="12" height="12" /> <rect x="168" y="204" width="12" height="12" /> <rect x="192" y="204" width="12" height="12" /> <rect x="240" y="204" width="12" height="12" /> <rect x="0" y="216" width="12" height="12" /> <rect x="12" y="216" width="12" height="12" /> <rect x="24" y="216" width="12" height="12" /> <rect x="36" y="216" width="12" height="12" /> <rect x="48" y="216" width="12" height="12" /> <rect x="60" y="216" width="12" height="12" /> <rect x="72" y="216" width="12" height="12" /> <rect x="96" y="216" width="12" height="12" /> <rect x="132" y="216" width="12" height="12" /> <rect x="144" y="216" width="12" height="12" /> <rect x="168" y="216" width="12" height="12" /> <rect x="192" y="216" width="12" height="12" /> <rect x="216" y="216" width="12" height="12" /> <rect x="240" y="216" width="12" height="12" /> <rect x="288" y="216" width="12" height="12" /> <rect x="0" y="228" width="12" height="12" /> <rect x="72" y="228" width="12" height="12" /> <rect x="96" y="228" width="12" height="12" /> <rect x="108" y="228" width="12" height="12" /> <rect x="144" y="228" width="12" height="12" /> <rect x="180" y="228" width="12" height="12" /> <rect x="192" y="228" width="12" height="12" /> <rect x="240" y="228" width="12" height="12" /> <rect x="276" y="228" width="12" height="12" /> <rect x="0" y="240" width="12" height="12" /> <rect x="24" y="240" width="12" height="12" /> <rect x="36" y="240" width="12" height="12" /> <rect x="48" y="240" width="12" height="12" /> <rect x="72" y="240" width="12" height="12" /> <rect x="108" y="240" width="12" height="12" /> <rect x="132" y="240" width="12" height="12" /> <rect x="156" y="240" width="12" height="12" /> <rect x="180" y="240" width="12" height="12" /> <rect x="192" y="240" width="12" height="12" /> <rect x="204" y="240" width="12" height="12" /> <rect x="216" y="240" width="12" height="12" /> <rect x="228" y="240" width="12" height="12" /> <rect x="240" y="240" width="12" height="12" /> <rect x="264" y="240" width="12" height="12" /> <rect x="0" y="252" width="12" height="12" /> <rect x="24" y="252" width="12" height="12" /> <rect x="36" y="252" width="12" height="12" /> <rect x="48" y="252" width="12" height="12" /> <rect x="72" y="252" width="12" height="12" /> <rect x="108" y="252" width="12" height="12" /> <rect x="120" y="252" width="12" height="12" /> <rect x="132" y="252" width="12" height="12" /> <rect x="144" y="252" width="12" height="12" /> <rect x="180" y="252" width="12" height="12" /> <rect x="192" y="252" width="12" height="12" /> <rect x="216" y="252" width="12" height="12" /> <rect x="276" y="252" width="12" height="12" /> <rect x="288" y="252" width="12" height="12" /> <rect x="0" y="264" width="12" height="12" /> <rect x="24" y="264" width="12" height="12" /> <rect x="36" y="264" width="12" height="12" /> <rect x="48" y="264" width="12" height="12" /> <rect x="72" y="264" width="12" height="12" /> <rect x="144" y="264" width="12" height="12" /> <rect x="156" y="264" width="12" height="12" /> <rect x="192" y="264" width="12" height="12" /> <rect x="252" y="264" width="12" height="12" /> <rect x="264" y="264" width="12" height="12" /> <rect x="288" y="264" width="12" height="12" /> <rect x="0" y="276" width="12" height="12" /> <rect x="72" y="276" width="12" height="12" /> <rect x="96" y="276" width="12" height="12" /> <rect x="108" y="276" width="12" height="12" /> <rect x="120" y="276" width="12" height="12" /> <rect x="144" y="276" width="12" height="12" /> <rect x="192" y="276" width="12" height="12" /> <rect x="204" y="276" width="12" height="12" /> <rect x="228" y="276" width="12" height="12" /> <rect x="240" y="276" width="12" height="12" /> <rect x="288" y="276" width="12" height="12" /> <rect x="0" y="288" width="12" height="12" /> <rect x="12" y="288" width="12" height="12" /> <rect x="24" y="288" width="12" height="12" /> <rect x="36" y="288" width="12" height="12" /> <rect x="48" y="288" width="12" height="12" /> <rect x="60" y="288" width="12" height="12" /> <rect x="72" y="288" width="12" height="12" /> <rect x="96" y="288" width="12" height="12" /> <rect x="108" y="288" width="12" height="12" /> <rect x="120" y="288" width="12" height="12" /> <rect x="132" y="288" width="12" height="12" /> <rect x="168" y="288" width="12" height="12" /> <rect x="192" y="288" width="12" height="12" /> <rect x="204" y="288" width="12" height="12" /> <rect x="252" y="288" width="12" height="12" /> <rect x="288" y="288" width="12" height="12" /> </g> </svg> </div> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <a href="#" class="back-to-top"><span class="show-for-medium-up">Back to Top</span><span class="show-for-small">Top</span></a> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="https://pub.mdpi-res.com/assets/js/modernizr-2.8.3.min.js?5227e0738f7f421d?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/jquery-1.12.4.min.js?4f252523d4af0b47?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/foundation-5.5.3.min.js?6b2ec41c18b29054?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/foundation-5.5.3.equalizer.min.js?0f6c549b75ec554c?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/jquery.multiselect.js?0edd3998731d1091?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/jquery.cycle2.min.js?63413052928f97ee?1732706938"></script> <script> // old browser fix - this way the console log rows won't throw (silent) errors in browsers not supporting console log if (!window.console) window.console = {}; if (!window.console.log) window.console.log = function () { }; var currentJournalNameSystem = "ijms"; $(document).ready(function() { $('select.foundation-select').multiselect({ search: true, minHeight: 130, maxHeight: 130, }); $(document).foundation({ orbit: { timer_speed: 4000, }, reveal: { animation: 'fadeAndPop', animation_speed: 100, } }); $(".chosen-select").each(function(element) { var maxSelected = (undefined !== $(this).data('maxselectedoptions') ? $(this).data('maxselectedoptions') : 100); $(this).on('chosen:ready', function(event, data) { var select = $(data.chosen.form_field); if (select.attr('id') === 'journal-browser-volume') { $(data.chosen.dropdown).addClass('UI_JournalBrowser_Volume_Options'); } if (select.attr('id') === 'journal-browser-issue') { $(data.chosen.dropdown).addClass('UI_JournalBrowser_Issue_Options'); } }).chosen({ display_disabled_options: false, disable_search_threshold: 7, max_selected_options: maxSelected, width: "100%" }); }); $(".toEncode").each(function(e) { var oldHref = $(this).attr("href"); var newHref = oldHref.replace('.botdefense.please.enable.javascript.','@'); $(this).attr("href", newHref); if (!$(this).hasClass("emailCaptcha")) { $(this).html(newHref.replace('mailto:', '')); } $(this).removeClass("visibility-hidden"); }); $(document).on('opened.fndtn.reveal', '[data-reveal]', function() { $(document).foundation('equalizer', 'reflow'); }); // fix the images that have tag height / width defined // otherwise the default foundation styles overwrite the tag definitions $("img").each(function() { if ($(this).attr('width') != undefined || $(this).attr('height') != undefined) { $(this).addClass("img-fixed"); } }); $("#basic_search, #advanced_search").submit(function(e) { var searchArguments = false; $(this).find("input,select").not("#search,.search-button").each(function() { if (undefined === $(this).val() || "" === $(this).val()) { $(this).attr('name', null); } else { $(this).attr('name'); searchArguments = true; } }); if (!searchArguments) { window.location = $(this).attr('action'); return false; } }); $(".hide-show-desktop-option").click(function(e) { e.preventDefault(); var parentDiv = $(this).closest("div"); $.ajax({ url: $(this).attr('href'), success: function(msg) { parentDiv.removeClass().hide(); } }); }); $(".generic-toggleable-header").click(function(e) { $(this).toggleClass("active"); $(this).next(".generic-toggleable-content").toggleClass("active"); }); /* * handle whole row as a link if the row contains only one visible link */ $("table.new tr").hover(function() { if ($(this).find("td:visible a").length == 1) { $(this).addClass("single-link"); } }, function() { $(this).removeClass("single-link"); }); $("table.new:not(.table-of-tables)").on("click", "tr.single-link", function(e) { var target = $(e.target); if (!e.ctrlKey && !target.is("a")) { $(this).find("td:visible a")[0].click(); } }); $(document).on("click", ".custom-accordion-for-small-screen-link", function(e) { if ($(this).closest("#basic_search").length > 0) { if ($(".search-container__advanced").first().is(":visible")) { openAdvanced() } } if (Foundation.utils.is_small_only()) { if ($(this).hasClass("active")) { $(this).removeClass("active"); $(this).next(".custom-accordion-for-small-screen-content").addClass("show-for-medium-up"); } else { $(this).addClass("active"); $(this).next(".custom-accordion-for-small-screen-content").removeClass("show-for-medium-up"); $(document).foundation('orbit', 'reflow'); } } if (undefined !== $(this).data("callback")) { var customCallback = $(this).data("callback"); func = window[customCallback]; func(); } }); $(document).on("click", ".js-open-small-search", function(e) { e.preventDefault(); $(this).toggleClass("active").closest(".tab-bar").toggleClass("active"); $(".search-container").toggleClass("hide-for-small-down"); }); $(document).on("click", ".js-open-menu", function(e) { $(".search-container").addClass("hide-for-small-down"); }); $(window).on('resize', function() { recalculate_main_browser_position(); recalculate_responsive_moving_containers(); }); updateSearchLabelVisibilities(); recalculate_main_browser_position(); recalculate_responsive_moving_containers(); if (window.document.documentMode == 11) { $("<link/>", { rel: "stylesheet", type: "text/css", href: "https://fonts.googleapis.com/icon?family=Material+Icons"}).appendTo("head"); } }); function recalculate_main_browser_position() { if (Foundation.utils.is_small_only()) { if ($("#js-main-top-container").parent("#js-large-main-top-container").length > 0) { $("#js-main-top-container").appendTo($("#js-small-main-top-container")); } } else { if ($("#js-main-top-container").parent("#js-small-main-top-container").length > 0) { $("#js-main-top-container").appendTo($("#js-large-main-top-container")); } } } function recalculate_responsive_moving_containers() { $(".responsive-moving-container.large").each(function() { var previousParent = $(".responsive-moving-container.active[data-id='"+$(this).data("id")+"']"); var movingContent = previousParent.html(); if (Foundation.utils.is_small_only()) { var currentParent = $(".responsive-moving-container.small[data-id='"+$(this).data("id")+"']"); } else if (Foundation.utils.is_medium_only()) { var currentParent = $(".responsive-moving-container.medium[data-id='"+$(this).data("id")+"']"); } else { var currentParent = $(".responsive-moving-container.large[data-id='"+$(this).data("id")+"']"); } if (previousParent.attr("class") !== currentParent.attr("class")) { currentParent.html(movingContent); previousParent.html(); currentParent.addClass("active"); previousParent.removeClass("active"); } }); } // cookies allowed is checked from a) local storage and b) from server separately so that the footer bar doesn't // get included in the custom page caches function checkCookiesAllowed() { var cookiesEnabled = localStorage.getItem("mdpi_cookies_enabled"); if (null === cookiesEnabled) { $.ajax({ url: "/ajax_cookie_value/mdpi_cookies_accepted", success: function(data) { if (data.value) { localStorage.setItem("mdpi_cookies_enabled", true); checkDisplaySurvey(); } else { $(".js-allow-cookies").show(); } } }); } else { checkDisplaySurvey(); } } function checkDisplaySurvey() { } window.addEventListener('CookiebotOnAccept', function (e) { var CookieDate = new Date; if (Cookiebot.consent.preferences) { CookieDate.setFullYear(CookieDate.getFullYear() + 1); document.cookie = "mdpi_layout_type_v2=mobile; path=/; expires=" + CookieDate.toUTCString() + ";"; $(".js-toggle-desktop-layout-link").css("display", "inline-block"); } }, false); window.addEventListener('CookiebotOnDecline', function (e) { if (!Cookiebot.consent.preferences) { $(".js-toggle-desktop-layout-link").hide(); if ("" === "desktop") { window.location = "/toggle_desktop_layout_cookie"; } } }, false); var hash = $(location).attr('hash'); if ("#share" === hash) { if (1 === $("#main-share-modal").length) { $('#main-share-modal').foundation('reveal', 'open'); } } </script> <script src="https://pub.mdpi-res.com/assets/js/lib.js?f8d3d71b3a772f9d?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/mdpi.js?c267ce58392b15da?1732706938"></script> <script>var banners_url = 'https://serve.mdpi.com';</script> <script type='text/javascript' src='https://pub.mdpi-res.com/assets/js/ifvisible.min.js?c621d19ecb761212?1732706938'></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/affix.js?ac4ea55275297c15?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/clipboard.min.js?3f3688138a1b9fc4?1732706938"></script> <script type="text/javascript"> $(document).ready(function() { var helpFunctions = $(".middle-column__help__fixed"); var leftColumnAffix = $(".left-column__fixed"); var middleColumn = $("#middle-column"); var clone = null; helpFunctions.affix({ offset: { top: function() { return middleColumn.offset().top - 8 - (Foundation.utils.is_medium_only() ? 30 : 0); }, bottom: function() { return $("#footer").innerHeight() + 74 + (Foundation.utils.is_medium_only() ? 0 : 0); } } }); if (leftColumnAffix.length > 0) { clone = leftColumnAffix.clone(); clone.addClass("left-column__fixed__affix"); clone.insertBefore(leftColumnAffix); clone.css('width', leftColumnAffix.outerWidth() + 50); clone.affix({ offset: { top: function() { return leftColumnAffix.offset().top - 30 - (Foundation.utils.is_medium_only() ? 50 : 0); }, bottom: function() { return $("#footer").innerHeight() + 92 + (Foundation.utils.is_medium_only() ? 0 : 0); } } }); } $(window).on("resize", function() { if (clone !== null) { clone.css('width', leftColumnAffix.outerWidth() + 50); } }); new ClipboardJS('.js-clipboard-copy'); }); </script> <script src="https://pub.mdpi-res.com/assets/js/jquery-ui-1.13.2.min.js?1e2047978946a1d2?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/slick.min.js?d5a61c749e44e471?1732706938"></script> <script> $(document).ready(function() { $(".link-article-menu").click(function(e) { e.preventDefault(); $(this).find('span').toggle(); $(this).next("div").toggleClass("active"); }); $(".js-similarity-related-articles").click(function(e) { e.preventDefault(); if ('' !== $('#recommended-articles-modal').attr('data-url')) { $('#recommended-articles-modal').foundation('reveal', 'open', $('#recommended-articles-modal').attr('data-url')); } }); $.ajax({ url: "/article/110408/similarity-related/show-link", success: function(result) { if (result.show) { $('#recommended-articles-modal').attr('data-url', result.link); $('.js-article-similarity-container').show(); } } }); $(document).on('opened.fndtn.reveal', '[data-reveal]', function() { var modal = $(this); if (modal.attr('id') === "author-biographies-modal") { modal.find('.multiple-items').slick({ slidesToShow: 1, nextArrow: '<a class="slick-next" href="#"><i class="material-icons">chevron_right</i></a>', prevArrow: '<a class="slick-prev" href="#"><i class="material-icons">chevron_left</i></a>', slidesToScroll: 1, draggable: false, }); modal.find('.multiple-items').slick('refresh'); } }); }); </script> <script> $(document).ready(function() { $(document).on('keyup', function (e) { if (e.keyCode == 27) { var hElem = $(this).find(".annotator-adder"); if (hElem.length){ hElem.css({'visibility':'hidden'}); } else { document.querySelector("hypothesis-adder").shadowRoot.querySelector(".annotator-adder").style.visibility = "hidden"; } } }); }); </script> <script> window.hypothesisConfig = function () { return { sidebarAppUrl: 'https://commenting.mdpi.com/app.html', showHighlights: 'whenSidebarOpen' , openSidebar: false , assetRoot: 'https://commentingres.mdpi.com/hypothesis', services: [{ apiUrl: 'https://commenting.mdpi.com/api/', authority: 'mdpi', grantToken: '', doi: '10.3390/ijms18091885' }], }; }; </script> <script async id="hypothesis_frame"></script> <script type="text/javascript"> if (-1 !== window.location.href.indexOf("?src=")) { window.history.replaceState({}, '', `${location.pathname}`); } $(document).ready(function() { var scifeedCounter = 0; var search = window.location.search; var mathjaxReady = false; // late image file loading $("img[data-lsrc]").each(function() { $(this).attr("src", $(this).data("lsrc")); }); // late mathjax initialization var head = document.getElementsByTagName("head")[0]; var script = document.createElement("script"); script.type = "text/x-mathjax-config"; script[(window.opera ? "innerHTML" : "text")] = "MathJax.Hub.processSectionDelay = 0;\n" + "MathJax.Hub.Config({\n" + " \"menuSettings\": {\n" + " CHTMLpreview: false\n" + " },\n" + " \"CHTML-preview\":{\n" + " disabled: true\n" + " },\n" + " \"HTML-CSS\": {\n" + " scale: 90,\n" + " availableFonts: [],\n" + " preferredFont: null,\n" + " preferredFonts: null,\n" + " webFont:\"Gyre-Pagella\",\n" + " imageFont:'TeX',\n" + " undefinedFamily:\"'Arial Unicode MS',serif\",\n" + " linebreaks: { automatic: false }\n" + " },\n" + " \"TeX\": {\n" + " extensions: ['noErrors.js'],\n" + " noErrors: {\n" + " inlineDelimiters: [\"\",\"\"],\n" + " multiLine: true,\n" + " style: {\n" + " 'font-size': '90%',\n" + " 'text-align': 'left',\n" + " 'color': 'black',\n" + " 'padding': '1px 3px',\n" + " 'border': '1px solid'\n" + " }\n" + " }\n" + " }\n" + "});\n" + "MathJax.Hub.Register.StartupHook('End', function() {\n" + " refreshMathjaxWidths();\n" + " mathjaxReady = true;\n" + "});\n" + "MathJax.Hub.Startup.signal.Interest(function (message) {\n" + " if (message == 'End') {\n" + " var hypoLink = document.getElementById('hypothesis_frame');\n" + " if (null !== hypoLink) {\n" + " hypoLink.setAttribute('src', 'https://commenting.mdpi.com/embed.js');\n" + " }\n" + " }\n" + "});"; head.appendChild(script); script = document.createElement("script"); script.type = "text/javascript"; script.src = "https://pub.mdpi-res.com/bundles/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"; head.appendChild(script); // article version checker if (0 === search.indexOf('?type=check_update&version=')) { $.ajax({ url: "/1422-0067/18/9/1885" + "/versioncheck" + search, success: function(result) { $(".js-check-update-container").html(result); } }); } $('#feed_option').click(function() { // tracker if ($('#scifeed_clicked').length<1) { $(this).append('<span style="display:none" id="scifeed_clicked">done</span>'); } $('#feed_data').toggle('slide', { direction: 'up'}, '1000'); // slideToggle(700); OR toggle(700) $("#scifeed_error_msg").html('').hide(); $("#scifeed_notice_msg").html('').hide(); }); $('#feed_option').click(function(event) { setTimeout(function(){ var captchaSection = $("#captchaSection"); captchaSection.removeClass('ui-helper-hidden').find('input').prop('disabled', false); // var img = captchaSection.find('img'); // img.attr('src', img.data('url') + "?" + (new Date()).getTime()); // $(".captcha_reload").trigger("click"); var img = document.getElementById('gregwar_captcha_scifeed'); img.src = '/generate-captcha/gcb_captcha?n=' + (new Date()).getTime(); },800); }); $(document).on('click', '.split_feeds', function() { var name = $( this ).attr('name'); var flag = 1 - ($(this).is(":checked")*1); $('.split_feeds').each(function (index) { if ($( this ).attr('name') !== name) { $(this)[0].checked = flag; } }); }); $(document).on('click', '#scifeed_submit, #scifeed_submit1', function(event) { event.preventDefault(); $(".captcha_reload").trigger("click"); $("#scifeed_error_msg").html(""); $("#scifeed_error_msg").hide(); }); $(document).on('click', '.subscription_toggle', function(event) { if ($(this).val() === 'Create SciFeed' && $('#scifeed_hidden_flag').length>0) { event.preventDefault(); // alert('Here there would be a captcha because user is not logged in'); var captchaSection = $("#captchaSection"); if (captchaSection.hasClass('ui-helper-hidden')) { captchaSection.removeClass('ui-helper-hidden').find('input').prop('disabled', false); var img = captchaSection.find('img'); img.attr('src', img.data('url') + "?" + (new Date()).getTime()); $("#reloadCaptcha").trigger("click"); } } }); $(document).on('click', '.scifeed_msg', function(){ $(this).hide(); }); $(document).on('click', '.article-scilit-search', function(e) { e.preventDefault(); var data = $(".article-scilit-search-data").val(); var dataArray = data.split(';').map(function(keyword) { return "(\"" + keyword.trim() + "\")"; }); var searchQuery = dataArray.join(" OR "); var searchUrl = encodeURI("https://www.scilit.net/articles/search?q="+ searchQuery + "&advanced=1&highlight=1"); var win = window.open(searchUrl, '_blank'); if (win) { win.focus(); } else { window.location(searchUrl); } }); display_stats(); citedCount(); follow_goto(); // Select the node that will be observed for mutations const targetNodes = document.getElementsByClassName('hypothesis-count-container'); // Options for the observer (which mutations to observe) const config = { attributes: false, childList: true, subtree: false }; // Callback function to execute when mutations are observed const callback = function(mutationList, observer) { for(const mutation of mutationList) { if (mutation.type === 'childList') { let node = $(mutation.target); if (parseInt(node.html()) > 0) { node.show(); } } } }; // Create an observer instance linked to the callback function const observer = new MutationObserver(callback); // Start observing the target node for configured mutations for(const targetNode of targetNodes) { observer.observe(targetNode, config); } // Select the node that will be observed for mutations const mathjaxTargetNode = document.getElementById('middle-column'); // Callback function to execute when mutations are observed const mathjaxCallback = function(mutationList, observer) { if (mathjaxReady && typeof(MathJax) !== 'undefined') { refreshMathjaxWidths(); } }; // Create an observer instance linked to the callback function const mathjaxObserver = new ResizeObserver(mathjaxCallback); // Start observing the target node for configured mutations mathjaxObserver.observe(mathjaxTargetNode); }); /* END $(document).ready */ function refreshMathjaxWidths() { let width = ($('.html-body').width()*0.9) + "px"; $('.MathJax_Display').css('max-width', width); $('.MJXc-display').css('max-width', width); } function sendScifeedFrom(form) { if (!$('#scifeed_email').val().trim()) { // empty email alert('Please, provide an email for subscribe to this scifeed'); return false; } else if (!$('#captchaSection').hasClass('ui-helper-hidden') && !$('#captchaSection').find('input').val().trim()) { // empty captcha alert('Please, fill the captcha field.'); return false; } else if( ((($('#scifeed_form').find('input:checkbox:checked').length)-($('#split_feeds:checked').length))<1) || ($('#scifeed_kwd_txt').length < 0 && !$('#scifeed_kwd_txt').val().trim()) || ($('#scifeed_author_txt').length<0 &&!$('#scifeed_author_txt').val().trim()) ) { alert('You did not select anything to subscribe'); return false; } else if(($('#scifeed_form').find('input:checkbox:checked').length)-($('#split_feeds2:checked').length)<1){ alert("You did not select anything to subscribe"); return false; } else { var url = $('#scifeed_subscribe_url').html(); var formData = $(form).serializeArray(); $.post(url, formData).done(function (data) { if (JSON.parse(data)) { $('.scifeed_msg').hide(); var res = JSON.parse(data); var successFeeds = 0; var errorFeeds = 0; if (res) { $('.scifeed_msg').html(''); $.each(res, function (index, val) { if (val) { if (val.error) { errorFeeds++; $("#scifeed_error_msg").append(index+' - '+val.error+'<br>'); } if (val.notice) // for successful feed creation { successFeeds++; // $("#scifeed_notice_msg").append(index+' - '+val.notice+'<br>'); $("#scifeed_notice_msg").append('<li>'+index+'</li>'); } } }); if (successFeeds>0) { text = $('#scifeed_notice_msg').html(); text = 'The following feed'+(successFeeds>1?'s have':' has')+ ' been sucessfully created:<br><ul>'+ text + '</ul>' +($('#scifeed_hidden_flag').length>0 ? 'You are not logged in, so you probably need to validate '+ (successFeeds>1?'them':' it')+'.<br>' :'' ) +'Please check your email'+(successFeeds>1?'s':'')+' for more details.'; //(successFeeds>1?' for each of them':'')+'.<br>'; $("#scifeed_notice_msg").html(text); $("#scifeed_notice_msg").show(); } if (errorFeeds>0) { $("#scifeed_error_msg").show();; } } $("#feed_data").hide(); } }); } } function follow_goto() { var hashStr = location.hash.replace("#",""); if(typeof hashStr !== 'undefined') { if( hashStr == 'supplementary') { document.getElementById('suppl_id').scrollIntoView(); } if( hashStr == 'citedby') { document.getElementById('cited_id').scrollIntoView(); } } } function cited() { $("#framed_div").toggle('fast', function(){ if ($(this).css('display') != 'none') { var loaded = document.getElementById("loaded"); if(loaded.innerHTML == "No") { // Load Xref result var container = document.getElementById("framed_div"); // This replace the content container.innerHTML = "<img src=\"https://pub.mdpi-res.com/img/loading_circle.gif?9a82694213036313?1732706938\" height=\"20\" width=\"20\" alt=\"Processing...\" style=\"vertical-align:middle; margin-right:0.6em;\">"; var url = "/citedby/10.3390%252Fijms18091885/2"; $.post(url, function(result) { if (result.success) { container.innerHTML = result.view; } loaded.innerHTML = "Yes"; }); } } return true; // for not going at the beginning of the page... }) return true; // for not going at the beginning of the page... } function detect_device() { // Added by Bastien (18/08/2014): based on the http://detectmobilebrowsers.com/ detector var check = false; (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows (ce|phone)|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4)))check = true})(navigator.userAgent||navigator.vendor||window.opera); return check; } function display_stats(){ $("#article_stats_div").toggle(); return false; } /* * Cited By Scopus */ function citedCount(){ $("#framed_div_cited_count").toggle('fast', function(){ if ($(this).css('display') != 'none') { var loaded = document.getElementById("loaded_cite_count"); // to load only once the result! if(loaded.innerHTML == "No") { // Load Xref result var d = document.getElementById("framed_div_cited_count"); // This replace the content d.innerHTML = "<img src=\"https://pub.mdpi-res.com/img/loading_circle.gif?9a82694213036313?1732706938\" height=\"20\" width=\"20\" alt=\"Processing...\" style=\"vertical-align:middle; margin-right:0.6em;\">"; $.ajax({ method : "POST", url : "/cite-count/10.3390%252Fijms18091885", success : function(data) { if (data.succ) { d.innerHTML = data.view; loaded.innerHTML = "Yes"; follow_goto(); } } }); } } // end else return true; // for not going at the beginning of the page... }) return true; // for not going at the beginning of the page... } </script><script type="text/javascript" src="https://pub.mdpi-res.com/assets/js/third-party/highcharts/highcharts.js?bdd06f45e34c33df?1732706938"></script><script type="text/javascript" src="https://pub.mdpi-res.com/assets/js/third-party/highcharts/modules/exporting.js?944dc938d06de3a8?1732706938"></script><script type="text/javascript" defer="defer"> var advancedStatsData; var selectedStatsType = "abstract"; $(function(){ var countWrapper = $('#counts-wrapper'); $('#author_stats_id #type_links a').on('click', function(e) { e.preventDefault(); selectedStatsType = $(this).data('type'); $('#article_advanced_stats').vectorMap('set', 'values', advancedStatsData[selectedStatsType]); $('#advanced_stats_max').html(advancedStatsData[selectedStatsType].max); $('#type_links a').removeClass('active'); $(this).addClass('active'); }); $.get('/1422-0067/18/9/1885/stats', function (result) { if (!result.success) { return; } // process article metrics part in left column var viewNumber = countWrapper.find(".view-number"); viewNumber.html(result.metrics.views); viewNumber.parent().toggleClass("count-div--grey", result.metrics.views == 0); var downloadNumber = countWrapper.find(".download-number"); downloadNumber.html(result.metrics.downloads); downloadNumber.parent().toggleClass("count-div--grey", result.metrics.downloads == 0); var citationsNumber = countWrapper.find(".citations-number"); citationsNumber.html(result.metrics.citations); citationsNumber.parent().toggleClass("count-div--grey", result.metrics.citations == 0); if (result.metrics.views > 0 || result.metrics.downloads > 0 || result.metrics.citations > 0) { countWrapper.find("#js-counts-wrapper__views, #js-counts-wrapper__downloads").addClass("visible").show(); if (result.metrics.citations > 0) { countWrapper.find('.citations-number').html(result.metrics.citations).show(); countWrapper.find("#js-counts-wrapper__citations").addClass("visible").show(); } else { countWrapper.find("#js-counts-wrapper__citations").remove(); } $("[data-id='article-counters']").removeClass("hidden"); } if (result.metrics.altmetrics_score > 0) { $("#js-altmetrics-donut").show(); } // process view chart in main column var jsondata = result.chart; var series = new Array(); $.each(jsondata.elements, function(i, element) { var dataValues = new Array(); $.each(element.values, function(i, value) { dataValues.push(new Array(value.tip, value.value)); }); series[i] = {name: element.text, data:dataValues}; }); Highcharts.setOptions({ chart: { style: { fontFamily: 'Arial,sans-serif' } } }); $('#article_stats_swf').highcharts({ chart: { type: 'line', width: $("#tabs").width() //* 0.91 }, credits: { enabled: false }, exporting: { enabled: true }, title: { text: jsondata.title.text, x: -20 //center }, xAxis: { categories: jsondata.x_axis.labels.labels, offset: jsondata.x_axis.offset, labels:{ step: jsondata.x_axis.labels.steps, rotation: 30 } }, yAxis: { max: jsondata.y_axis.max, min: jsondata.y_axis.min, offset: jsondata.y_axis.offset, labels: { steps: jsondata.y_axis.steps }, title: { enabled: false } }, tooltip: { formatter: function (){ return this.key.replace("#val#", this.y); } }, legend: { align: 'top', itemDistance: 50 }, series: series }); }); $('#supplement_link').click(function() { document.getElementById('suppl_id').scrollIntoView(); }); $('#stats_link').click(function() { document.getElementById('stats_id').scrollIntoView(); }); // open mol viewer for molbank special supplementary files $('.showJmol').click(function(e) { e.preventDefault(); var jmolModal = $("#jmolModal"); var url = "/article/110408/jsmol_viewer/__supplementary_id__"; url = url.replace(/__supplementary_id__/g, $(this).data('index')); $('#jsmol-content').attr('src', url); jmolModal.find(".content").html($(this).data('description')); jmolModal.foundation("reveal", "open"); }); }); !function() { "use strict"; function e(e) { try { if ("undefined" == typeof console) return; "error"in console ? console.error(e) : console.log(e) } catch (e) {} } function t(e) { return d.innerHTML = '<a href="' + e.replace(/"/g, """) + '"></a>', d.childNodes[0].getAttribute("href") || "" } function n(n, c) { var o = ""; var k = parseInt(n.substr(c + 4, 2), 16); for (var i = c; i < n.length; i += 2) { if (i != c + 4) { var s = parseInt(n.substr(i, 2), 16) ^ k; o += String.fromCharCode(s); } } try { o = decodeURIComponent(escape(o)); } catch (error) { console.error(error); } return t(o); } function c(t) { for (var r = t.querySelectorAll("a"), c = 0; c < r.length; c++) try { var o = r[c] , a = o.href.indexOf(l); a > -1 && (o.href = "mailto:" + n(o.href, a + l.length)) } catch (i) { e(i) } } function o(t) { for (var r = t.querySelectorAll(u), c = 0; c < r.length; c++) try { var o = r[c] , a = o.parentNode , i = o.getAttribute(f); if (i) { var l = n(i, 0) , d = document.createTextNode(l); a.replaceChild(d, o) } } catch (h) { e(h) } } function a(t) { for (var r = t.querySelectorAll("template"), n = 0; n < r.length; n++) try { i(r[n].content) } catch (c) { e(c) } } function i(t) { try { c(t), o(t), a(t) } catch (r) { e(r) } } var l = "/cnd-cgi/l/email-protection#" , u = ".__cf_email__" , f = "data-cfemail" , d = document.createElement("div"); i(document), function() { var e = document.currentScript || document.scripts[document.scripts.length - 1]; e.parentNode.removeChild(e) }() }(); </script><script type="text/javascript"> function setCookie(cname, cvalue, ctime) { ctime = (typeof ctime === 'undefined') ? 10*365*24*60*60*1000 : ctime; // default => 10 years var d = new Date(); d.setTime(d.getTime() + ctime); // ==> 1 hour = 60*60*1000 var expires = "expires="+d.toUTCString(); document.cookie = cname + "=" + cvalue + "; " + expires +"; path=/"; } function getCookie(cname) { var name = cname + "="; var ca = document.cookie.split(';'); for(var i=0; i<ca.length; i++) { var c = ca[i]; while (c.charAt(0)==' ') c = c.substring(1); if (c.indexOf(name) == 0) return c.substring(name.length, c.length); } return ""; } </script><script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script><script> $(document).ready(function() { if ($("#js-similarity-related-data").length > 0) { $.ajax({ url: '/article/110408/similarity-related', success: function(response) { $("#js-similarity-related-data").html(response); $("#js-related-articles-menu").show(); $(document).foundation('tab', 'reflow'); MathJax.Hub.Queue(["Typeset", MathJax.Hub]); } }); } }); </script><link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/jquery-ui-1.10.4.custom.min.css?80647d88647bf347?1732706938"><link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/magnific-popup.min.css?04d343e036f8eecd?1732706938"><script type="text/javascript" src="https://pub.mdpi-res.com/assets/js/magnific-popup.min.js?2be3d9e7dc569146?1732706938"></script><script> $(function() { $(".js-show-more-academic-editors").on("click", function(e) { e.preventDefault(); $(this).hide(); $(".academic-editor-container").removeClass("hidden"); }); }); </script> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/vmap/jqvmap.min.css?126a06688aa11c13?1732706938"> <script src="https://pub.mdpi-res.com/assets/js/vmap/jquery.vmap.min.js?935f68d33bdd88a1?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/vmap/jquery.vmap.world.js?16677403c0e1bef1?1732706938"></script> <script> function updateSlick() { $('.multiple-items').slick('setPosition'); } $(document).ready(function() { $('.multiple-items').slick({ slidesToShow: 1, nextArrow: '<a class="slick-next" href="#"><i class="material-icons">chevron_right</i></a>', prevArrow: '<a class="slick-prev" href="#"><i class="material-icons">chevron_left</i></a>', slidesToScroll: 1, responsive: [ { breakpoint: 1024, settings: { slidesToShow: 1, slidesToScroll: 1, } }, { breakpoint: 600, settings: { slidesToShow: 1, slidesToScroll: 1, } }, { breakpoint: 480, settings: { slidesToShow: 1, slidesToScroll: 1, } } ] }); $('.multiple-items').show(); $(document).on('click', '.reviewReportSelector', function(e) { let path = $(this).attr('data-path'); handleReviews(path, $(this)); }); $(document).on('click', '.viewReviewReports', function(e) { let versionOne = $('#versionTab_1'); if (!versionOne.hasClass('activeTab')) { let path = $(this).attr('data-path'); handleReviews(path, versionOne); } location.href = "#reviewReports"; }); $(document).on('click', '.reviewersResponse, .authorResponse', function(e) { let version = $(this).attr('data-version'); let targetVersion = $('#versionTab_' + version); if (!targetVersion.hasClass('activeTab')) { let path = targetVersion.attr('data-path'); handleReviews(path, targetVersion); } location.href = $(this).attr('data-link'); }); $(document).on('click', '.tab', function (e) { e.preventDefault(); $('.tab').removeClass('activeTab'); $(this).addClass('activeTab') $('.tab').each(function() { $(this).closest('.tab-title').removeClass('active'); }); $(this).closest('.tab-title').addClass('active') }); }); function handleReviews(path, target) { $.ajax({ url: path, context: this, success: function (data) { $('.activeTab').removeClass('activeTab'); target.addClass('activeTab'); $('#reviewSection').html(data.view); }, error: function (xhr, ajaxOptions, thrownError) { console.log(xhr.status); console.log(thrownError); } }); } </script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/affix.js?v1?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/storage.js?e9b262d3a3476d25?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/jquery-scrollspy.js?09cbaec0dbb35a67?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/magnific-popup.js?4a09c18460afb26c?1732706938"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/underscore.js?f893e294cde60c24?1732706938"></script> <script type="text/javascript"> $('document').ready(function(){ $("#left-column").addClass("show-for-large-up"); $("#middle-column").removeClass("medium-9").removeClass("left-bordered").addClass("medium-12"); $(window).on('resize scroll', function() { /* if ($('.button--drop-down').isInViewport($(".top-bar").outerHeight())) { */ if ($('.button--drop-down').isInViewport()) { $("#js-button-download").hide(); } else { $("#js-button-download").show(); } }); }); $(document).on('DOMNodeInserted', function(e) { var element = $(e.target); if (element.hasClass('menu') && element.hasClass('html-nav') ) { element.addClass("side-menu-ul"); } }); </script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/articles.js?5118449d9ad8913a?1732706938"></script> <script> repositionOpenSideBar = function() { $('#left-column').addClass("show-for-large-up show-for-medium-up").show(); $('#middle-column').removeClass('large-12').removeClass('medium-12'); $('#middle-column').addClass('large-9'); } repositionCloseSideBar = function() { $('#left-column').removeClass("show-for-large-up show-for-medium-up").hide(); $('#middle-column').removeClass('large-9'); $('#middle-column').addClass('large-12').addClass('medium-12'); } </script>   <script type="text/plain" data-cookieconsent="marketing"> !function(e,t,n,s,u,a){e.twq||(s=e.twq=function(){s.exe?s.exe.apply(s,arguments):s.queue.push(arguments); },s.version='1.1',s.queue=[],u=t.createElement(n),u.async=!0,u.src='//static.ads-twitter.com/uwt.js', a=t.getElementsByTagName(n)[0],a.parentNode.insertBefore(u,a))}(window,document,'script'); // Insert Twitter Pixel ID and Standard Event data below twq('init','o2pip'); twq('track','PageView'); </script>  <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'8e92ff388d513ded',t:'MTczMjcxOTcyMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html>

CINXE.COM

A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer